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ABSTRACT	
Satellite	 cells	 are	 progenitor	 cells	 that	 persist	 in	 adult	 muscle	 in	 a	 quiescent	 state.	 Upon	 injury,	
growth	or	hypertrophy,	satellite	cells	become	activated,	proliferate	and	differentiate	into	myoblasts.	
Hepatocyte	 growth	 factor	 (HGF)	 induces	 activation	 of	 quiescent	 satellite	 cells	 in	 vivo.	 Also,	 HGF	
binding	to	its	receptor,	c-Met,	leads	eventually	to	transcription	of	key	myogenic	genes	namely	Myf-5	
and	 MyoD.	 Satellite	 cells’	 responses	 to	 HGF	 are	 varied	 and	 time	 and	 concentration	 dependent	
effects	 on	 satellite	 cell	 fate	 have	 been	 reported,	 although	 published	 results	 are	 inconsistent.	
Previous	 studies	 have	 not	 standardised	 initial	 conditions	 prior	 to	 interventions,	 thus	 complicating	
comparison	and	conclusions.	Finally,	recent	evidence	implicates	microRNAs	(miRs)	as	active	players	
maintaining	 quiescence	 in	 various	 cells,	 but	 HGF	 effects	 on	 miRNA	 expression	 are	 unknown	 in	
quiescent	or	activated	satellite	cells.	
The	 overarching	 aim	was	 to	 determine	 the	 time	 and	 concentration	 dependent	 effects	 of	 HGF	 on	
quiescent	 satellite	 cells	 by	 analysing	 key	 myogenic	 gene	 and	 miRNA	 expression	 after	 first	
standardising	 myoblast	 characteristics.	 Primary	 human	 myoblasts	 (PHM)	 explanted	 from	 human	
muscle	biopsies	were	 cultured	 in	 a	 serum	 free	media,	 supplemented	with	 synthetic	 growth	 factor	
free	 serum	 (KOSR),	 for	 10	 days	 to	 induce	 quiescence.	 Multicolour	 flow	 cytometry	 and	 cell	 cycle	
analyses	were	performed	to	characterise	the	PHMs	maintained	in	serum	free	culture	with	regard	to	
undifferentiated	 and	quiescent	 status.	 Intervention	with	 rh-HGF	 included	4	 conditions:	 2	 different	
concentrations	and	2	different	durations.	The	myogenic	 regulatory	 factors,	Myf-5	and	MyoD	were	
analysed	using	Western	blotting,	while	their	mRNA	expression,	along	with	miR-31	expression,	were	
analysed	using	qPCR.	
Effects	 of	 10	 d	 culture	 in	 quiescence	 media:	 PHMs	 maintained	 viability	 and	 undifferentiated	
morphology.	Flow	cytometry	analyses	of	satellite	cell	markers	indicated	that	98%	of	PHMs	remained	
positive	for	CD34	confirming	their	undifferentiated	state.	Activation	and	proliferation	markers	CD56	
and	Ki-67,	decreased	 from	26%	 to	2%	and	 from	85%	 to	46%	 respectively.	While	Myf-5	expression	
remained	 constant	 (~98%)	 for	 this	 period,	MyoD	 expression	 dropped	 from	 20%	 to	 9%.	 Cell	 cycle	
progression	was	 reduced:	 The	 percentage	 of	 G1-phase	 cells	 increased	 from	 58%	 to	 87%,	while	 S-
phase	cells	dropped	from	42%	to	10%.	
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Effects	of	treating	quiescent	PHMs	with	rh-HGF:	Treatment	lead	to	significant	(p<0.0001)	time	(24	h	
and	 48	 h)	 and	 concentration	 (2	 ng/mL	 and	 10	 ng/mL)	 dependent	 increases	 in	 endogenous	 HGF	
protein.	c-Met	receptor	content	increased	significantly	(p<0.01)	only	with	exposure	to	high	dose	HGF	
(10	 ng/mL)	 within	 24	 h.	 Although	MyoD	mRNA	 expression	 decreased	 (~2	 to	 3-fold)	 with	 all	 HGF	
conditions,	 MyoD	 protein	 decreased	 only	 after	 48	 h	 in	 low	 HGF	 (2	 ng/mL)	 compared	 to	 other	
treatment	 groups	 and	 untreated	 control.	 Myf-5	 mRNA	 expression	 decreased	 moderately	 (up	 to	
~0.5-fold)	 in	 all	 HGF	 conditions,	 but	Myf-5	 protein	 decreased	 only	 with	 high	 dose	 HGF	 (slightly).	
Finally,	 miR-31	 expression	 decreased	 upon	 HGF	 treatment,	 although	 not	 consistently	 for	 all	 HGF	
conditions.	 This	 thesis	 confirmed	 time	and	 concentration	dependent	effects	of	HGF	on	myoblasts.	
More	specifically,	diverse	effects	on	MyoD	and	Myf-5	were	not	abolished	here	when	satellite	cells	
were	 first	 rendered	 quiescent.	 HGF	 affected	 miR-31,	 thus	 elucidating	 a	 new	 mechanism	 for	
influencing	myoblasts.	
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OPSOMMING	
Satellietselle	 is	 voorvader	 stamselle	wat	 in	 ‘n	onaktiewe	 toestand	 in	volwasse	 spiere	gevind	word.	
Met	 besering,	 groei	 of	 hipertrofie,	 word	 satellietselle	 geaktiveer,	 waarna	 hulle	 vermenigvuldig	 en	
differensiëer	 na	 mioblaste.	 Hepatosiet	 groeifaktor	 (HGF)	 ontlok	 aktivering	 van	 onaktiewe	
satellietselle	 in	 vivo.	 Ook	 sal	 HGF	 binding	 aan	 sy	 reseptor,	 c-Met,	 transkripsie	 van	 belangrike	
miogeniese	gene,	naamlik	Myf-5	en	MyoD,	bemiddel.	Satellietselle	toon	egter	verskillende	reaksies	
teenoor	HGF,	wat	tyd-	en	konsentrasie-afhanklik	is,	maar	resultate	in	verskeie	gepubliseerde	studies	
toon	dat	satellietsel	noodlot	nie	noodwendig	konsekwent	is	nie.	Aangesien	eksperimentale	kondisies	
egter	nie	gestandardiseer	was	voor	supplementering	nie,	is	inter-studie	vergelykings	gekompliseerd.	
MikroRNSe	(miRs)	speel	ook	‘n	aktiewe	rol	 in	handhawing	van	verskeie	selsoorte	as	onaktief,	maar	
dit	 is	 nog	 onbekend	 of	 HGF	 miR	 uitdrukking	 onaktiewe	 of	 onlangs	 geaktiveerde	 satellietselle	
beïnvloed.	
Die	hoofdoel	was	om	die	tyd-	en	konsentrasie-afhanklike	gevolge	van	HGF	op	gevestigde	onaktiewe	
satellietselle	 te	 bestudeer	 deur	 die	 ontleding	 van	 die	 belangrikste	miogeniese	 gene	 en	moontlike	
gepaardgaande	miR-	uitdrukking.	Primêre	menslike	mioblaste	(PHM)	afkomstig	ban	spierbiopsies	 is	
vir	10	dae	gekweek	in	serum-vrye	medium,	aangevul	met	sintetiese	groeifaktor-vrye	serum	(KOSR),	
om	 onaktiwiteit	 teweeg	 te	 bring.	 Multikleurvloeisitometrie	 en	 selsiklusanalise	 is	 uitgevoer	 om	
karakteristieke	van	PHM	te	ontleed	m.b.t.		ongedifferensiëerdheid	en	die	toestand	van	onaktiwiteit.	
Supplementering	 van	 PHM	 met	 rh-HGF	 het	 onder	 4	 kondisies	 plaasgevind:	 twee	 verskillende	
konsentrasies	 en	 twee	 verskillende	 tydsperiodes.	 Die	 miogeniese	 regulerende	 faktore	 Myf-5	 en	
MyoD	 is	 daarna	 ontleed	 met	 behulp	 van	 die	 immunoklad-tegniek,	 terwyl	 hul	 mRNS	 en	 miR-31	
uitdrukking,	met	kwantitatiewe	PKR	ontleed	is.	
Effek	van	10	dae	in	serum-vrye	kultuur:	 lewensvatbaarheid	en	‘n	ongedifferensiëerde	morfologie	is	
gehandhaaf	 in	 PHM,	 selsiklus	 progressie	 is	 terselfdertyd	 onderdruk.	 Vloeisitometriese	 analise	 het	
bewys	dat	98%	van	PHM	deurgaans	positief	was	vir	CD34	wat	ongedifferensiëerdheid	kwantitatief	
bevestig.	Merkers	van	aktivering	en	vermeerdering,	CD56	en	Ki-67,	het	gedaal	van	26%	tot	2%,	en	
van	 85%	 tot	 45%	 respektiewelik.	 Alhoewel	Myf-5	 uitdrukking	 konstant	 gebly	 het	 oor	 die	 tydperk	
(~98%),	 het	MyoD	 uitdrukking	 gedaal	 van	 20%	 tot	 9%.	 Selsiklus:	 die	 persentasie	 G1-fase	 selle	 het	
toegeneem	van	58%	na	87%,	terwyl	die	persentasie	S-fase	selle	gedaal	het	van	42%	tot	10%.		
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Effek	 van	 rh-HGF	 toediening:	 HGF	 het	 gelei	 tot	 beduidende	 (p<0.0001)	 stygings	 in	 endogene	HGF	
proteine	wat	 beide	 tyd	 (24	 uur	 en	 48	 uur)	 en	 konsentrasie	 (2	 ng/mL	 of	 10	 ng/mL)	 afhanklik	was.	
Reseptorvlakke	van	c-Met	het	aansienlik	toegeneem	(p<0.01)	na	24	uur	behandeling	met	hoë	dosis	
HGF.	Alhoewel	MyoD	mRNS	twee-tot	drievoudig	verminder	het	onder	alle	HGF	kondisies,	het	MyoD	
protein	slegs	ná	48	uur	behandeling	met	die	lae	HGF	dosis	gedaal.	Dalings	in	Myf-5	mRNS	was	matig	
(tot	~0.5-voudig)	met	lae	en	hoë	HGF,	maar	Myf-5	protein	het	slegs	met	hoë	dosis	HGF	toediening	
gedaal.	Laastens	het	miR-31	uitdrukking	afgeneem	met	HGF	toediening,	ofskoon	hierdie	bevinding	in	
party	 HGF	 kondiesies	 egter	 onbeslis	 was.	 Hierdie	 tesis	 beam	 tyd-	 en	 konsentrasie-afhanklike	
uitwerkings	 van	HGF	 op	mioblaste.	Meer	 spesifiek,	 diwerse	 uitwerkings	 op	MyoD	 en	Myf-5	 is	 nie	
deur	eersgaande	sinkronisasie	van	die	onaktiewe	staat	verwyder	nie.	HGF	beinvloed	miR-31,	dus	is	‘n	
nuwe	meganisme	vir	effekte	op	mioblaste	onthul.	
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CHAPTER	1	
INTRODUCTION	
Skeletal	muscle	satellite	cells	are	uni-potent	stem	cells	present	 in	adult	 skeletal	muscle	and	play	a	
key	role	in	muscle	growth	and	regeneration.	These	cells	are	the	precursors	to	myocytes,	which	fuse	
together	 to	 form	 multinucleated	 myofibres	 surrounded	 by	 the	 sarcolemma	 that	 is	 in	 turn	
surrounded	by	a	basement	membrane.	Even	though	satellite	cells	were	first	discovered	more	than	
50	years	ago,	the	underlying	molecular	mechanisms	that	regulate	their	activation,	self-renewal	and	
entry	 into	 the	myogenic	 programme	 is	 still	 not	 fully	 understood.	 Elucidating	 these	 key	molecular	
mechanisms	 regulating	 satellite	 cell	 function	 can	 provide	 novel	 insights	 into	 skeletal	 muscle	
regeneration	in	adults.		
This	chapter	will	focus	on	the	physiological	importance	of	satellite	cells	and	discuss	their	regulation.	
The	key	molecular	role	players	that	govern	the	transition	of	satellite	cells	from	a	quiescent	 into	an	
activated	 state,	 as	 well	 as	 the	 signaling	 mechanisms	 that	 regulate	 satellite	 cell	 activation	 and	
proliferation,	will	be	discussed.	Although	numerous	growth	factors	are	known	to	affect	satellite	cell	
activity,	 the	 specific	 focus	 of	 the	 research	 project	 in	 this	 thesis	was	 on	Hepatocyte	 growth	 factor	
(HGF)	and	its	role	in	stimulating	quiescent	satellite	cells	to	become	active,	to	re-enter	the	cell	cycle	
and	 to	 proliferate.	 This	 chapter	 will	 therefore	 also	 discuss	 the	 binding	 of	 HGF	 to	 its	 cell	 surface	
receptor,	c-Met,	and	the	subsequent	signaling	that	occurs	through	the	MAPK/ERK	pathway	resulting	
in	satellite	cell	activation.	Furthermore,	the	literature	highlighting	potential	time	and	concentration	
dependent	 effects	 of	 HGF	 signaling	 thought	 to	 govern	 differential	 satellite	 cell	 behaviours	will	 be	
discussed.	 Finally,	 the	 role	 of	 microRNAs	 (miRNAs)	 in	 maintaining	 satellite	 cell	 quiescence	 is	
considered	and	how	they	may	‘prime’	satellite	cells	to	re-enter	the	cell	cycle	more	efficiently.	
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1.1 THE	MUSCLE	SATELLITE	CELL	
1.1.1 THE	DISCOVERY	OF	SATELLITE	CELLS:	A	BRIEF	HISTORY	
Research	 on	 skeletal	 muscle	 growth	 and	 repair	 dates	 back	 to	 the	 early	 and	mid-19th	 century.	 As	
described	by	Scharner	and	Zammit	(2011),	embryonic	myogenesis,	muscle	degeneration	and	muscle	
regeneration	were	first	described	during	this	time	(Scharner	&	Zammit	2011).	It	would	take	another	
century	for	the	key	player	in	muscle	regeneration,	the	muscle	stem	cell,	to	be	discovered	and	for	its	
role	 to	 be	 elucidated.	 Skeletal	 muscle	 stem	 cells	 were	 discovered	 by	 two	 independent	 groups	 in	
1961	(Katz	1961;	Mauro	1961)	and	were	called	‘satellite	cells’	by	Mauro,	based	on	their	peripheral	
position	on	the	muscle	fibre.	Satellite	cells	were	described	to	be	 located	on	the	muscle	fibre	 itself,	
nestled	 in	 between	 the	 plasma	 membrane	 (sarcolemma)	 and	 the	 basement	 membrane	 (basal	
lamina)	 (Mauro	 1961).	 These	 newly	 discovered	 cells	 had	 a	 unique	 morphology:	 large	 nuclear-to-
cytoplasm	ratio,	few	organelles	(see	Figure	1.1)	and	visibly	condensed	chromatin	during	interphase,	
which	are	 characteristic	of	mitotically	quiescent	 (G0	phase)	 cells	 (Schultz	et	al.	1978).	Due	 to	 their	
position,	Mauro	(1961)	immediately	hypothesized	that	satellite	cells	played	a	role	in	skeletal	muscle	
regeneration	 and	 post-natal	 skeletal	myogenesis.	 This	 hypothesis	was	 confirmed	 shortly	 after	 the	
discovery	of	satellite	cells	in	several	landmark	experiments.		
Until	 the	1960s,	only	myoblasts	were	known	to	have	mitotic	potential,	as	they	had	been	shown	to	
incorporate	tritiated	thymidine	during	in	vivo	muscle	regeneration	(Bintliff	&	Walker	1960)	and	also	
to	 fuse	and	 form	myotubes	 in	vitro	 (Capers	1960).	 In	1965,	however,	a	paper	by	Shafiq	&	Gorycki	
(1965)	 showed	 that	 following	 muscle	 damage,	 satellite	 cells	 were	 often	 seen	 in	 the	 peripheral	
regions	 of	 the	 damaged	 area	 indicating	 a	 wide-spread	 influence	 (Shafiq	 &	 Gorycki	 1965).	 In	 the	
following	year,	Church	et	al.	 (1966)	 showed	that	 the	satellite	cell	pool	 is	 replenished	after	a	crush	
injury.	 This	 was	 evident	 in	 the	 reappearance	 of	 satellite	 cells	 on	 newly	 synthesized	 myotubes	
(Church	 et	 al.	 1966),	 implying	 that	 satellite	 cells	 represented	 a	 pool	 of	 ‘reserve	 cells’.	 In	 1968,	
evidence	 that	quiescent	 satellite	 cells	 could	undergo	mitosis	was	provided	by	 Shafiq	et	al.	 (1968).	
The	 authors	 showed	 that	 satellite	 cells	 of	 3	 week	 old	 rats	 undergo	 mitosis	 after	 intraperitoneal	
injection	of	the	cytotoxic	agent,	colchicine	(Shafiq	et	al.	1968).	These	observations	were	confirmed	
by	Reznik	M.	(1969)	who	showed	that	satellite	cells	incorporated	tritiated	[3H]	thymidine	upon	cold	
injury	 of	 the	 gastrocnemius	 muscle	 in	 normal,	 adult,	 white	 mice	 (NIH,	 GP)	 (Reznik	 1969).	 The	
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observations	 produced	 in	 these	 studies	 proved	without	 doubt	 that	 satellite	 cells	 undergo	mitosis	
upon	muscle	 injury.	 In	further	support	of	this	notion,	muscle	biopsies	from	patients	suffering	from	
Duchenne	 muscular	 dystrophy	 (congenital	 and	 pathological	 condition	 associated	 with	 muscular	
degeneration)	were	shown	to	have	more	satellite	cells	in	proximity	of	the	damaged	and	regenerating	
muscle	 fibres.	Also	 these	satellite	cells	had	a	cytoplasmic	morphology	 traditionally	associated	with	
proliferating	 cells	 (Laguens	 1963;	 Shafiq	 et	 al.	 1967).	 Taken	 together,	 it	 became	 clear	 that	 the	
behaviours	exhibited	by	satellite	cells	 in	muscles	that	have	been	exposed	to	pathological	 injuries	 is	
similar	 to	 that	of	physically	 injured	muscles,	 suggesting	an	 inherent	pattern	of	behaviour.	The	 fact	
that	the	morphology	exhibited	by	these	satellite	cells	was	akin	to	that	of	foetal	myoblasts	gave	rise	
to	the	hypothesis	that	satellite	cells	may	be	the	precursor	cells	that	give	rise	to	myoblasts	 in	adult	
muscle.	Proof	that	satellite	cells	are	indeed	precursors	to	myoblasts	was	provided	in	1975	when	two	
separate	 in	 vitro	 studies	using	 isolated	 single	muscle	 fibres	harvested	 from	adult	 rats	and	 juvenile	
japanese	 quail,	 respectively,	 were	 published.	 Bischoff	 R.	 (Bischoff	 1975)	 and	 Konigsberg	 et	 al.	
(Konigsberg	et	al.	1975)	both	showed	that	satellite	cells	on	these	single	fibres	started	to	migrate	off	
the	 necrotic	 myofibre	 and	 then	 proliferated.	 These	 newly	 proliferating	 cells	 then	 fused	 to	 form	
multinucleated	myotubes.	These	landmark	studies	(Bischoff	1975;	Konigsberg	et	al.	1975)	confirmed	
that	 satellite	 cells	 are	 indeed	 the	 key	 role	 players	 in	 regeneration.	 The	 question	 still	 remained	
whether	or	not	satellite	cells	could	be	classified	as	true	stem	cells.	By	definition,	a	stem	cell,	whether	
it	 be	 embryonic	 or	 adult,	 must	 possess	 the	 ability	 to	 both	 replicate	 itself	 (self-renew)	 and	 to	
differentiate	(Lodish	&	Berk	2003).	By	the	1980’s,	the	notion	that	satellite	cells	were	responsible	for	
muscle	 regeneration	 and	 growth	was	 fundamentally	 established	 and	 accepted.	 However,	 the	 key	
aspect	that	was	still	not	fully	addressed	was	their	potential	for	self-renewal.	
In	 1970	 and	 1971,	 Moss	 and	 Leblond	 were	 the	 first	 to	 provide	 evidence	 in	 support	 of	 the	 self-
renewal	hypothesis.	 The	authors	 showed	 that	 tritiated	 thymidine	was	being	 incorporated	 into	 the	
satellite	cells	of	growing	 rats	and	 that	myonuclei	at	 similar	 time	points	began	 to	exhibit	 this	 label,	
implicating	satellite	cells	as	the	main	source	of	new	myonuclei.	The	gain	of	myonuclei	 through	the	
fusion	 of	 satellite	 cells	 to	 myofibres	 is	 key	 to	 maintain	 the	 nuclear	 domain	 during	 growth	 and	
hypertrophy	 (Moss	 &	 Leblond	 1970;	 Moss	 &	 Leblond	 1971).	 Also,	 and	 more	 importantly,	 it	 was	
estimated	that	after	each	division,	not	all	of	the	satellite	cell	progeny	gave	rise	to	myonuclei.	Moss	
and	Leblond’s	(1970,	1971)	observations	were	thus	two-fold:	firstly	they	demonstrated	that	certain	
divisions	gave	 rise	 to	a	myonucleus	and	a	daughter	 satellite	 cell	 (Moss	&	Leblond	1971),	 secondly	
their	finding	introduced	the	concept	of	asymmetric	cell	division.	Conclusive	evidence	to	the	issue	of	
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self-renewal	 in	 satellite	 cells	was	however	only	provided	 several	 years	 later,	 in	2005.	Collins	et	al.	
(2005)	 performed	 a	 single	myofibre	 transplantation	 assay,	 in	which	 various	 single	 skeletal	muscle	
myofibres	 were	 transplanted	 into	 irradiated	muscle	 of	mdx/nude	 mice	 incapable	 of	 regeneration	
due	to	prior	experimental	depletion	of	endogenous	satellite	cells	 (Collins	et	al.	2005).	The	authors	
observed	 that,	 upon	 transplantation,	 the	 few	 satellite	 cells	 present	 on	 the	 implanted	 myofibre	
generated	a	population	of	hundreds	of	satellite	cells	and	thousands	of	myonuclei.	Quantification	of	
cell	numbers	 indicated	 that	7-22	satellite	cells	proliferated	and,	upon	 fusion,	were	able	 to	provide	
~25,000-30,000	myonuclei,	while	at	the	same	time	replenishing	the	satellite	cell	population	(10-fold	
increase)	 (Collins	 et	 al.	 2005).	 Furthermore,	 the	 newly	 expanded	 satellite	 cell	 populations	 were	
proven	 to	 be	 fully	 functional,	 as	 they	 were	 capable	 of	 supporting	 several	 rounds	 of	 muscle	
regeneration	(Collins	et	al.	2005).	Further	evidence	supporting	the	finding	of	Collins	et	al.	(2005)	was	
provided	when	single	satellite	cells	were	transplanted	into	the	muscles	of	scid/mdx	irradiated	mice.	
The	progeny	generated	from	these	single	cells	not	only	differentiated	and	fused	into	myofibres,	but	
also	 remained	 in	 the	 host	 muscle	 (Sacco	 et	 al.	 2008).	 Taken	 together,	 these	 studies	 irrefutably	
proved	the	capability	of	satellite	cells	to	self-renew	and	generate	new	muscle	fibres.	However,	the	
factors	controlling	satellite	cells	had	not	been	elucidated	and	in	the	first	5	yars	of	the	decade	starting	
in	the	year	2000,	a	wave	of	research	 led	by	developmental	biologists,	began	this	arduous	task	and	
laid	down	a	substantial	platform	of	knowledge.		
Figure	1.1:	Graphical	representation	of	a	skeletal	muscle	fibre	and	its	peripheral	environment.	
In	an	in	vivo	environment	the	quiescent	satellite	cell	resides	on	the	muscle	fibre,	between	the	basal	lamina	and	
the	plasma	membrane	(sarcolemma)	of	the	muscle	fibre.	Image	modified	and	reproduced	without	permission	
from	(Bentzinger	et	al.	2012).	
Plasma	membrane	
(sarcolemma)	
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1.1.2 THE	EMBRYONIC	ORIGINS	OF	ADULT	SATELLITE	CELLS	
Adult	muscle	satellite	cells	are	derived	 from	mesodermal	precursor	cells,	which	originate	 from	the	
dermomyotome,	an	epithelial	structure	that	develops	on	the	dorsal	side	of	the	presomitic	paraxial	
mesoderm	(Gros	et	al.	2005;	Scaal	&	Christ	2004;	Schienda	et	al.	2006).	The	dermomyotome,	which	
can	 be	 distinguished	 between	 the	 epaxial	 and	 hypaxial	 region,	 gives	 rise	 to	 several	 multipotent	
mesodermal	 progenitor	 cells	 (Buckingham	 2006).	 The	 different	 fates	 of	 the	 cells	 present	 in	 the	
dermomyotome	are	highly	dependent	on	where	 they	are	 located	within	 it.	 This	 is	 due	 to	 the	 fact	
that	 these	 mesodermal	 progenitor	 cells	 are	 differentially	 exposed	 to	 potentiating	 and	 inhibiting	
signals	 from	 the	 surrounding	 tissues,	 specifically	 the	 notocord,	 neural	 tube,	 dorsal	 ectoderm	 and	
myotome.	 There	 they	 are	 influenced	 to	 generate	 different	 cell	 types	 and	 tissues	 (such	 as	 dermal	
fibroblasts,	 brown	 adipose	 tissue,	 endothelial	 cells,	 vascular	 smooth	 muscle	 and	 skeletal	 muscle)	
(Buckingham	2006).			
Embryonic	 muscle	 development	 occurs	 in	 two	 distinct	 phases:	 i)	 the	 formation	 of	 the	 primary	
myotome	(situated	beneath	the	demomyotome)	by	post-mitotic	mononucleated	myocytes	(Gros	et	
al.	2004;	Kalcheim	&	Ben-Yair	2005)	which	is	then	followed	by	ii)	the	formation	and	expansion	of	the	
myotome.	Importantly,	the	formation	and	expansion	of	the	myotome	(2nd	stage)	also	results	in	the	
creation	 of	 myogenic	 progenitor	 cells	 that	 contribute	 to	 initial	 myogenesis,	 but	 are	 not	 all	
incorporated	into	fibres.	During	this	stage	the	central	portion	of	the	dermomyotome	undergoes	an	
epithelial-to-mesenchymal	 transition	 and	multipotent	mesodermal	 progenitor	 cells	 present	 in	 the	
demomyotome	begin	 to	express	Paired	box	3	 (Pax3)	and	Paired	box	7	 (Pax7)	 transcription	 factors	
(Kassar-Duchossoy	et	al.	2005).	These	Pax3/Pax7	expressing	progenitor	cells	begin	to	migrate	from	
the	 central	 region	 of	 the	 dermomyotome	 to	 the	 previously	 formed	 primary	 myotome	 and	 then	
proliferate	enlarging	the	myotome	(Gros	et	al.	2005;	Kassar-Duchossoy	et	al.	2005;	Relaix	et	al.	2004;	
Relaix	et	al.	2005).	In	the	myotome	Pax3/Pax7-expressing	myogenic	progenitor	cells	form	a	pool	of	
proliferating	cells	with	 the	capacity	 to	differentiate	 into	myoblasts	and	ultimately	 fuse	 together	 to	
form	 myofibres.	 This	 is	 achieved	 through	 the	 expression	 of	 basic	 helix-loop-helix	 (bHLH)	 factors	
associated	 with	 the	 myogenic	 regulatory	 factor	 family	 (MRF)	 (Seale	 &	 Rudnicki	 2000;	 Otto	 et	 al.	
2009).	 Examples	 of	 such	 MRFs	 with	 bHLH	 motifs	 are	 MyoD	 and	 Myf-5.	 Of	 the	 proliferating	
Pax3/Pax7-expressing	myogenic	progenitor	cell	pool,	many	will	induce	MyoD	and	Myf-5	expression,	
associated	 with	 exit	 from	 the	 cell	 cycle.	 MyoD	 and	 Myf-5	 in	 turn	 regulate	 the	 transcription	 of	
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myogenin	and	myogenic	regulatory	factor-4	(MRF4),	causing	these	cells	to	differentiate	and	fuse	into	
myofibres	 (Sabourin	&	Rudnicki	 2000).	However,	 not	 all	 Pax3/Pax7-expressing	 cells	 present	 in	 the	
myotome	exit	the	cell	cycle	and	undergo	fusion.		
Some	 of	 the	 proliferating	 Pax3/Pax7-expressing	 myogenic	 progenitor	 cells	 endure	 into	 the	 late	
stages	of	etal	development	and	become	the	source	of	postnatal	adult	muscle	stem	cells	(Gros	et	al.	
2005;	 Relaix	 et	 al.	 2005).	 As	mentioned	 before,	 the	 postnatal	 adult	muscle	 stem	 cells	 reside	 in	 a	
specific	location	between	the	sarcolemma	and	basal	lamina	of	muscle	fibres	(Mauro	1961).	Ohlstein	
et	al.	(2004)	defines	such	a	specific	location	in	a	tissue	where	stem	cells	can	reside	for	an	indefinite	
period	of	time	as	the	‘stem	cell	niche’	(Ohlstein	et	al.	2004).	A	growing	body	of	evidence	 indicates	
that	the	muscle	satellite	cell	niche	is	incredibly	complex	and	highly	specific	to	ensure	the	survival	and	
maintenance	of	the	satellite	cell	pool	(Pinto	et	al.	2003;	Zhang	et	al.	2003;	Calvi	et	al.	2003;	Shen	et	
al.	2004;	Tumbar	et	al.	2004).	The	satellite	cell	niche	 is	 characterized	by	an	extensive	extracellular	
matrix	 (ECM)	with	 vascular	 and	 neural	 networks	 that	 facilitate	 cell-cell	 interactions	 and	 allow	 for	
autocrine	and	paracrine	molecular	communication	 (Dumont	et	al.	2015).	The	complex	 interactions	
governing	 the	 muscle	 satellite	 cell	 niche	 ensures	 tight	 regulation	 of	 satellite	 cell	 quiescence,	
activation,	 proliferation	 and	 self-renewal.	 The	 role	 that	 the	 niche	 plays	 in	 maintaining	 a	 balance	
between	satellite	cell	 self-renewal	and	differentiation	becomes	crucial	 in	 the	context	of	 injury	and	
muscle	 regeneration,	 since	 the	 proliferation	 and	 differentiation	 of	 all	 the	 satellite	 cells	 would	
ultimately	 deplete	 the	 satellite	 cell	 pool.	 However,	 if	 too	 few	 satellites	 become	 activated	 and	
differentiate,	 the	 outcome	 would	 be	 insufficient	 muscle	 regeneration.	 It	 has	 been	 shown	 that	
activated	 satellite	 cells	 have	 the	 ability	 to	 return	 to	 a	 quiescent	 state	 thus	 helping	 to	maintain	 or	
even	regenerate	the	satellite	cell	pool	(Zammit	et	al.	2004).	This	behaviour	in	adult	satellite	cells	 is	
thought	to	be	promoted	by	Pax7,	again	emphasizing	the	importance	of	the	embryonic	signals.	
1.1.3 SATELLITE	CELL	MAINTENANCE:	QUIESCENCE,	ACTIVATION	AND	SELF-RENEWAL	
In	 adult	 uninjured,	 fully	 grown	 and	 rested	 skeletal	 muscle,	 satellite	 cell	 quiescence	 would	 be	 an	
energetically	 inexpensive	state.	Nonetheless,	the	maintenance	of	satellite	cells	 in	a	quiescent	state	
(G0)	is	a	tightly	controlled	process.	
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1.1.3.1 Maintenance	of	quiescence	
Gene	expression	profiling	studies	utilizing	microarray	analysis	techniques	have	revealed	that	satellite	
cells	express	a	vast	array	of	genes	associated	with	the	regulation	of	quiescence	(Fukada	2011;	Liu	et	
al.	2013).	In	particular,	the	cell	cycle	inhibitors:	cyclin-dependent	kinase	inhibitors	p27kip1	and	p57kip2,	
the	 retinoblastoma	 protein	 (Rb)	 and	 Sprouty-1	 were	 highly	 expressed	 in	 satellite	 cells.	 These	
negative	 regulators	 of	 the	 cell	 cycle,	 together	 with	 other	 factors	 such	 as	 environmental	 cues	
(mechanical	interaction	with	ECM)	and	microRNAs	(miR-489,	and	miR-31),	all	function	in	concert	to	
maintain	satellite	cells	 in	a	quiescent	state	 (G0).	The	expression	of	 these	effectors	 is	 stimulated	by	
upstream	signaling	pathways.	
The	mechanisms	that	promote	satellite	cell	activation	or	that	disrupt/override	quiescence	signaling	
remain	unclear,	but	it	is	known	that	quiescent	satellite	cells	respond	to	a	plethora	of	niche	signals	in	
vivo	such	as	changes	 in	the	composition	and/or	structure	of	 the	ECM	(Boldrin	et	al.	2010)	and	the	
secretion	of	growth	factors	(Anderson	2006).	The	nature	of	their	response	is	influenced	by	the	type	
of	stimulus	or	injury	(e.g.	chemical,	ischemic,	and	traumatic)	(Baj	et	al.	2005).	
1.1.3.2 Activation	and	proliferation	
The	ECM	of	the	basal	lamina	is	primarily	composed	of	type	IV	collagen,	fibronectin,	entactin,	laminin,	
glycoproteins	 and	 proteoglycans	 (Sanes	 2003).	 This	 ECM	 is	 fundamental	 to	 the	 survival	 and	
regulation	of	 satellite	 cells	 as	 it	provides	both	 structural	 support	 and	harbours	 key	growth	 factors	
that	influence	satellite	cells	(Baj	et	al.	2005;	Anderson	2006;	Boldrin	et	al.	2010)	(refer	to	Section	1.2	
for	detailed	information	on	the	role	of	specific	growth	factors	in	regulating	satellite	cell	activity).		
The	physical	 interaction	between	the	ECM	and	satellite	cells	ensures	that	any	mechanical	stimulus	
originating	from	the	extracellular	compartment	 is	transduced	into	an	intracellular	signal	 in	satellite	
cells	 resulting	 in	 activation	 (Boppart	 et	 al.	 2006).	 This	 tethering	 is	 achieved	 by	 α7/β1-integrins	
present	on	the	satellite	cell	surface	that	anchor	it	to	the	basal	lamina	(Song	et	al.	1992;	Boppart	et	al.	
2006).	 Also,	 present	 in	 the	 ECM	are	 numerous	 growth	 factors	 of	 critical	 importance	 to	 regulating	
satellite	 cells.	 These	 molecules	 are	 generally	 inactive	 precursors	 and	 are	 bound	 to	 cell	 surface	
proteoglycans	 present	 on	 satellite	 cells.	 As	 soon	 as	mechanical	 disruption	 of	 the	 ECM	 is	 incurred,	
proteolytic	enzymes	like	serine	proteases	and	matrix	metalloproteinases	(MMP)	can	be	triggered	to	
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release	these	inactive	growth	factors,	which	in	turn	become	free	to	bind	to	their	target	receptors	on	
satellite	cells.	One	such	growth	factor	in	vivo	is	HGF.	
The	predominant	growth	factor	known	to	induce	dormant	satellite	cells	to	exit	quiescence	and	enter	
the	cell	cycle	is	HGF.	The	biological	effects	elicited	by	HGF	are	brought	about	via	signaling	through	its	
tyrosine	kinase	receptor,	c-Met,	which	is	able	to	activate	several	downstream	effector	pathways	that	
have	pleiotropic	effects	influencing	key	processes	of	proliferation,	differentiation,	migration	and	cell	
survival	(Miyazawa	et	al.	1994;	Boros	&	Miller	1995;	Zarnegar	&	Michalopoulos	1995;	Matsumoto	&	
Nakamura	1997).		
HGF/c-Met	signaling,	activates	several	downstream	effector	pathways	intrinsic	to	receptor	tyrosine	
kinase	(RTK)	signaling.	In	the	context	of	activation	and	subsequent	proliferation	of	satellite	cells,	HGF	
induces	the	activation	of	the	mitogen-activated	protein	kinase/extracellular	signal-regulated	kinases	
(MAPK/ERK)	 pathway.	 A	 study	 using	 cultured	 chicken	 skeletal	 muscle	 satellite	 cells	 showed	 that	
MAPK/ERK	activation	was	mediated	by	Grb2’s	association	with	the	phosphorylated	multifunctional	
docking	 site	 on	 c-Met’s	 carboxy	 terminal	 domain	 (Leshem	 et	 al.	 2002).	 Furthemore,	 in	 the	 same	
study,	 activation	 of	 the	MAPK/ERK	pathway	was	 also	 shown	 to	 inhibit	 satellite	 cell	 differentiation	
(Leshem	et	 al.	 2002).	 This	 is	 achieved	 in	 a	 dual	manner:	 Firstly,	MAPK/ERK	 inhibits	 the	 activity	 of	
MRF/E-protein	complexes	required	for	myogenic	differentiation,	while	at	the	same	time	inducing	the	
expression	of	 Twist,	 an	 inhibitor	 of	MyoD	 (Gal-Levi	 et	 al.	 1998;	 Leshem	et	 al.	 2000;	 Leshem	et	 al.	
2002).	 Secondly,	 it	 inhibits	 the	 cell	 cycle	 inhibitor	 p27Kip1	 resulting	 in	 the	 accumulation	 of	 hyper-
phosphorylated	retinoblastoma	protein,	which	stimulates	increased	proliferation	and	entry	into	the	
S-phase	 of	 the	 cell	 cycle	 (Leshem	 et	 al.	 2000;	 Leshem	&	 Halevy	 2002).	 Thus	 HGF/c-Met	 signaling	
through	 the	 MAPK/ERK	 pathway,	 elicits	 a	 dual	 effect	 on	 satellite	 cells	 by	 promoting	 their	
proliferation	and	in	parallel	inhibiting	their	differentiation.		
In	 support	of	an	effect	of	HGF	on	MRFs,	exogenous	HGF	was	 shown	 to	 simultaneously	 induce	 the	
gene	 transcription	 of	 Myf-5	 (role	 in	 proliferation)	 and	 inhibit	 MyoD	 expression	 (role	 in	
differentiation)	 in	vitro	 (Yamane	et	al.	2004).	The	effects	attributed	to	HGF	 injected	 into	uninjured	
hindlimb	muscle	 in	 vivo	were	 confirmed	 by	 in	 vitro	 studies	 using	 satellite	 cells	 isolated	 from	 12-
month-old	male	Sprague-Dawley	rats.	Here	 inhibition	of	HGF	abrogated	all	of	the	biological	effects	
elicited	by	HGF	 in	vivo	(Tatsumi	et	al.	1998).	In	summary,	because	HGF	activates	quiescent	satellite	
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cells	and	increases	their	proliferation,	it	functions	mainly	in	the	initial	stages	of	muscle	regeneration	
(Tatsumi	et	al.	1998;	Miller,	Thaloor,	Matteson	&	Grace	K	Pavlath	2000).	
Following	 activation	 satellite	 cells	 re-enter	 the	 cell	 cycle	 and	 begin	 proliferating,	 essentially	
becoming	myoblasts.	However,	this	activation	isn’t	restricted	to	the	satellite	cells	in	the	immediate	
vicinity	 of	 the	 damaged	 area;	 distant	 satellite	 cells	 also	 become	 activated	 and	 migrate	 to	 the	
affected	area	(Schultz	et	al.	1985).	Satellite	cells	display	remarkable	mobility/migration	abilities;	they	
not	only	have	the	capacity	 to	migrate	across	a	particular	muscle	 fibre,	but	can	also	migrate	across	
the	 basal	 lamina	 and	 connective	 tissue	 to	 adjacent	 fibres	 (Watt	 et	 al.	 1987;	Hughes	&	Blau	 1990;	
Jockusch	&	Voigt	2003)	in	response	to	chemotactic	factors	such	as	HGF,	Transforming	growth	factor-
beta	 (TGF-β),	 Fibroblast	 growth	 factor-6	 (FGF-6)	 and	 Platelet-derived	 growth	 factor	 (PDGF)	
(Husmann	et	al.	1996;	Bischoff	1997;	Karalaki	et	al.	2009).		
The	activation	and	migration	of	satellite	cells	seems	to	be	accompanied	by	decreased	expression	of	
CD34,	a	cell	surface	glycoprotein	that	functions	as	a	cell-cell	adhesion	factor	(Alfaro	et	al.	2011).	This	
may	 facilitate	 not	 only	 the	migration	 but	 also	 proliferation	 of	 satellite	 cells	 (Alfaro	 et	 al.	 2011).	 It	
follows	 that	 proteins	 used	 to	 characterize	 satellite	 cells	 are	 themselves	 not	 stablely	 present.	
Nonetheless,	proliferating	myogenic	precursor	cells	are	characterized	by	the	expression	of	MRFs.		
The	first	MRFs	to	be	upregulated	are	Myf-5	and	MyoD.	Studies	using	myofibres	isolated	from	adult	
mice	showed	that	satellite	cells	expressed	either	Myf-5	or	MyoD	after	24	h	in	culture,	after	explant	
and	co-express	them	by	48	h	(Cornelison	&	Wold	1997;	Zammit	et	al.	2002).	This	 in	vitro	data	was	
supported	by	in	vivo	studies	using	mice	(CD1	outbred)	injected	intramuscularly	with	cardiotoxin	(10-5	
M) (Cooper	et	al.	1999)	This	selective	expression	of	these	two	MRFs	suggests	they	may	play	different
roles	in	guiding	myogenic	progenitor	cell	fates.	Studies	illustrating	the	crucial	role	of	MyoD	and	Myf-
5	 expression	 in	 myogenic	 differentiation	 and	 muscle	 regeneration	 have	 been	 extensively	
documented	(Megeney	et	al.	1996;	Sabourin	et	al.	1999;	Asakura	et	al.	2007;	Gayraud-Morel	et	al.	
2007).	MyoD−/−	mutant	mice	display	 significantly	 reduced	muscle	mass	and	muscle	 regeneration	 is	
impaired	 with	 evidence	 that	 myoblasts	 in	 the	 injured	 area	 fail	 to	 differentiate	 and	 fuse	 to	 form	
functional	myotubes	(Megeney	et	al.	1996).	In	contrast	it	appears	that	there	may	also	be	a	distinct	
subpopulation	 of	 ‘committed’	 satellite	 cells	 in	 normal	 uninjured	 muscle	 (Rantanen	 et	 al.	 1995).	
These	committed	cells	were	shown	to	already	express	MyoD,	desmin	and	myogenin	as	early	as	12	h	
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after	 contusion	 injury	 to	 the	 gastrocnemius	 or	 toxic	 injury	 to	 the	 soleus	 (compared	 to	 24	 h	 post	
injury,	 which	 is	 more	 usually	 observed),	 indicating	 these	 cells	 may	 be	 selected	 to	 differentiate	
without	 first	 proliferating	 (Rantanen	 et	 al.	 1995).	 Furthermore	 satellite	 cell	 proliferation	was	 only	
seen	24	h	after	injury	(Rantanen	et	al.	1995).	
MyoD	is	thus	critical	for	myogenic	precursor	cells	to	commit	to	differentiation	(Sabourin	et	al.	1999).	
Furthermore,	when	cultured	in	myogenic	differentiation	media,	MyoD−/−	myoblasts	exhibit	sustained	
proliferation	(Megeney	et	al.	1996).	Conversely,	Myf5−/−	myoblasts	have	a	compromised	proliferative	
ability	 (Gayraud-Morel	 et	 al.	 2007).	 Therefore	 predominant	 MyoD	 expression	 induces	
differentiation,	 as	 can	 be	 seen	 in	 Myf5−/−	 myoblasts	 (Montarras	 et	 al.	 2000),	 while	 Myf-5	
predominance	 in	 MyoD−/−	 myoblasts	 is	 associated	 with	 enhanced	 proliferation	 and	 delayed	
differentiation	(Sabourin	et	al.	1999).	Research	therefore	unequivocably	points	towards	there	being	
distinct	roles	for	to	MyoD	and	Myf-5.		
These	distinct	roles	of	MyoD	and	Myf-5	individually	serve	to	establish	different	satellite	cell	fates	but	
cell	 fate	 might	 be	 dependent	 on	 the	 expression	 of	 these	 transcription	 factors	 in	 relation	 to	 one	
another	within	satellite	cells	(Rudnicki	et	al.	2008).	Satellite	cells	in	vivo	express	both	MyoD	and	Myf-
5	and	thus	show	intermediate	behaviours	when	compared	to	the	extremes	generated	in	KO	mouse	
models.	 In	 addition,	 satellite	 cell-derived	 C2C12	myoblasts	 from	 normal	mice	 express	 both	MyoD	
and	Myf-5	in	vitro.	It	has	been	shown	that	they	are	expressed	at	different	times	during	the	cell	cycle:	
MyoD	expression	is	at	its	highest	in	mid	G1,	while	Myf-5	expression	peaks	at	G0	and	G2	(Kitzmann	et	
al.	1998).	However,	in	an	in	vivo	environment	a	multitude	of	extrinsic	factors	can	disrupt	this	balance	
between	MyoD	and	Myf-5	expression	and	as	a	consequence	affect	the	cell	cycle	dynamics	of	satellite	
cells.	 As	 a	 result,	 it	 is	 essential	 to	 consider	 extrinsic	 mechanisms	 that	 play	 a	 role	 in	 satellite	 cell	
activation,	 proliferation	 and	 differentiation,	 as	 these	 ultimately	 ensure	 balanced	 and	 functional	
muscle	 regeneration	 and	 growth.	 These	 considerations	 are	 important	 both	when	 researching	 the	
molecular	responses	of	satellite	cells	 in	vitro	and	when	considering	satellite	cell-based	therapy	as	a	
potential	avenue	for	muscle	regeneration.	
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1.1.3.3 Return	to	quiescence	and	self-renewal	
Activated	primary	satellite	cells,	 isolated	 from	both	rat	and	mice	muscle,	 rapidly	upregulate	MyoD	
expression	within	the	first	24	h	in	in	vitro	culture	(Yablonka-Reuveni	et	al.	1999;	Zammit	et	al.	2004).	
After	 72	 h	 in	 culture	 media	 (DMEM	 and	 10%	 (v/v)	 horse	 serum),	 proliferating	 Pax7+/MyoD+	
myoblasts,	 may	 even	 start	 to	 differentiate	 by	 downregulating	 Pax7	 whilst	 starting	 to	 upregulate	
Myogenin	 expression,	 possibly	 as	 a	 result	 of	 increased	 confluency.	 However,	 a	 subpopulation	 of	
these	Pax7+/MyoD+	myoblasts	can	repress	MyoD	while	maintaining	Pax7	expression	and	eventually	
exit	 the	cell	 cycle	 (ie:	neither	 remaining	 in	proliferation	nor	 tending	 to	differentiate)	 (Halevy	et	al.	
2004;	 Zammit	 et	 al.	 2004).	 Other	 authors	 have	 also	 shown	 that	 after	 3-4	 weeks	 in	 culture	
Pax7+/MyoD−	 myoblasts	 begin	 to	 express	 Nestin,	 an	 intermediate	 fillament	 protein,	 typical	 of	
immature	 cells	 (Day	 et	 al.	 2007).	 Thus,	 it	 seems	 that	 MyoD	 expressing	 myoblasts	 which	 are	
considered	 to	be	 committed	 to	differentiation	 are	 able	 to	 regress	 and	 return	 to	 a	more	 stem-like	
state.	This	mechanism	of	satellite	cell	renewal	via	lineage	regression	from	Pax7+/MyoD+	myoblasts	is	
thought	 to	 be	promoted	by	 Pax7	 (Zammit	 et	 al.	 2004).	 This	 could	 be	 an	 important	mechanism	 to	
ensure	survival	of	 the	satellite	cell	pool,	as	 it	was	shown	that	 reduction	 in	 the	capacity	of	satellite	
cells	to	regenerate	the	satellite	cell	pool	correlated	with	decreased	number	of	satellite	cells	in	aged	
muscle	(Day	et	al.	2010).		
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Table	 1.1:	 Summary	 of	 key	 studies	 regarding	 the	 expression	 of	 MRFs	 and	 satellite	 cell	
proliferation,	differentiation,	quiescence	and	self-renewal.	
Authors	 Study	design	
(Model,	culture	type)	
Culture	period/	
Time	points	
Results	
Yablonka-
Ruveni	et	al.	
1999	
Balb/C	and	MyoD-/-	mice,	isolated	
single	muscle	fibre	cultures	and	
tissue-dissociated	satellite	cell	
cultures.	
0	-	9	days.	 MyoD-/-	satellite	cells	exhibit	
enhanced	proliferation	but	fail	to	
express	myogenin	and	differentiate	
compared	to	wildtype	satellite	cells	
from	Balb/C	mice.	
Zammit	et	al.	
2004	
Adult	wildtype	and	3F-nlacz-E	
transgenic	mice,	isolated	muscle	
fibre	cultures.	
0	h	-	120	h.	 Small	populations	of	proliferating	
Pax7+/MyoD+	myoblasts	begin	to	
loose	MyoD	expression	at	48	h	and	
72	h,	exit	the	cell	cycle	(96	-	120	h)	
and	do	not	differentiate.	
Halevy	et	al.	
2004	
9	day	post-hatch	chicken,	
dissociated	myoblast	cultures.	
0	-	15	days.	 Percentage	of	Pax7+/MyoD-	
myoblasts	increased	over	the	15	
days	culture	period,	resembling	a	
reserve	cell	phenotype.	
Pax7+/MyoD-	myoblasts	do	not	
express	myogenin	and	do	not	
differentiate.	
Day	et	al.	
2007	
Juvenile	(1-2	months)	and	adult	(4-
9	months)	NES-GFP	transgenic	mice	
(C57BL/6	background)	crossed	with	
Myf5nLacZ/+	mice	(enriched	Balb/C	
background),	single	myofibre	
cultures.	
4	weeks.	 NES/GFP	expression	declined	
following	satellite	cell	activation	but	
reacquired	after	3	weeks	in	
myogenic	cultures	by	non-
proliferating	Pax7+	progeny.	
The	ability	of	satellite	cells	to	return	to	quiescence	has	also	been	seen	 in	vivo	(Shea	et	al.	2010).	In	
mice	injured	with	barium	chloride	(1.2%),	post-injury	BrdU	labelling	showed	that	most	Pax7+	satellite	
cells	 in	 the	 TA/EDL	muscles	became	activated	 and	proliferated,	 but	 a	 small	 population	of	 satellite	
cells	 that	carried	the	BrdU	 label	were	shown	to	exit	 the	cell	cycle.	The	exit	of	 these	Pax7+	satellite	
cells	was	concomitant	with	upregulation	of	Sprouty-1	expression	 (Shea	et	al.	2010).	Sprouty-1	 is	a	
negative	regulator	of	receptor	tyrosine	kinase	(RTK)	signaling	and	has	been	shown	to	be	expressed	in	
quiescent	satellite	cells	(Shea	et	al.	2010).	In	a	second	experiment	inhibition	of	Sprouty-1	resulted	in	
significantly	 reduced	 numbers	 of	 remaining	 satellite	 cells	 after	 their	 activation	 and	 proliferation.	
Since	HGF	and	FGF	regulate	activation	and	proliferation	by	activating	the	ERK	pathway,	the	inhibitory	
effects	of	Sprouty-1	on	satellite	cells	is	most	likely	due	to	its	negative	regulation	of	the	ERK	signaling	
pathway.	However,	 it	was	shown	that	only	a	specific	subpopulation	of	these	satellite	cells	required	
Sprouty-1	expression	to	return	to	a	quiescent	state	(Shea	et	al.	2010).	Although	the	concept	behind	
the	 self-renewal	of	 satellite	 cells	 is	 relatively	well	 accepted,	 the	 complex	mechanistic	 regulation	 is	
still	unclear.		
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One	mechanism	 to	 ensure	 the	 survival	 of	 a	 satellite	 cell	 pool	 lies	 in	 how	 satellite	 cells	 replicate.	
There	 are	 essentially	 two	ways	 in	which	 stem	 cells	 can	 replicate	 and	 self-renew:	 symmetrical	 and	
asymmetrical	cell	division.	In	the	former	type	a	parental	cell	gives	rise	to	two	identical	daughter	cells	
with	 the	 same	characteristics	and	 stemness,	while	 the	 latter	produces	 two	daughter	 cells	 that	are	
functionally	 different:	 a	 more	 differentiated	 daughter	 cell	 that	 is	 not	 able	 to	 self-renew	 and	 a	
daughter	stem	cell	capable	of	both	differentiation	and	self-renewal.	Thus,	it	seems	as	though	there	
are	several	distinct	methods	 in	place	for	satellite	cells	 to	self-renew	and	replenish	the	satellite	cell	
pool.	
Kuang	 et	 al.	 (2007)	 investigated	whether	 satellite	 cells	 undergo	 symmetrical	 or	 asymmetrical	 cell	
division.	They	employed	a	Cre-LoxP	based	technique	(Myf5Cre;R26R-loxP-stop-loxP-YFP)	to	track	the	
lineage	of	 satellite	 cells	 and	were	 the	 first	 to	 show	 that	muscle	 satellite	 cells	 are	 able	 to	perform	
both	symmetric	and	asymmetric	cell	division	within	their	niche	(Kuang	et	al.	2007).	It	was	suggested	
that	the	orientation	of	the	mitotic	spindle	relative	to	the	longitude	axis	of	the	myofibre	dictates	the	
choice	between	symmetric	or	asymmetric	division	(Kuang	et	al.	2007).	Asymmetric	cell	division	was	
observed	 in	 Pax7+/Myf-5−	 cells	 when	 the	 mitotic	 spindle	 was	 orientated	 perpendicular	 to	 the	
myofibre	 axis,	 generating	 a	 daughter	 satellite	 cell	 (Pax7+/Myf-5−)	 and	 a	 daughter	 myogenic	 cell	
(Pax7+/Myf-5+).	The	more	stem-like	Pax7+/Myf-5−	daughter	cell	was	generated	on	the	basal	side,	 in	
contact	with	the	basal	lamina,	while	the	more	differentiated	Pax7+/Myf-5+	cell	was	generated	on	the	
apical	side,	next	to	the	plasma	membrane	(Kuang	et	al.	2007).	This	doesn’t	mean	that	Pax7+/Myf-5+	
cells	 and	 Pax7+/Myf-5−	 cells	 are	 not	 both	 capable	 of	 further	 symmetric	 cell	 division,	 but	 that	
symmetric	division	was	 limited	to	situations	when	the	mitotic	spindle	was	parallel	 to	the	myofibre	
axis,	causing	both	daughter	cells	to	be	in	contact	with	the	basal	 lamina	and	the	plasma	membrane	
equally.	Further	experimentation	revealed	that	only	the	Pax7+/Myf-5−	were	able	to	reconstitute	the	
satellite	 cell	 compartment	 (approximately	 7-fold	 more	 efficiently	 than	 Pax7+/Myf-5+),	 when	
transplanted	into	Pax7−/−	muscles	(Kuang	et	al.	2007).		
In	 an	 in	 vivo	 environment	 satellite	 cells	 are	 exposed	 to	 a	 variety	 of	 factors	 that	 may	 regulate	
mechanisms	for	satellite	cell	self-renewal.	Under	normal	physiological	conditions	satellite	cells	may	
favour	asymmetric	self-renewal,	as	this	would	be	sufficient	to	maintain	muscle	homeostasis	and	the	
parent	 pool,	 but	 then	 switch	 to	 symmetric	 proliferation	 in	 response	 to	 injury	 to	 provide	 the	
necessary	amount	of	cells	needed	for	functional	regeneration	(Morrison	&	Kimble	2006).	
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In	 summary,	 a	 fundamental	 aspect	 of	 satellite	 cells	 is	 their	 ability	 to	 self-renew,	 and	 it	 seems	 as	
though	satellite	cells	that	don’t	express	Myf-5	(Pax7+/Myf-5−)	are	far	more	capable	at	self	renewing	
and	 generating	 undifferentiated	 satellite	 cells.	 Thus	 Pax7+/Myf-5−	 represent	 a	 bona	 fide	 stem	 cell	
population	while	Pax7+/Myf-5+	 represent	a	population	of	more	differentiation-prone	satellite	cells.	
However,	Myf-5’s	primary	role	was	earlier	shown	to	induce	proliferation,	as	MyoD−/−	myoblasts	elicit	
enhanced	 proliferation	 and	 delayed	 differentiation	 (Sabourin	 et	 al.	 1999).	 Therefore	 it	 seems	 as	
though	 satellite	 cells	 exist	 as	 a	 heterogeneous	 population	 of	 precursors.	 This	 raises	 the	 question	
whether	 all	 these	 precursors	 will	 respond	 similarly	 to	 external	 factors	 such	 as	 a	 rapid	 change	 in	
growth	 factors,	or	 if	 the	responses	of	satellite	cells	 to	such	 factors	needs	 to	be	qualified	based	on	
pre-exposure	characteristics.	
1.1.4 IDENTIFICATION	AND	HETEROGENEITY	OF	SATELLITE	CELLS	
The	 understanding	 that	 the	 adult	muscle	 satellite	 cell	 population	 is	 so	 heterogeneous	 has	 gained	
more	and	more	ground	in	recent	years.	Up	until	20	years	ago,	satellite	cells	were	simply	classified	as	
a	 homogeneous	 population	 of	 uni-potent	muscle	 progenitors	 (Bischoff	 &	 Heintz	 1994).	Mounting	
evidence	suggests	otherwise	and	it	seems	as	though	satellite	cell	subpopulations	can	differ	in	gene	
expression	signatures	and	myogenic	proliferation	propensity.	
1.1.4.1 Heterogeneity	of	gene	expression	signatures	
Cells	that	express	the	key	myogenic	genes,	Pax3	and	Pax7	are	able	to	transcribe	genes	important	for	
myogenesis	 and	 are	 thus	 considered	 to	 be	 muscle	 precursor	 cells.	 Studies	 using	 transgenic	 mice	
carrying	reporter	genes	for	Pax7	and	Pax3	showed	that	only	a	subset	of	Pax7+	satellite	cells	express	
Pax3	 (Montarras	 et	 al.	 2005;	 Relaix	 et	 al.	 2006),	 potentially	 implying	 that	 only	 Pax7,	 its	 close	
homologue,	 is	 critical	 for	 the	 activation	 of	 the	 downstream	myogenic	 programme	and	 is	 thus	 the	
most	specific	marker	 for	satellite	cells.	This	was	confirmed	 in	a	study,	where	FACS-isolated	muscle	
satellite	cells	(CD45−/CD11b−/CD31−/Sca-1−/α7-integrin+/CD34+)	were	analysed	for	Pax7,	Pax3,	Myf-5	
and	MyoD	expression	using	qPCR.	The	authors	reported	that	only	Pax7	was	expressed	in	all	isolated	
cells,	while	 Pax3	 expression	was	 variable	 and	 only	 25%	 of	 the	 cells	 expressed	MyoD	 (Sacco	 et	 al.	
2008).	 In	 vivo,	 satellite	 cells	 also	 display	 heterogeneity	 e.g.	 in	 Dlk-1,	 c-Met	 and	 Neuronal	 cell	
adhesion	 molecule	 (NCAM/CD56)	 (Lindström	 et	 al.	 2010),	 while	 immunofluorescence	 staining	
revealed	 that	 a	 subpopulation	 of	 satellite	 cells	 don’t	 express	 CD34,	 M-cadherin	 and	 Myf-5	
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(Beauchamp	et	al.	2000).	Further	contributing	to	the	idea	that	different	populations	of	satellite	cells	
display	 heterogeneous	 gene	 expression,	 two	 studies	 have	 shown	 that	 cranial	 muscle	 exhibits	
distinctly	different	molecular	signatures	to	that	of	somatic	muscle	(present	in	the	thorax,	abdomen	
and	limbs)	(Schmalbruch	1976;	Harel	et	al.	2009).		
1.1.4.2 Heterogeneity	in	myogenic	proliferation	propensity	
A	 study	 where	 continuous	 BrdU	 administration	 was	 used	 to	 label	 proliferating	 satellite	 cells,	 in	
growing	 rats	 soleus	 and	 EDL	 muscles,	 revealed	 that	 that	 only	 80%	 of	 the	 satellite	 cells	 readily	
entered	the	cell	cycle	while	the	other	20%	of	satellite	cells	entered	the	cell	cycle	at	a	much	slower	
rate	 (Schultz	 1996).	 Further	 research	 is	 however	 needed	 to	 ascertain	 whether	 these	 differing	
satellite	 cell	 populations	 were	 co-localized	 or	 exposed	 to	 different	 signaling	 factors	 within	 their	
immediate	environment,	since	differential	exposure	to	signaling	factors	may	affect	the	mitotic	rate.	
Nonetheless,	Schultz	E.	(1996)	hypothesized	that	the	slow,	less	responsive	satellite	cells	represented	
a	 ‘reserve	 population’	 that	 remain	 in	 a	 quiescent	 state,	 and	 only	 proliferate	 if	 extensive	 muscle	
regeneration	 is	 required	 (Schultz	 1996).	 In	 line	 with	 this	 hypothesis,	 a	 recent	 study	 in	 which	
fluorescent	PKH26	was	used	to	trace	cell	divisions	showed	that	 long-term	self-renewal	abilities	are	
retained	 in	 slow-dividing	 satellite	 cells	 (Ono	 et	 al.	 2012).	 Satellite	 cells	 seem	 to	 also	 display	
heterogeneity	with	regards	to	their	differentiation	potential.	Satellite	cells	from	transplanted	tibialis	
anterior	(TA)	muscle	grafts	were	shown	to	contribute	significantly	less	to	the	number	of	regenerated	
myofibres	in	mdx/nude	mice,	when	compared	to	satellite	cells	grafted	from	the	extensor	digitorum	
longus	 (EDL)	or	soleus	muscle	 (Beauchamp	et	al.	2000).	Taken	together	these	studies	highlight	the	
possibility	 that	 different	 populations	 of	 satellite	 cells	 might	 vary	 in	 their	 proliferation	 and	
differentiation	potential.	
In	 a	 subsequent	 study,	 Kuang	 et	 al.	 (2007)	 utilized	 reporter	 gene	 mice	 and	 showed	 that	 13%	 of	
quiescent	satellite	cells	on	the	EDL	muscles,	isolated	from	Myf5-nLacZ	mice,	were	LacZ−,	suggesting	a	
less	 committed	 cell	 fate	 (Kuang	 et	 al.	 2007).	 In	 addition,	 using	 the	 Cre-LoxP	 system,	 the	 authors	
demonstrated	 that	 10%	 of	 satellite	 cells	 in	Myf5Cre;	 ROSA26R-YFP	mice	 did	 not	 express	 YFP.	 The	
implications	of	this	finding	were	two-fold:	Firstly,	it	signified	that	the	small	subpopulation	of	satellite	
cells	 had	 never	 expressed	 Myf-5	 and	 secondly	 that	 these	 Pax7+/YFP−	 satellite	 cells	 might	 have	 a	
distinct	regenerative	potential.	When	transplanted	into	regenerating	muscles	of	Pax7−/−	mice,	these	
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Pax7+/YFP−	 cells	 showed	 a	 profound	 ability	 to	 repair	 the	 muscle	 and	 reconstituted	 the	 stem	 cell	
niche,	while	the	Pax7+/YFP+	cells	immediately	differentiated.		
It’s	thus	clear	that	satellite	cells	are	not	a	homogeneous	population	of	muscle	progenitor	cells,	 like	
once	 thought,	 but	 rather	 exist	 as	 incredibly	 heterogeneous	 populations,	 with	 different	 gene	
expression	 patterns,	 differentiation	 potential	 and	 cell	 fates	 during	 postnatal	 muscle	 growth	 and	
regeneration.		
1.1.4.3 Satellite	cell	markers	
Even	 in	 adult	 muscle	 that	 has	 no	 pathology,	 has	 not	 been	 subjected	 to	 damage	 and	 is	 not	
undergoing	hypertrophy	i.e.	under	normal	physiological	conditions,	satellite	cells	express	a	plethora	
of	markers,	including	the	transcription	factors	Pax7	(Seale	et	al.	2000)	and	Pax3	(Relaix	et	al.	2006),	
the	cluster	of	differentiation	protein	CD34	(Beauchamp	et	al.	2000),	the	myogenic	regulatory	factors	
MyoD	(Zammit	et	al.	2004)	and	Myf-5	(Beauchamp	et	al.	2000),	the	receptor	tyrosine	kinase	c-Met	
(Allen	et	al.	1995;	Cornelison	&	Wold	1997;	Wozniak	et	al.	2003),	cell	adhesion	molecule	M-cadherin	
(Irintchev	 et	 al.	 1994),	 neural	 cell	 adhesion	 molecule	 (NCAM)	 (aka	 CD56)	 (Schubert	 et	 al.	 1989;	
Boldrin	 et	 al.	 2010),	 cell	 surface	 attachment	 receptor	 α7/β1-integrin	 	 (Burkin	 &	 Kaufman	 1999;	
Gnocchi	 et	 al.	 2009),	 myocyte	 nuclear	 factor	 (MNF)	 (Garry	 et	 al.	 1997),	 Syndecan-3	 and	 -4	
(Cornelison	et	al.	2001)	and	Sca-1	(Mitchell	et	al.	2005).	With	the	exception	of	Pax7,	none	of	these	
markers	 are	 exclusive	 to	 adult	 muscle	 satellite	 cells.	 Rather	 satellite	 cells	 in	 muscle	 samples	 are	
identified	according	to	anatomical	position,	nuclear	morphology	in	addition	to	one	or	more	markers.	
However	once	 satellite	 cells	have	been	 isolated	 from	 their	muscle	 niche	and	are	 cultured	 in	 vitro,	
analysis	 of	 specific	marker	 expression	 is	 the	 primary	way	 to	 ascertain	 their	 identity.	 Furthermore	
analysing	 the	 expression	 of	 specific	 markers	 can	 also	 be	 used	 to	 assess	 the	 activation	 status	 of	
satellite	cells	and	 to	 identify	 the	presence	of	 specific	 subpopulations.	Refer	 to	Table	1.2	below	for	
detailed	information	on	the	major	satellite	cell	markers	and	when	they	are	known	to	be	expressed.	
It’s	important	to	note	that	satellite	cells	exhibit	heterogeneity	with	regards	to	marker	expression	as	
their	expression	in	satellite	cells	 is	a	dynamic	process.	Gain-of-function	and	loss-of-function	studies	
performed	by	Mitchell	et	al.	(2005)	showed	that	Sca-1	had	a	functional	role	 in	regulating	myoblast	
proliferation	and	differentiation,	and	that	Sca-1	expression	was	not	static	but	rather	dynamic	in	their	
primary	mouse	myoblast	 cell	 cultures	 (Mitchell	 et	 al.	 2005).	 Experiments	 using	 primary	 cells	 from	
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Sca-1/GFP	transgenic	mice	showed	that	when	GFP+-	and	GFP--sorted	cells	were	mixed	in	culture,	GFP	
expression	was	modulated	 both	 positively	 and	 negatively	 (Mitchell	 et	 al.	 2005).	 Before	 co-culture	
GFP+	 cells	were	 infected	with	 a	 β-galactosidase	 (β-gal)	 expressing	 retrovirus,	while	GFP-	 cells	were	
infected	with	 a	 control	 retrovirus.	 After	 48	 h	 of	 co-culture,	 GFP-/β-gal+	 and	 GFP+/β-gal-	 cells	 were	
present	in	the	culture.	In	contrast,	no	dynamic	modulation	of	GFP	expression	was	seen	under	clonal	
conditions	 (Mitchell	 et	 al.	 2005).	 The	mechanisms	underlying	 the	dynamic	expression	of	 Sca-1	are	
currently	unknown,	however	 it’s	clear	that	changes	 in	Sca-1	were	highly	dependent	on	the	growth	
conditions	 (Mitchell	et	al.	2005).	Mitchell	et	al.	 (2005)	thus	provided	evidence	toward	the	concept	
that	satellite	cell	heterogeneity	can	be	modulated	by	the	microenvironment.		
In	conclusion	because	any	intervention	in	vitro	could	cause	satellite	cells	to	alter	their	properties	and	
make	them	more	or	 less	similar	with	regards	to	marker	expression,	 it	 is	crucial	 to	 identify	satellite	
cells	 as	 accurately	 as	 possible,	 prior	 to	 intervention	 (e.g.	 addition	 of	 a	 growth	 factor)	 in	 order	 to	
determine	their	‘baseline’	characteristics.	
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Table	1.2:	Summary	of	key	markers	of	satellite	cells.	
Satellite	
cell	marker	
Biological	
function	
Satellite	cell	
state	
expression	
Marker	
localization	
Expression	in	other	cell	
types	 Refrences	
MNF	
TF:	myogenic	
cell	
differentiation	
Q,	A	 Nucleus	
Myonuclei	in	
regenerating	fibers,	
myocytes,brain	and	
kidney	
(Garry	et	al.	1997)	
NCAM	
(CD56)	
GP:	Cell-cell	
adhesion	 A	
Cell	
Membrane	
Myoblasts,	myotubes,	
lymphocytes,	NK	cells,	
dendritic	cells,	neurons,	
glia	
(Schubert	et	al.	1989;	
Boldrin	et	al.	2010)	
CD34	 GP:	Cell-cell	adhesion	 Q,	A	
Cell	
Membrane	
Hematopoietic	stem	
and	progenitor	cells	 (Beauchamp	et	al.	2000)	
c-Met	 R:	Signaling	 Q,	A	 Cell	Membrane	
pericytes,	neural	crest	
lineage	
(Allen	et	al.	1995;	
Cornelison	&	Wold	1997;	
Wozniak	et	al.	2003)	
M-cadherin	 GP:	Cell-cell	adhesion	 Q,	A	
Cell	
Membrane	
Granular	cells	of	the	
cerebellum	and	brain	 (Irintchev	et	al.	1994)	
β1-integrin	 R:	Signaling	 Q,	A	 Cell	Membrane	 widely	expressed	
(Burkin	&	Kaufman	1999;	
Boppart	et	al.	2006)	
α7-integrin	 R:	Signaling	 Q,	A	 Cell	Membrane	
Fibers,	neurons,	
vasculature	and	
nervous	system	
(Burkin	&	Kaufman	1999;	
Boppart	et	al.	2006)	
Syndecan-3	 Co-R:	Signaling	 Q,	A	 Cell	Membrane	
Macrophages,	
leukocytes,	
chondorcytes,	uterine	
tissue,	ovarian	cancer	
(Cornelison	et	al.	2001)	
Syndecan-4	 Co-R:	Signaling	 Q,	A	 Cell	Membrane	
Macrophages,	
leukocytes,	mammary	
cells,	breast	cancer	
(Cornelison	et	al.	2001)	
Sca-1	
GP:	signaling	
(True	functions	
still	unclear)	
Q,	A	 Cell	Membrane	
Hematopoietic	stem	
cells	 (Mitchell	et	al.	2005)	
Footnote:	Table	1.2	depicts	the	most	notable	satellite	cell	markers,	 their	nature	and	known	functions,	when	
they	are	expressed	in/on	satellite	cells,	their	 localization	and	other	cell	types	that	are	also	known	to	express	
them.	TF	-	Transcription	Factor;	GP	-	Glycoprotein;	R	-	Receptor;	Co-R	-	Co-receptor.	Q	-	Quiescent	state;	A	-	
Activated	state.	Table	adapted	from	(Boldrin	et	al.	2010).	
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1.2 	GROWTH	FACTORS	IN	SATELLITE	CELL	REGULATION	
As	 mentioned	 before,	 upon	 mechanical	 disruption	 of	 the	 ECM,	 proteolytic	 enzymes	 like	 serine	
proteases	 and	 matrix	 metalloproteinases	 (MMPs)	 trigger	 the	 release	 of	 inactive	 growth	 factors,	
which	can	then	induce	chemotaxis,	proliferation	and	differentiation	of	satellite	cells.	Macrophages,	
which	 invade	 and	 phagocytose	 areas	 where	 tissue	 damage	 is	 present	 upon	 injury,	 also	 release	
growth	 factors	 such	 as,	 Fibroblast	 growth	 factor	 (FGF)	 and	 Insulin-like	 growth	 factor	 (IGF)	 and	
cytokines	such	as	Interleukin-6	(IL-6)	which	elicit	mitogenic	effects	on	satellite	cells	(Tidball	&	Villalta	
2010;	Kharraz	et	al.	2013;	Saclier	et	al.	2013).	Also,	even	resident	supporting	cells	such	as	fibroblasts	
and	 vascular	 endothelial	 cells	 of	 damaged	blood	 vessels,	 can	 release	 factors	 that	 support	 satellite	
cell	proliferation	(Ceafalan	et	al.	2014).	
The	 released/activated	growth	 factors	 in	 turn	bind	 to	 their	 respective	 receptors	on	 the	 surface	of	
satellite	cells	 in	order	to	regulate	satellite	cell	activity.	This	section	will	discuss	the	role	of	some	of	
the	most	 prominent	 growth	 factors	 known	 to	 affect	 satellite	 cell	 activation	 and	will	 highlight	 the	
superiority	of	HGF	signaling	in	inducing	satellite	cells	to	exit	quiescence.		
1.2.1 FIBROBLAST	GROWTH	FACTOR	(FGF)	
Fibroblast	 growth	 factors	 (FGFs)	 are	 a	 large	 family	 of	 related	 growth	 factors	 that	 function	 as	
powerful	 mitogens,	 and	 signal	 through	 the	 MAPK/ERK	 pathway.	 FGFs	 are	 secreted	 in	 high	
concentrations	 by	 satellite	 cells,	 in	 an	 autocrine	 fashion	 (Hannon	 et	 al.	 1996),	 and	 fibroblasts	 in	
response	to	in	vivo	skeletal	muscle	damage.	FGF	signaling	is	mediated	through	binding	to	one	of	four	
transmembrane	 tyrosine	 kinases	 FGF	 receptors	 (FGFR)	 (FGFR1-4)	 with	 differential	 ligand	 binding	
specificity.	 In	 satellite	 cells	 FGFR-1	 and	 -4	 are	 the	 predominant	 isoforms	 expressed	 and	 are	
upregulated	 during	 muscle	 regeneration	 (Floss	 et	 al.	 1997).	 However,	 they	 have	 been	 shown	 to	
induce	opposite	effects:	in	an	 in	vitro	cell	culture	study,	constitutive	expression	of	a	full-length	FGF	
receptor-1	and	transient	transfection	of	a	truncated,	non-functional	form	showed	that	this	receptor	
regulated	satellite	cell	proliferation	(Scata	et	al.	1999),	whereas	qPCR	analysis	of	in	vitro	satellite	cell	
cultures	 showed	 that	 FGFR-4	 is	 highly	 expressed	 in	 differentiating	 satellite	 cells	 and	 myofibres	
(Kästner	 et	 al.	 2000).	 FGF	 signaling	 and	 the	 influence	 that	 it	 has	 on	 satellite	 cell	 function	 is	 thus	
dependent	on	 the	 specific	 ligand.	 FGF-1,	 -2,	 -4	 and	 -6	are	 known	 to	greatly	 stimulate	 satellite	 cell	
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proliferation	 in	 vitro	 (Sheehan	 &	 Allen	 1999;	 Kästner	 et	 al.	 2000),	 whilst	 only	 FGF-1	 and	 -2	 were	
shown	 to	 also	 inhibit	 satellite	 cell	 differentiation.	 In	 vivo,	 FGF-6,	which	 is	 expressed	 specifically	 in	
muscle	(deLapeyrière	et	al.	1993),	plays	a	crucial	role	during	regeneration.	This	is	evident	in	a	study	
done	 by	 Floss	 et	 al.	 (1997),	 which	 demonstrated	 that	 FGF-6−/−	 mutant	 mice	 displayed	 reduced	
proportions	of	MyoD−	and	myogenin-expressing	cells	9	days	after	a	single	freeze-crush	injury	(Floss	
et	 al.	 1997).	 In	 addition,	 morphological	 alterations	 and	 changes	 to	 the	 adhesion	 properties	 of	
satellite	cells	were	evident	in	the	FGF-6−/−	mutant	mice	(Floss	et	al.	1997).			
1.2.2 INSULIN-LIKE	GROWTH	FACTOR	(IGF)	
Insulin-like	growth	factor	is	produced	primarily	in	the	liver	in	adult	mammals	and	has	two	isoforms	
that	work	 in	 a	 paracrine	 fashion:	 IGF-I	 and	 IGF-II	 are	 released	 and	bind	 to	 distant	 cells	 and	 signal	
through	 the	 IGF-I	 receptor	 (IGF-1R).	 However	 during	 growth	 and	 regeneration	 other	 cells	 may	
synthesize	IGF	isoforms	that	act	in	an	autocrine	fashion.	Both	these	isoforms	participate	in	satellite	
cell	 regulation	 through	 promotion	 of	 cellular	 proliferation	 and	 differentiation,	 however	 the	 time	
frames	for	their	expression	during	muscle	regeneration	is	different	(IGF-I	expression	precedes	that	of	
IGF-II)	(Hayashi	et	al.	2000).	IGF-I	is	known	to	stimulate	both	proliferation	and	differentiation	(Allen	
&	Boxhorn	1989),	whereas	IGF-II	only	induces	the	latter	and	its	expression	is	heightened	just	before	
differentiation	 (Florini	et	al.	1996).	The	effect	 that	 IGF-I	has	on	satellite	cell	proliferation	has	been	
attributed	 to	 the	 direct	 stimulation	 of	 Cyclin-D	 expression	 (Bark	 et	 al.	 1998),	 whereas	 its	
downstream	 effects	 on	 myogenin	 gene	 expression	 promotes	 differentiation	 (Florini	 et	 al.	 1991).	
Both	 isoforms	 are	 critical	 to	 myoblast	 differentiation	 as	 is	 evident	 in	 in	 vitro	 siRNA	 knock-down	
experiments,	 indicating	compromised	differentiation	 in	the	absence	of	either	 IGF-I	or	 IGF-II	 (Florini	
et	al.	1996).	
1.2.3 INTERLEUKIN-6	(IL-6)	
Interleukin-6	 (IL-6)	 is	 a	multifunctional	 cytokine	with	 very	 powerful	 inflammatory	 properties,	 as	 it	
plays	a	central	role	 in	the	acute-phase	response	(Geiger	et	al.	1988;	Gauglitz	et	al.	2008).	 It’s	been	
shown	to	be	released	by	a	range	of	cells	including,	neutrophils,	macrophages,	fibroblasts,	myofibers	
and	satellite	cells	(Kurek	et	al.	1996;	Gallucci	et	al.	1998;	Tidball	&	Villalta	2010;	Kharraz	et	al.	2013;	
Saclier	et	al.	2013).	Due	to	the	fact	that	IL-6	has	been	observed	to	promote	satellite	cell	proliferation	
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in	 response	 to	 injury	 (Cantini	&	Carraro	1995),	 our	 group	 (Dr.	 P	 Steyn,	Unpublished)	 (Steyn	2015)	
investigated	the	effects	of	IL-6	on	satellite	cells	and	the	molecular	mechanisms	underlying	IL-6‘s	pro-
proliferative	effects.	These	experiments	showed	that	IL-6	is	a	very	powerful	mitogen,	with	the	ability	
to	markedly	 increase	satellite	cell	proliferation.	However,	 the	effects	elicited	by	 IL-6	seemed	to	be	
dose	dependent,	with	low	concentrations	of	IL-6	(10	pg/mL)	actively	maintaining	satellite	cells	in	the	
cell	cycle.	In	contrast,	a	1000-fold	increase	in	IL-6	concentrations	(10	ng/mL)	promoted	satellite	cell	
cell-cycle	exit	and	differentiation.	These	dose-dependent	dual	effects	of	 IL-6	on	satellite	cells	were	
shown	 to	 be	 due	 to	 differential	 activation	 of	 the	 Janus	 Kinase/Signal	 Transducer	 and	 Activator	 of	
Transcription/Suppressor	 Of	 Cytokine	 Signaling	 (JAK/STAT/SOCS)	 pathway.	 Low	 IL-6	 levels	 caused	
preferential	activation	of	JAK1/STAT3,	which	lead	to	increased	proliferation,	as	its	signaling	induced	
hyper-phosphorylation	 of	 the	 retinoblastoma	 protein	 (Rb),	 a	 powerful	 stimulator	 of	 cell	 cycle	
progression.	 The	 high	 dose	 instead	 favoured	 cell	 cycle	 exit	 and	 differentiation	 by	 preferentially	
signaling	 through	 the	 JAK2/STAT2	 pathway,	 which	 in	 turn	 induced	 increased	 MyoD	 expression.	
MyoD	 negatively	 regulates	 retinoblastoma,	 by	 preventing	 its	 hyper-phosphorylation	 (Steyn	 2015).	
These	results	support	the	pro-proliferative	effects	of	IL-6	on	satellite	cells	that	have	been	reported	in	
the	literature	and	provide	evidence	into	the	molecular	mechanisms	that	underpin	them.	
All	the	growth	factors	listed	thus	far	only	affect	the	proliferation	and	differentiation	of	satellite	cells.	
None	 of	 them	 are	 known	 to	 perform	 the	 first	 key	 aspect	 of	 muscle	 regeneration	 which	 is	 the	
activation	of	 dormant	 satellite	 cells.	 To	date	only	one	 growth	 factor	 is	 known	 to	have	 this	 ability:	
hepatocyte	growth	factor	(HGF).	
1.2.4 HEPATOCYTE	GROWTH	FACTOR	(HGF)	
HGF	(aka	Scatter	factor	or	Hepatopoietin-A)	is	a	growth	factor	that	was	first	identified	in	1984,	when	
it	was	 shown	 to	 stimulate	 the	 growth	 of	 hepatocytes	 in	 damaged	 rat	 livers	 (Michalopoulos	 et	 al.	
1984).	HGF	has	since	been	detected	in	several	tissues	and	organs	and	is	thought	to	be	produced	by	
cells	with	mesenchymal	 origins	 (Zarnegar	&	Michalopoulos	 1995),	 particularly	 fibroblasts,	 in	 liver,	
lung,	epithelial	and	brain	tissue	(Stoker	1989;	Hamanoue	et	al.	1996;	Matsumoto	&	Nakamura	1997).	
This	 growth	 factor	 elicits	 pleiotropic	 effects,	 ranging	 from	 cell	 proliferation,	 differentiation	 and	
migration	 and	 is	 critical	 during	 embryogenesis	 for	 normal	 organ	 development	 (Sonnenberg	 et	 al.	
1993;	Santos	et	al.	1994;	Schmidt	et	al.	1995;	Maina	et	al.	1996;	Takayama	et	al.	1996;	Birchmeier	&	
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Gherardi	1998).	In	addition	to	being	required	for	organogenesis,	it	is	now	known	that	the	biological	
effects	 of	 HGF	 in	 adult	 tissues	 range	 from	 stimulating	 cell	 proliferation,	 cell	 survival,	 motility,	
angiogenesis	and	morphogenesis	(Miyazawa	et	al.	1994;	Zarnegar	&	Michalopoulos	1995).	The	vast	
array	of	cellular	processes	HGF	is	known	to	induce	in	different	tissues	and	cell	types,	is	also	seen	in	
adult	skeletal	muscle	and	more	specifically	with	satellite	cells.	In	skeletal	muscle,	HGF	can	stimulate	
satellite	cell	proliferation	(Miller,	Thaloor,	Matteson	&	Grace	K	Pavlath	2000),	induce	differentiation	
(Miller,	Thaloor,	Matteson	&	Grace	K	Pavlath	2000),	aid	in	their	migration	and	is	a	powerful	mitogen	
(Miller,	 Thaloor,	Matteson	&	Grace	 K	 Pavlath	 2000).	 It	 therefore,	 along	with	 other	 known	 growth	
factors,	plays	a	central	role	in	all	stages	of	the	satellite	cell	life	cycle.	However,	within	the	context	of	
muscle	 regeneration	 following	 damage,	 HGF	 plays	 the	 most	 crucial	 role:	 satellite	 cell	 activation	
through	both	paracrine	and	autocrine	signaling	(Allen	et	al.	1995).	
1.2.4.1 The	structure	and	properties	of	HGF	
Although	 several	 isoforms	 of	HGF	 exist	 in	 humans,	 the	main	 isoform	 is	 synthesized	 from	 a	~6	 Kb	
mRNA	 transcript	 located	on	Chromosome	7	which	generates	an	83	kDa	protein	 (Seid	et	 al.	 1991).	
This	protein	is	then	secreted	as	an	inactive	single	chain	precursor	(pro-HGF)	and	stored	in	the	ECM,	
bound	 to	 heparan	 sulfate	 proteoglycans	 (HSPG)	 (Strain	 1993;	 Derksen	 et	 al.	 2002).	 Proteolytic	
cleavage	 of	 pro-HGF,	 by	 urokinase-type	 plasminogen	 activator	 (uPA)	 or	 HGF	 activator	 (HGFA)	
(Miyazawa	et	al.	1994;	Shimomura	et	al.	1995;	Miyazawa	2010),	generates	a	mature	and	active	α/β	
heterodimer,	with	a	69	kDa	alpha	subunit	 linked	to	a	34	kDa	beta	subunit	(Nakamura	et	al.	1989).	
The	alpha	subunit	is	comprised	of	an	N-terminal	hairpin	loop	(HL)	and	four	kringle	domains	(K1-K4),	
while	the	beta	subunit	contains	a	serine	protease-like	(SPH)	domain.	HGF	binds	with	high	affinity	to	
specific	transmembrane	receptors	and	induces	intracellular	signaling.		
To	 date	 sequences	 of	 6	 isoforms	 of	 HGF	 have	 been	 deposited	 on	 UniProtKB,	 of	 which	 only	 2	
alternatively	 spliced	 transcript	 variants	 are	 known	 to	 generate	 functional	 proteins:	 NK1	 and	 NK2	
(Chan	et	 al.	 1991;	Miyazawa	et	 al.	 1991;	Cioce	et	 al.	 1996).	 These	 isoforms	 represent	 functionally	
active	truncated	versions	of	the	full	HGF	protein,	which	compete	with	HGF	for	binding	to	its	receptor	
c-Met	 (discussed	 in	 Section	 1.2.4.3)	 (Lokker	&	Godowski	 1993;	 Cioce	 et	 al.	 1996;	 Jakubczak	 et	 al.	
1998).	 However,	 they	 differ	 from	 HGF	 in	 both	 their	 regulation	 and	 their	 biological	 and	 cellular	
activities	(Lokker	et	al.	1992).	
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1.2.4.2 Pro-HGF	vs.	mature	HGF	
Under	 normal	 physiological	 conditions	 pro-HGF	 is	 maintained	 sequestered	 in	 the	 ECM	 bound	 to	
HSPGs	due	to	 its	high	affinity	for	them	(Naldini	et	al.	1991).	The	pro-HGF	form	does	however	have	
low	affinity	 for	 c-Met	but	 is	unable	 to	 induce	any	 tyrosine	activity	 (Naldini	 et	 al.	 1992).	 Thus,	 two	
critical	steps	are	required	to	induce	receptor	activation:	a)	release	of	pro-HGF	from	HSPGs	and	b)	the	
conversion	of	pro-HGF	into	the	mature	and	active	heterodimer.		
Release	of	pro-HGF	from	HSPGs	
Matrix	metalloproteinases	 (MMPs)	 play	 a	 key	 role	 in	 ECM	degradation	 during	wound	healing	 and	
tissue	remodelling,	and	it	is	now	also	known	that	MMPs	mediate	HGF	release	from	HSPGs	(Yamada	
et	 al.	 2006).	 It	 has	been	 reported	previously	 that	nitric	oxide	 (NO)	mediates	 activation	of	 satellite	
cells	 after	 crush	 injury	 (Anderson	 2000),	 whilst	 mechanical	 stretching	 of	 quiescent	 satellite	 cells	
induced	their	activation	 in	vitro	(Tatsumi	et	al.	2001).	There	could	thus	be	a	link	between	chemical	
signaling	and	mechanical	perturbation	 in	 the	activation	of	 satellite	cells.	 Indeed,	 studies	geared	 to	
elucidate	this	possible	link	showed	that	mechanical	stretching	of	satellite	cells	in	vitro	induced	nitric	
oxide	synthase	(NOS)	activity	and	that	both	the	neuronal	(nNOS)	and	endothelial	(eNOS)	isoforms	of	
NOS	were	present	in	the	culture	medium	(Tatsumi	et	al.	2006).	Furthermore,	the	HGF	released	from	
mechanical	stretching	was	shown	to	be	NO-dependent	(Tatsumi	et	al.	2002).	 It	therefore	seems	as	
though	an	intimate	relationship	between	nitric	oxide	production	and	HGF	release	exists,	supporting	
the	notion	that	in	an	in	vivo	muscle	injury	scenario,	satellite	cell	activation	is	mediated	by	chemical	
signals	 and	 mechanical	 perturbation	 of	 the	 ECM.	 Anderson	 (2000)	 proposed	 a	 model	 for	 NO-
mediated	 HGF	 release	 following	 mechanical	 shearing	 of	 the	 muscle	 fibre	 (Anderson	 2000).	 This	
incomplete	model	has	been	 supported	by	 growing	evidence	 (Anderson	2000;	 Tatsumi	et	 al.	 2001;	
Tatsumi	 et	 al.	 2002;	 Tatsumi	 et	 al.	 2006).	 The	model	 hypothesises	 that	 insult	 to	 the	muscle	 fibre	
causes	mechanical	 shearing	 of	 the	myofibre	 and	 surrounding	 ECM,	which	 stimulates	 activation	 of	
nNOS,	 present	beneath	 the	 sarcolemma	of	 the	 skeletal	muscle	 fibres	 (Grozdanovic	&	Baumgarten	
1999).	Activation	of	nNOS	causes	a	massive	release	of	nitric	oxide	which	in	turn	mediates	the	release	
of	 pro-HGF	 from	 HSPGs.	 The	manner	 by	 which	 NO	mediates	 this	 is	 however	 unknown,	 although	
recent	 evidence	 suggests	 that	 MMPs	 are	 in	 fact	 involved	 in	 the	 NO-mediated	 release	 of	 HGF	
(Yamada	et	al.	2006).	MMP-2	was	subsequently	shown	to	be	produced	in	satellite	cells	treated	with	
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a	NO	donor	(sodium	nitroprusside),	which	resulted	in	HGF	release	into	the	culture	medium	(Yamada	
et	al.	2008).	NO-activated	MMP-2	may	thus	well	mediate	release	of	pro-HGF	from	HSPGs	in	vivo.	
Conversion	of	pro-HGF	into	the	mature	and	active	HGF	
Newly	released	pro-HGF,	 in	response	to	mechanical	perturbation	of	 the	ECM,	requires	subsequent	
proteolytic	 cleavage	 and	 conversion	 into	 its	 mature	 and	 active	 form:	 the	 α/β	 heterodimer.	 This	
conversion	 takes	 place	 in	 the	 ECM	 where	 a	 milieu	 of	 proteases,	 (comprising	 urokinase-type	
plasminogen	activator	 (uPA),	 tissue-type	plasminogen	activator	 (tPA),	blood	 coagulation	 factor	XII,	
factor	 XI,	 hepatocyte	 growth	 factor	 activator	 (HGFA),	 plasma	 kallikrein,	 matriptase	 and	 hepsin)	
convert	HGF	to	its	active	form	(Naldini	et	al.	1992;	Shimomura	et	al.	1995;	Lee	et	al.	2000;	Peek	et	al.	
2002;	 Kirchhofer	 et	 al.	 2005).	 Of	 note,	 urokinase-type	 plasminogen	 activator	 (uPA)	 proteolytically	
cleaves	 specific	 residues	 on	 pro-HGF	 (Naldini	 et	 al.	 1992),	 due	 to	 the	 proteolytic	 cleavage	 site	
present	on	HGF	being	identical	to	that	found	on	plasminogen	(Miyazawa	et	al.	1989;	Miyazawa	et	al.	
1994).	Similarly	to	HGF,	uPA	is	present	in	the	ECM	in	an	inactive	form,	and	needs	to	be	enzymatically	
cleaved	to	 its	active	form,	which	 is	carried	out	by	serum	derived	proteases	(Naldini	et	al.	1992).	 In	
contrast,	 hepatocyte	 growth	 factor	 activator	 (HGFA)	 (a	 blood	 coagulation	 factor	 XII-like	 serine	
protease)	 (Miyazawa	 et	 al.	 1993;	Miyazawa	 et	 al.	 1998)	 is	 present	 both	 in	 serum	 and	 in	 plasma.	
However,	the	HGFA	present	in	serum	is	in	an	active	form,	while	the	one	found	in	plasma	is	found	in	
an	 inactive	 form,	 and	 requires	 proteolytic	 cleavage	 to	 become	 active	 (Shimomura	 et	 al.	 1993).	
Conversion	of	inactive	HGFA	into	its	mature	form	is	performed	by	thrombin	(Shimomura	et	al.	1993)	
thereby	linking	the	activation	of	HGFA	exclusively	to	injured	tissue	(Miyazawa	et	al.	1996).	It	is	thus	
clear	that	maturation	involves	an	intricate	series	of	events,	each	with	numerous	players	interacting	
with	each	other,	to	coordinate	the	release	of	pro-HGF	from	HSPGs	and	subsequently	convert	it	to	its	
mature	and	active	heterodimer,	able	to	bind	c-Met	with	high	affinity.	However,	HGF	does	not	only	
act	in	a	paracrine	fashion,	but	also	in	an	autocrine	manner,	with	satellite	cells	having	been	reported	
to	actively	synthesize	and	release	HGF	when	cultured	in	vitro	(Sheehan	et	al.	2000).		
HGF	mRNA	 is	 present	 in	 cultured	 satellite	 cells	 and	has	 been	 shown	 to	be	 translated	 into	protein	
(Sheehan	 et	 al.	 2000).	 Moreover,	 HGF	 protein	 has	 been	 detected	 in	 the	 conditioned	 media,	
signifying	that	satellite	cells	were	secreting	HGF.	Evidence	that	the	secreted	HGF	was	acting	on	the	
satellite	 cells	 to	 promote	 proliferation	 in	 an	 autocrine	 fashion,	 was	 confirmed	 by	 Sheehan	 et	 al.	
(2000),	who	used	the	addition	of	neutralizing	HGF	antibodies	and	showed	a	significant	reduction	in	
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satellite	 cell	 proliferation	 (Sheehan	 et	 al.	 2000).	 Taken	 together,	 these	 data	 indicate	 that	 satellite	
cells	 are	 able	 to	 synthesize	 and	 release	 the	 active	 form	 of	 HGF,	 which	 then	 acts	 as	 an	 autocrine	
signaling	 molecule	 to	 stimulate	 further	 satellite	 cell	 proliferation.	 The	 in	 vitro	 data	 suggests	 the	
source	 of	 mature	 HGF	 evident	 in	 an	 injured	 ECM	 environment,	 may	 not	 only	 be	 as	 a	 result	 of	
proteolytic	 cleavage	 of	 pro-HGF	 but	 could	 also	 be	 derived	 from	de	 novo	HGF	 production.	Mature	
HGF	 has	 also	 been	 extracted	 from	 the	 ECM	 of	 uninjured	 rat	 muscles	 (Tatsumi	 &	 Allen	 2004),	
suggesting	 that	 the	 active	 form	 of	 HGF	 is	 also	 present	 in	 the	 ECM	 in	 an	 uninjured	 in	 vivo	
environment.	It	therefore	seems	as	though	mature	HGF,	just	like	pro-HGF,	is	also	sequestered	in	the	
ECM	by	HSPGs	(Sheehan	et	al.	2000;	Tatsumi	&	Allen	2004).	The	biological	significance	for	this	is	still	
unclear,	however,	mature	HGF	displays	a	far	greater	affinity	for	c-Met	compared	to	HSPGs.		
1.2.4.3 The	HGF	receptors	
On	the	surface	of	satellite	cells	there	are	two	main	types	of	receptors	to	which	HGF	is	able	to	bind:	i)	
c-Met,	 a	 high-affinity	 receptor	 and	 ii)	 heparan	 sulphate	 proteoglycans	 (HSPGs)	which	 represent	 a	
group	of	low-affinity	ligand	biding	sites.		
c-Met	
c-Met,	is	a	heterodimeric	transmembrane	glycoprotein	composed	of	an	alpha	subunit	(50	kDa)	and	a	
larger	beta	subunit	(145	kDa),	which	are	linked	together	via	a	disulphide	bond	(Tempest	et	al.	1988;	
Giordano	et	al.	1989;	Komada	et	al.	1993).	The	alpha	subunit	 is	entirely	extracellular	and	together	
with	the	amino-terminal	region	of	the	beta	subunit,	forms	the	semaphorin	(Sema)	domain	(Stamos	
et	al.	2004).	The	extracellular	portion	of	the	beta	subunit,	however,	is	further	composed	of	a	plexin-
semaphorin-integrin	(PSI)	domain	(Kozlov	et	al.	2004)	and	four	immunoglobulin-plexin-transcription	
(IPT)	 domains	 (Bork	 et	 al.	 1999).	 The	 intracellular	 portion	 of	 the	 beta	 subunit	 is	 composed	 of	 a	
distinctive	 juxtamembrane	 sequence	 located	 just	 underneath	 the	 plasma	membrane	 and	 has	 two	
domains:	 i)	a	tyrosine	kinase	catalytic	domain	and	ii)	a	multifunctional	docking	site	domain,	on	the	
carboxy-terminal	region.	The	kinase	domain	is	central	to	c-Met	activity	as	once	it’s	phosphorylated,	
it	 induces	activation	of	the	receptor	while	the	two	flanking	domains	modulate	c-Met	signaling:	The	
juxtamembrane	 sequence	 negatively	 regulates	 c-Met	 signaling,	 while	 the	 multifunctional	 docking	
site	 is	 critical	 to	 the	 recruitment	 of	 signal	 transducers	 and	 adaptors	 required	 for	 c-Met	 signaling	
(Comoglio	et	al.	2008;	Trusolino	et	al.	2010).	
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Figure	1.2:	Domain	structure	of	c-Met	receptor.	
c-Met	is	composed	of	two	subunits:	the	α	chain,	which	is	entirely	extracellular	and	the	beta	chain.	The	alpha	
chain	together	with	the	amino-terminal	region	of	the	β-chain,	forms	the	semaphorin	(Sema)	domain.	Located	
on	the	extracellular	portion	of	the	beta	subunit	are	also	the	plexin-semaphorin-integrin	(PSI)	domain	and	four	
immunoglobulin-plexin-transcription	(IPT)	domains.	The	intracellular	portion	of	the	beta	subunit	is	composed	
of:	i)	a	distinctive	juxtamembrane	sequence	located	just	underneath	the	plasma	membrane	and	ii)	a	tyrosine	
kinase	catalytic	domain	and	a	multifunctional	docking	 site	domain.	 Image	modified	and	 reproduced	without	
permission	from	(Organ	&	Tsao	2011).	
Both	 the	 alpha	 and	 beta	 chains	 of	 HGF	 play	 key	 roles	 in	 c-Met	 binding	 and	 activation,	 and	 their	
cooperation	 is	necessary	 to	elicit	HGF’s	biological	activities.	HGF	 is	a	bivalent	 ligand,	as	 it	 contains	
both	high	and	low	affinity	binding	sites	for	c-Met:	The	high	affinity	binding	site	for	c-Met	is	present	
on	the	alpha	chain	of	HGF,	while	the	low	affinity	binding	site	is	present	on	the	beta	chain,	within	the	
SPH	 domain	 (Matsumoto	 et	 al.	 1998).	 In	 2008,	 Basilico	 et	 al.	 showed	 that	 it’s	 the	 IPT	 domain,	
specifically	IPT	3	and	4,	on	c-Met	that	binds	the	alpha	chain	of	HGF	with	high	affinity	(Basilico	et	al.	
2008),	 and	 that	 this	 interaction	provided	 the	necessary	binding	 strength	 to	 keep	HGF	bound	 to	 c-
Met.	 In	contrast,	 the	beta	chain	of	HGF	complexes	with	 the	Sema	domain	on	c-Met	but	 this	weak	
interaction	 is	required	for	correct	c-Met	activation,	rather	than	actual	binding	 (Stamos	et	al.	2004;	
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Matsumoto	et	al.	1998).	Indeed,	pro-HGF	is	able	to	bind	c-Met	with	high	affinity,	but	is	not	able	to	
induce	signaling	(Lokker	et	al.	1992),	due	to	the	fact	that	proteolytic	cleavage	of	pro-HGF	is	required	
to	expose	 the	 residues	on	 the	β-chain	of	HGF	 that	bind	 the	Sema	domain	 (Kirchhofer	et	 al.	 2004;	
Kirchhofer	et	al.	2007).	However,	the	interaction	of	the	α-chain	of	HGF	with	IPT3	and	4,	on	a	c-Met	
receptor	 lacking	a	Sema	domain,	 is	sufficient	to	activate	the	kinase	domain	(Basilico	et	al.	2008).	 It	
therefore	seems	as	though	the	interaction	between	β-HGF	and	the	Sema	domain	is	critical	for	c-Met	
to	distinguish	between	the	inactive	and	active	forms	of	HGF.	In	conclusion,	it’s	clear	that	there	is	a	
complex	 interaction	between	HGF	and	 c-Met:	 The	 IPT	domain	provides	a	 stable	anchorage	 site	 to	
which	the	α-chain	of	HGF	is	able	to	bind,	while	the	interaction	between	the	Sema	domain	and	the	β-
chain	of	HGF	confers	selective	sensitivity	to	mature	HGF.		
Heparan	sulphate	proteoglycans	
HSPGs	are	cell	 surface	molecules	 that	 can	 function	as	 secondary	 receptors	 for	a	variety	of	growth	
factors	(Casar	et	al.	2004;	Dreyfuss	et	al.	2009).	By	binding	to	them,	they	enhance	the	formation	of	
their	 receptor-signaling	 complexes,	 and	 play	 a	 role	 in	 their	 signaling	 (reviewed	 in	 Bernfield	 et	 al.	
1999).	
In	 the	case	of	HGF,	HSPGs	are	not	critical	 for	HGF/c-Met	signaling,	but	 function	as	 low	affinity	co-
receptors	that	interact	with	the	ligand-receptor	complex	to	enhance	signaling	(Zioncheck	et	al.	1995;	
Kemp	 et	 al.	 2006).	 There	 are	 several	 proposed	 theories	 as	 to	 how	 HSPGs	 can	 increase	 ligand-
receptor	signaling.	Firstly,	HSPGs	may	bind	the	ligand	and	help	present	it	to	its	high	affinity	receptor.	
However,	 high	 affinity	 receptors	 display	 binding	 constants	 10-	 to	 100-fold	 higher	 for	 their	 ligands	
compared	to	the	low	affinity	receptors,	ligands	will	thus	always	preferentially	bind	their	high	affinity	
receptors	(Schlessinger	et	al.	1995).	A	more	plausible	role	for	HSPG,	is	that	due	to	their	abundance	
on	 the	 cell	 surface,	 they	 may	 concentrate	 the	 ligand	 at	 the	 cell	 surface,	 thereby	 increasing	 the	
chances	of	HGF/c-Met	interactions	(Schlessinger	et	al.	1995;	Kemp	et	al.	2006).	Furthermore,	HSPGs	
seem	 to	 promote	 HGF	 oligomerization	 and	 stabilize	 the	 dimeric	 ligand,	 resulting	 in	 facilitated	
receptor	 dimerization	 and	 activation	 (Zioncheck	 et	 al.	 1995).	 Finally,	 HSPG-HGF	 interactions	 may	
potentiate	c-Met	signaling	as	 their	association	can	mediate	 the	 formation	of	a	 ternary	c-Met-HGF-
HSPG	 complex.	 This	 complex	 could	 result	 in	 bringing	 intracellular	 effectors	 of	 the	 c-Met	 signaling	
pathway	 in	closer	proximity,	 thereby	aiding	their	activation	(Derksen	et	al.	2002).	However,	HSPGs	
seem	critical	 for	 the	activity	of	 the	naturally	occurring	 isoforms	of	HGF,	NK1	and	NK2,	since	 in	 the	
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absence	of	HSPGs	in	vitro,	these	isoforms	are	shown	to	be	unable	to	bind	c-Met	(Schwall	et	al.	1996;	
Chirgadze	 et	 al.	 1999).	 Interactions	 between	 HSPGs	 and	 NK1,	 has	 been	 demonstrated	 to	 induce	
conformational	 changes	 to	 the	HGF	 splice	 variant,	 enabling	 it	 to	bind	 to	 c-Met	 (Schlessinger	et	 al.	
1995).	
The	interaction	between	HSPGs	and	growth	factors	bound	to	their	primary	receptors,	is	mediated	by	
the	heparan	sulphate	chains	 located	on	HSPG,	which	are	selectively	sulphated	at	specific	positions	
by	 Sulf1	 (Robertson	 et	 al.	 1992).	 The	 degree	 to	 which	 these	 heparan	 sulphate	 (HS)	 chains	 are	
sulphated,	 and	 at	 what	 positions,	 can	 therefore	 affect	 HPSG	 interactions	 with	 growth	 factors,	
ultimately	 impacting	 the	 receptor-ligand	 signaling	 (Bernfield	 et	 al.	 1999).	 A	 direct	 correlation	 has	
been	 found	 between	 increasing	 amounts	 of	 sulphated	 HSPGs	 and	 increased	 c-Met	 receptor	
phosphorylation	 (Zioncheck	 et	 al.	 1995),	 implicating	 that	 the	 amount	 of	 HSPG	 sulphation	 is	
important	 for	 efficient	 binding	 to	 HGF,	 and	 the	 higher	 degree	 of	 sulphation	 on	 HS	 chains,	 the	
stronger	the	interactions	are	between	HGF	and	HSPGs.		
1.2.4.4 HGF	signaling	
Once	 HGF	 binds	 to	 c-Met	 it	 induces	 receptor	 homodimerization	 and	 phosphorylation	 of	 two	
conserved	tyrosine	residues	within	the	catalytic	domain:	Y1234	and	Y1235	(Rodrigues	&	Park	1994).	
Their	phosphorylation	is	critical	for	intracellular	signaling	as	they	induce	phosphorylation	of	tyrosines	
1349	and	1356	which	 in	turn	are	located	in	the	multifunctional	docking	site	(Ponzetto	et	al.	1994).	
Phosphorylated	Y1349/1356	then	recruit	effectors	of	the	c-Met	signaling	pathways	(Birchmeier	et	al.	
2003;	 Trusolino	 et	 al.	 2010;	 Organ	 &	 Tsao	 2011),	 including	 e.g.	 the	 ERK	 pathway,	 the	
phosphoinositide	 3'-kinase/Akt	 (PI3K/Akt)	 (Leshem	 et	 al.	 2002;	 Halevy	 &	 Cantley	 2004),	 the	
p38/MAPK	(Wu	et	al.	2000)	and	the	JAK/STAT	(Jang	&	Baik	2013)	(refer	to	Figure	1.3).	Activation	of	
these	 intracellular	pathways	 results	 in	 the	expression	of	 key	myogenic	genes	which	guide	 satellite	
cell	activation	and	fate.	
HGF	 has	 a	 very	 powerful	 control	 over	 satellite	 cells,	 inducing	 their	 activation	 and	 proliferation	 in	
order	 to	 generate	 sufficient	 numbers	 of	 proliferating	 myogenic	 precursor	 cells	 required	 for	
functional	muscle	regeneration.	However	c-Met	signaling	is	tightly	controlled	and	modulated.	c-Met	
signaling	 is	 regulated	 in	 the	 intracellular	 compartment	via	 negative	 feedback	 loops	 that	 inhibit	 its	
signaling.	 This	 is	 achieved	by	phosphorylation	of	 tyrosine	 (Y1003),	 present	 on	 the	 juxtamembrane	
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sequence	of	c-Met,	which	recruits	a	ubiquitin	ligase	to	the	receptor	(Comoglio	et	al.	2008;	Trusolino	
et	al.	2010).	Also,	some	of	the	pathways	downstream	of	c-Met	can	also	signal	satellite	cells	to	exit	
from	 the	 cell	 cycle	 and	 differentiate	 or	 return	 to	 quiescence.	 PI3K/Akt	 signaling	 was	 shown	 to	
enhance	 transcriptional	 activity	 of	 MyoD	 and	 MEF2,	 both	 important	 regulators	 of	 cellular	
differentiation,	with	MyoD	 critical	 to	myoblast	 differentiation	 as	 it	 regulates	myogenin	 expression	
(Xu	&	Wu	 2000).	 Similarly	 p38/MAPK	 signaling	 is	 also	 a	 positive	 regulator	 of	myogenesis	 through	
MyoD	 and	 MEF2	 proteins,	 as	 it	 was	 shown	 to	 enhance	 their	 transcriptional	 activities	 (Wu	 et	 al.	
2000).	 Activation	 of	 the	 p38/MAPK	 pathway	 is	 independent	 of	 the	 PI3K/Akt	 pathway,	 and	 could	
function	 parallel	 to	 PI3K/Akt	 signaling	 to	 induce	 myogenesis,	 however,	 inhibiting	 either	 pathway	
resulted	 in	 loss	of	myoblast	differentiation	 (Wu	et	al.	2000).	Finally,	 the	 JAK/STAT	 family	has	been	
implicated	 in	 promoting	 and	 repressing	 both	 myoblast	 proliferation	 and	 differentiation.	 JAK1-
STAT1/3	 induces	 proliferation	while	 it	 seems	 as	 though	 STAT2/3	 phosphorylation	 through	 JAK2	 is	
required	for	differentiation.	
It’s	 clear	 that	 depending	 on	 which	 pathway	 is	 activated	 in	 response	 to	 HGF	 binding,	 different	
molecular	and	cellular	responses	are	elicited	that	ultimately	stimulates	satellite	cell	proliferation	or	
differentiation.	
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Figure	1.3:	HGF	signaling	through	c-Met	
HGF	binding	 to	 c-Met	 causes	 receptor	homodimerization,	which	 leads	 to	phosphorylation	of	 two	 conserved	
tyrosine	 residues	 within	 the	 catalytic	 domain	 (in	 blue):	 Y1234	 and	 Y1235.	 Their	 phosphorylation	 induce	
phosphorylation	 of	 tyrosines	 1349	 and	 1356	 located	 in	 the	 multifunctional	 docking	 site	 (in	 purple).	
Phosphorylated	Y1349/1356	 then	 recruit	effectors	of	 the	c-Met	 signaling	pathway,	which	signal	 through	 the	
ERK	 pathway	 or	 the	 PI3K/Akt	 pathway.	 c-Met	 also	 signals	 through	 the	 p38/MAPK	 and	 JAK/STAT	 pathway.	
Image	modified	and	reproduced	without	permission	from		(Organ	&	Tsao	2011).	
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1.3 THE	INTRICATE	RELATIONSHIP	BETWEEN	SATELLITE	CELLS	AND	HGF	
1.3.1 DOSE	 DEPENDENT	 EFFECTS	 OF	 HGF	 ON	 SATELLITE	 CELLS:	 LOW	 vs.	 HIGH	
CONCENTRATIONS	
HGF’s	 effect	 on	 satellite	 cells	 has	 recently	 been	 shown	 to	 be	 concentration	 dependent,	 perhaps	
explaining	 the	 complexity	 to	 HGF/c-Met	 signaling	 and	 satellite	 cell	 regulation	 in	 muscle	
regeneration.	It	was	observed	that	satellite	cells	elicit	different	behaviours	in	vitro	depending	on	the	
concentrations	of	HGF	(Yamada	et	al.	2010).	Varying	HGF	concentrations	in	the	culture	media	either	
stimulated	or	 repressed	 satellite	 cell	 proliferation.	 It	was	 shown	 that	2.5	ng/mL	of	HGF	maximally	
stimulated	 satellite	 cell	 proliferation,	while	proliferating	 satellite	 cells	 treated	 for	24	h	 -	 76	h	with	
concentrations	of	HGF	ranging	from	10-500	ng/mL	showed	decreased	proliferation,	in	an	HGF	dose-
dependent	manner	 (Yamada	et	al.	 2010).	 The	 reduced	proliferation	exhibited	by	 the	 satellite	 cells	
cultured	with	high	concentrations	of	HGF	was	not	due	 to	 impairment	of	 their	 cellular	viability	nor	
were	the	satellite	cells	differentiating,	as	subsequent	treatment	with	lower	HGF	concentrations	(2.5	
ng/mL)	 induced	 re-activation	 and	 re-established	 increased	 proliferation	within	 a	 48	 h	 time	 frame.	
Yamada	et	al.	(2010),	hypothesized	that	high	levels	of	HGF	were	inducing	cellular	quiescence.		
Evidence	supporting	their	hypothesis	was	provided	by	analysing	the	satellite	cell	mRNA	expression	
levels	 of	 known	 negative	 (myostatin)	 and	 positive	 (MyoD)	 regulators	 of	 myogenesis	 post-HGF	
treatment.	 In	 cells	 treated	 with	 high	 concentrations	 of	 HGF	 elevations	 in	 intracellular	 myostatin	
protein	 levels	 as	 well	 as	 the	 release	 of	 myostatin	 into	 the	 conditioned	 media	 was	 evident.	
Concentrations	of	HGF	ranging	 from	10	 -	50	ng/mL	were	enough	to	 induce	significant	 increases	of	
intracellular	myostatin	levels	(Yamada	et	al.	2010).	Furthermore,	low	levels	of	myogenin	expression	
were	seen	in	cells	treated	with	2.5	ng/mL	and	500	ng/mL	HGF,	while	MyoD	protein	expression	was	
only	seen	in	the	2.5	ng/mL	HGF	cultures	(Yamada	et	al.	2010).	These	findings	support	the	idea	that	
high	 concentrations	 of	 HGF	 induce	 cellular	 quiescence,	 as	 both	 myogenin	 and	MyoD	 expression,	
which	 are	 pivotal	 for	myoblast	 differentiation,	were	 inhibited	by	 high	HGF	 concentrations.	 Similar	
results	have	been	described	by	other	groups:	 i)	 addition	of	50	and	100	ng/mL	of	HGF	 in	an	organ	
culture	 system	 of	 embryonic	 mouse	 tongue	 decreased	 myogenin	 and	 MyoD	 mRNA	 levels	
significantly	 (Yamane	 et	 al.	 2004),	 ii)	 2	 ng/mL	 of	 HGF	 stimulated	 C2C12	 and	 human	 skeletal	
myoblasts	 (HSkM)	 proliferation	 in	 vitro,	 while	 10	 ng/mL	 resulted	 in	 significantly	 decreased	
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proliferation	 (Walker	 et	 al.	 2015),	 and	 iii)	 MyoD	 expression	 along	 with	 myotube	 fusion	 was	
significantly	decreased	in	differentiating	C2C12	and	HSkM	cells	treated	with	2	ng/mL	of	HGF	(Walker	
et	 al.	 2015).	 Conversely,	 Walker	 et	 al.	 (2015)	 reported	 that	 10	 ng/mL	 of	 HGF	 stimulated	
differentiation	 in	 C2C12	 and	 HSkM	 cell	 cultures,	 as	 they	 displayed	 increased	 MyoD+	 cells	 and	
increased	myotube	formation.	This	is	not	in	agreement	with	the	findings	of	Yamada	et	al.	(2010),	as	
they	 reported	no	MyoD	expression	 in	 their	 study.	However	 the	concentrations	of	HGF	used	 in	 the	
two	 studies	 were	 50-fold	 different,	 10	 ng/mL	 versus	 500	 ng/mL,	 and	 thus	 cannot	 be	 compared	
directly.	 On	 the	 other	 hand	 Walker	 et	 al.’s	 (2015)	 findings	 are	 consistent	 with	 the	 in	 vivo	 data	
reported	by	Miller	et	al.	(2000).	The	authors	reported	a	3-fold	increase	in	MyoD+	myoblasts	in	the	TA	
muscles	of	mice,	1	day	after	 simultaneous	 injury	and	 injection	with	50	ng	of	HGF	 (Miller,	Thaloor,	
Matteson	&	Grace	K	Pavlath	2000).	Miller	et	al.	(2000)	also	investigated	the	dose	effects	of	HGF	in	
their	 studies.	 In	 an	 experiment,	 Miller	 et	 al.	 (2000)	 showed	 that	 injured	 muscles	 treated	 with	 a	
single,	daily	 injection	of	50	ng	of	HGF,	 starting	on	 the	day	of	 injury	and	continuing	 through	day	3,	
displayed	 significantly	 less	 regenerated	 fibres	 (7	 days	 post-injury)	 compared	 to	 injured	 muscles	
injected	daily	with	only	6.25	ng	HGF	(Miller,	Thaloor,	Matteson	&	Grace	K	Pavlath	2000).	This	in	vivo	
data	 corroborates	previous	work	by	Gal-Levi	et	al.	 (1998)	with	 chicken	 satellite	 cells	 and	 supports	
the	notion	that	HGF	inhibits	differentiation,	in	a	dose-dependent	manner	(Gal-Levi	et	al.	1998).	Thus	
it	 seems	 that	 different	 concentrations	 of	 HGF	 affect	 the	 expression	 of	 key	 myogenic	 genes	
differently,	 supporting	 the	 notion	 that	 HGF	 can	 regulate	 satellite	 cell	 fate	 and	 promote	 either	
proliferation	or	differentiation.	However,	effects	of	 ‘high’	concentrations	may	be	 influenced	by	the	
model	being	investigated.	
1.3.2 TIME	DEPENDENT	EFFECTS	OF	HGF	ON	SATELLITE	CELLS:	EARLY	vs.	LATE	
Another	 important	 consideration	 is	 the	 timing	 of	 HGF	 exposure	 and	 possible	 timing-dose	
interactions.	In	an	‘early’	time	phase	after	muscle	injury	HGF	present	in	the	ECM	in	a	low	amount	is	
released	and	would	bind	 to	 c-Met,	 stimulating	 satellite	 cell	 activation	 and	proliferation.	 In	 a	 ‘late’	
time	phase	the	concentrations	of	HGF	in	the	ECM	are	much	higher	due	to	i)	a	large	amount	of	HGF	
being	 released	 from	 HSPGs	 following	 extensive	 ECM	 degradation;	 ii)	 autocrine	 secretion;	 and	 iii)	
additional	HGF,	 produced	 from	 the	 liver	 and	 spleen,	 delivered	 to	 the	 site	 of	 injury	via	 blood	 flow	
(Suzuki	et	al.	2002).		
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In	experimental	models	satellite	cells	seem	to	elicit	different	responses	to	HGF,	depending	on	when	
in	 the	muscle	 regeneration	 time-frame	 they	are	exposed	 to	HGF.	Miller	et	al.	 (2000)	 showed	 that	
treatment	with	50	ng	of	HGF	2	and	3	days	post-injury	did	not	 further	 increase	myoblast	numbers	
compared	 to	muscles	 treated	with	HGF	on	 the	day	of	 injury	 (Miller,	 Thaloor,	Matteson	&	Grace	K	
Pavlath	 2000).	 Furthermore,	multiple	 injections	 of	HGF	 significantly	 inhibited	muscle	 regeneration	
and	 this	 inhibition	 was	 found	 to	 be	 time	 dependent.	 In	 this	 experiment,	 injured	 muscles	 were	
treated	with	a	single	daily	injection	of	50	ng	of	HGF	starting	on	different	days	after	injury	(0-2	days;	
2-4	days	and	4-6	days).	Muscle	samples	treated	with	50	ng	of	HGF	on	days	2-4,	after	injury,	displayed	
the	 least	 regeneration	 (Miller,	 Thaloor,	 Matteson	 &	 Grace	 K	 Pavlath	 2000).	 Miller	 et	 al.	 (2000)	
hypotheiszed	 the	 reason	 as	 to	why	HGF	 treatment	 inhibited	 fibre	 formation	 so	 significantly	when	
administered	 2-4	 days	 after	 injury	 is	 due	 to	 the	 fact	 that,	 in	 vivo,	myoblast	 fusion	 occures	 in	 the	
period	 between	 day	 2	 and	 day	 3.	 But	 the	 effect	 of	 HGF	may	 be	 influenced	 by	 the	 c-Met	 protein	
expression,	 which	 has	 been	 shown	 to	 be	 upregulated	 in	 proliferating	 satellite	 cells	 but	
downregulated	in	differentiating	myoblasts	(Gal-Levi	et	al.	1998;	Miller,	Thaloor,	Matteson	&	Grace	
K	Pavlath	2000;	Yamada	et	al.	2010).	
In	summary	the	regulation	of	satellite	cell	proliferation	and	differentiation	 is	thus	tightly	regulated	
by	HGF/c-Met	 signaling	 and	 the	 effects	 of	 this	 signaling	 seem	 to	 be	 both	 concentration	 and	 time	
dependent.	The	data	presented	in	Sections	1.1.3.2	and	1.2.4.4.	implicate	HGF’s	regulation	of	satellite	
cells	to	be	mediated	by	different	downstream	signaling	pathways	which	favour	either	proliferation	
or	differentiation,	while	data	present	 in	Sections	1.3.1	and	1.3.2	explain	a	 time	and	concentration	
component	to	HGF	regulation	of	satellite	cell	fate	during	muscle	regeneration.		
Stellenbosch University  https://scholar.sun.ac.za
34	
Table	 1.3:	 Summary	 of	 key	 studies	 regarding	 the	 dose-	 and	 time-dependent	 effects	 of	 HGF	 on	
satellite	cells	in	vivo	and	in	vitro.	
Authors	 Study	design	
(model,	intervention)	
Time	points/culture	period	 Results	
Yamada	et	al.	
2010	
Primary	culture	of	
satellite	cells	isolated	
from	9-month-old	
Sprague-Dawley	rats;	
2.5	ng/mL	-	500	
ng/mL	of	HGF.	
0	h	-	76	h	treatment	
period	for	HGF	dose	time	
course	study	(48	h	post-
plating)	and	0	h	-	48	h	for	
HGF	reactivation	study.	
2.5	ng/mL	HGF	induced	maximal	
proliferation	as	seen	by	increased	BrdU	
positive	cells.	
10	-	500	ng/mL	HGF	induced	decreased	
proliferation	activity	in	a	concentration	
dependent	manner.	
10	-	50	ng/mL	HGF	induced	myostatin	
expression.	
MyoD	and	myogenin	levels	were	low	or	
absent	at	500	ng/mL	HGF.	
Yamane	et	al.	
2004	
Organ	culture	system	
of	embryonic	(E13)	
ICR	mouse	tongue;	
0,	50	or	100	ng/mL	of	
HGF.	
8	day	culture.	 50	and	100	ng/mL	HGF	
decreased	MyoD,	myogenin	and	muscle	
creatine	kinase	mRNA	expression	
significantly.	
50	and	100	ng/mL	HGF	increased	Myf-5	
mRNA	expression.	
Walker	et	al.	
2015	
C2C12	and	human	
skeletal	myoblasts	
(HSkM)	cell	culture;	
0,	2	or	10	ng/mL	of	
HGF.	
Up	to	7	day	cell	culture.	
Samples	analysed	at	1,	3,	5	
and	7	days.	
2ng/mL	of	HGF	stimulated	C2C12	and	
HSkM	proliferation;	10	ng/mL	resulted	
in	significantly	decreased	proliferation.	
2	ng/mL	of	HGF	significantly	decreased	
MyoD	levels	along	with	myotube	fusion	
in	differentiating	C2C12s	and	HSkMs.	
10	ng/mL	of	HGF	stimulated	
differentiation	in	C2C12	and	HSkM	as	
seen	by	increased	MyoD+	cells	and	
myotube	formation.	
Miller	et	al.	
2000	
4	-	6	week	old	
C57BL/6	male	mice;	
in	vivo	administration	
of	0,	6.25	and	50	ng	
HGF.	
Muscle	samples	collected	
7	days	post-injury.	
HGF	administered	on	day	
of	injury	and	daily	from	
day	of	injury.	
50	ng	HGF	induced	3-fold	increase	in	
MyoD+	myoblasts	1	day	after	
simultaneous	injury	and	injection.	
Injured	muscles	displayed	significantly	
less	regenerated	fibres	when	treated	
with	a	single,	daily	injection	of	50	ng	of	
HGF	compared	to	6.25	ng	HGF.	
Injured	muscles	displayed	significantly	
less	regenerated	fibres	when	treated	
with	50	ng	of	HGF	on	days	2-4,	after	
injury,	when	compared	to	injured	
muscles	treated	with	50	ng	of	HGF	on	
days	0-2	or	4-6,	after	injury.	
Gal-Levi	et	al.	
1998	
Primary	chicken	
satellite	cells	(4-5	
days	old	chickens)	
and	C2C12s;	
0	-	100	ng/mL	of	HGF	
and	pCSAcHGF	
plasmids	for	
transient	transfection	
4	days	culture.	
Samples	analysed	at	2	and	
4	days.	
2	-	20	ng/mL	HGF	stimulated	DNA	
synthesis,	but	higher	concentrations	
(50	-	100	ng/mL)	reduced	DNA	
synthesis.	
Myosin	heavy	chain	protein	was	
decreased	in	an	HGF	dose-dependent	
manner.	
Ectopic	expression	of	HGF	inhibited	
differentiation	and	decreased	MyoD	
and	myogenin	protein	levels.	
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Whether	 the	 dose	 and	 time	 dependent	 effects	 presented	 affect	 all	 satellite	 cells	 or	 just	 a	 sub	
population	still	remains	unclear,	especially	since	distinct	populations	of	satellite	cells	with	different	
mitotic	rates	have	been	observed	 in	vivo	(Schultz	1996;	Ono	et	al.	2010)	and	satellite	cells	differ	 in	
expression	 of	 typical	 markers	 and	 may,	 for	 this	 reason,	 differ	 in	 their	 responses	 to	 HGF.	
Furthermore,	the	in	vivo	agonistic	and	antagonistic	effects	elicited	by	other	growth	factors	(eg:	NK1,	
NK2,	 IGF-I,	 FGF,	 IL-6)	 could	 also	 influence	 HGF’s	 dose	 and	 time	 dependent	 effects.	 Finally,	 HGF’s	
regulation	 of	 satellite	 cells	 could	 be	 due	 to	 an	 influence	 on	 the	 expression	 of	 specific	microRNAs	
(miRNAs),	 which	 are	 present	 in	 muscle	 cells	 and	 have	 been	 found	 to	 regulate	 all	 stages	 of	
myogenesis,	during	both	embryogenesis	and	adulthood.	
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1.4 MICRO	 RNA:	 BIOGENESIS	 AND	 FUNCTION	 IN	 SKELETAL	 MUSCLE	 AND	
SATELLITE	CELLS	
MicroRNAs	 (miRNAs)	 are	 short	 (18-24	 nucleotides)	 single-stranded	 non-coding	 RNA	 molecules,	
involved	in	post-transcriptional	gene	regulation.	Expression	of	miRNAs,	has	been	detected	in	muscle	
cells	 and	 they	 play	 specific	 roles	 in	 their	 differentiation	 during	 embryogenesis	 and	 adulthood.	
Mounting	evidence	has	however	shown	that	miRNAs	interact	with	MRFs	in	all	stages	of	myogenesis:	
beginning	 with	 the	 earliest	 evidence	 of	 satellite	 cell	 differentiation	 into	 myoblast	 precursor	 cells	
(MPCs);	subsequent	differentiation	of	MPCs	into	myoblasts;	fusion	of	myoblasts	into	myotubes	and	
finally	 myotube	 maturation	 into	 functional	 myofibres.	 The	 muscle	 specific	 miRNAs	 are	 termed	
‘myomiRs’	and	have	also	been	 implicated	 in	actively	maintaining	satellite	cells	 in	a	quiescent	state	
(Crist	et	al.	2012;	Cheung	et	al.	2012).	
In	eukaryotic	 cells,	miRNAs	 can	be	encoded	 in	both	 the	 intronic	 regions	of	 a	 coding	gene	or	 from	
non-coding	 intergenic	 sequences	 (Lee	 et	 al.	 2002;	 Mourelatos	 et	 al.	 2002).	 RNA	 Polymerase	 II	
transcribes	 miRNA	 from	 these	 sequences	 (see	 Step	 1,	 Figure	 1.4)	 as	 long	 precursor	 molecules,	
termed	 primary-miRNA	 (pri-miRNA),	which	may	 contain	 several	miRNAs	 embedded	within	 hairpin	
folds	 (Kim	2005).	The	RNA	binding	protein	DGCR8	associates	with	 the	hairpins	present	on	 the	pri-
miRNA	and	together	with	Drosha,	an	RNase	III	endonuclease,	forms	a	microprocessor	complex	(see	
Step	 2,	 Figure	 1.4)	 (Lee	 et	 al.	 2003;	 Denli	 et	 al.	 2004;	 Landthaler	 et	 al.	 2004).	 This	 complex	 then	
generates	 a	~70	 nt	 precursor-miRNA	 (pre-miRNA)	 hairpin	 in	 the	 nucleus.	 The	 pre-miRNA	 is	 then	
exported	 into	the	cytoplasm	via	 the	nucleocytoplasmic	shuttler	Exportin-5	(see	Step	3,	Figure	1.4),	
for	further	processing	(Yi	et	al.	2003;	Bohnsack	et	al.	2004;	Lund	et	al.	2004).	 In	the	cytoplasm	the	
pre-miRNA	hairpin	is	bound	by	the	endonuclease	Dicer,	which	cleaves	the	stem-loop	region	off	the	
pre-miRNA,	 generating	 a	 short	 double-stranded	miRNA	 (see	 Step	 4,	 Figure	 1.4)	 (Hammond	 et	 al.	
2000;	Bernstein	et	al.	2001).	TRBP,	another	RNA	binding	protein,	binds	a	miRNA	strand	and	loads	it	
into	 Argonaute,	 forming	 an	 RNA-induced	 silencing	 complex	 (RISC)	 (see	 Step	 5,	 Figure	 1.4)	
(Chendrimada	et	al.	2005;	Haase	et	al.	2005).	
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Figure	1.4:	MicroRNA	(miRNA)	biosynthesis	and	functions	in	eukaryotic	cells.	
In	 the	 canonical	microRNA	 (miRNA)	 bosynthesis	 pathway,	 (1)	 RNA	 Polymerase	 II	 transcribes	 long	 precursor	
molecules,	 termed	primary-miRNA	 (pri-miRNA),	 from	 intronic	or	 intergenic	 sequences.	 	 (2)	 The	RNA	binding	
protein	DGCR8	associates	with	the	hairpins	present	on	the	pri-miRNA	and	together	with	Drosha,	an	RNase	III	
endonuclease,	 forms	 the	microprocessor	 complex.	 This	 complex	 then	 generates	 a	 ~70	 nt	 precursor-miRNA	
(pre-miRNA)	 hairpin	 in	 the	 nucleus.	 (3)	 The	 pre-miRNA	 is	 then	 exported	 into	 the	 cytoplasm	 via	 the	
nucleocytoplasmic	shuttler	Exportin-5	for	further	processing	(see	step	4-5	in	text).	(6)	The	RISC	complex	then	
binds	target	mRNA	stands	and	either	inhibits	their	translation	or	causes	their	degradation.	Image	modified	and	
reproduced	without	permission	from	(Lodish	et	al.	2008).		
The	 sequence	 similarity	 between	 the	 miRNA	 and	 its	 target	 mRNA	 allows	 the	 RISC	 complex	 to	
associate	 with	 the	 mRNA,	 usually	 within	 its	 3’-UTR,	 and	 silence	 its	 expression	 (Bartel	 2009).	
Depending	on	the	degree	of	complementarity	between	the	miRNA	and	the	mRNA,	the	RISC	complex	
can	either	inhibit	the	translation	of	the	mRNA	(partial	complementarity)	or	degrade	the	mRNA	(total	
complementarity)	(see	Step	6,	Figure	1.4).	Since	RISC-mediated	gene	silencing	doesn’t	require	100%	
1	
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complementarity	 between	 the	miRNA	and	 the	mRNA,	 a	 single	miRNA	 can	 target	multiple	mRNAs.	
This	mechanism	could	target	a	multi-gene	network	driving	a	specific	cell	fate	transition.	
	Therefore,	miRNAs	represent	an	incredibly	powerful	tool	for	post-transcriptional	gene	regulation.	In	
addition,	 miRNAs	 have	 tissue-	 and	 organ-specific	 expression,	 implicating	 them	 as	 important	
regulators	 of	 cellular	 differentiation	 and	 this	 is	 the	 case	 during	 embryogenesis	 and	 adulthood.	
Indeed	 differentiation	 of	 stem	 cells	 into	 their	 terminally	 differentiated	 counterparts	 requires	 the	
precise	and	coordinated	activation	and	silencing	of	specific	genetic	programmes,	which	is	mediated	
in	part	by	miRNA-induced	silencing	reviewed	extensively	by	Shenoy	and	Blelloch	(Shenoy	&	Blelloch	
2014).	
1.4.1 MICRO	RNAs	IN	MUSCLE	
Muscle	 specific	miRNAs,	 termed	 ‘myomiRs’,	 play	 a	 far	 greater	 role	 than	was	 expected	when	 they	
were	first	discovered	(Wang	et	al.	2009;	Crist	&	Buckingham	2009).	Of	note	miR-1,	miR-133	and	miR-
206,	 elicit	 muscle	 specific	 expression	 and	 have	 been	 shown	 to	 play	 a	 key	 role	 in	 myoblast	
differentiation	 (Wang	 et	 al.	 2009;	 Crist	 &	 Buckingham	 2009).	 miR-1	 has	 been	 shown	 to	 promote	
myoblast	 differentiation	 by	 repressing	 histone	 deacetylase	 (HDAC-4),	 thereby	 maintaining	 MEF2	
activity	(Chen	et	al.	2006;	Lu	et	al.	2000)	and	miR-206	targets	the	p180	subunit	of	DNA	polymerase	
alpha,	 facilitating	cell	 cycle	withdrawal	 (Kim	et	al.	2006).	 In	 contrast,	miR-133,	promotes	myoblast	
proliferation	by	repressing	serum	response	factor	(SRF)	and	by	doing	so	inhibits	myogenesis	(Chen	et	
al.	2006).	miR-1	and	miR-133	are	present	on	the	same	pri-miRNA	and	thus	get	expressed	together,	
even	though	they	perform	directly	opposing	roles	 in	myogenesis	(Kim	et	al.	2006).	Moreover,	non-
myo	miRNAs	such	as	miR-29	and	miR-181	 for	example	are	also	known	to	play	a	 regulatory	 role	 in	
myogenesis.	 miR-29	 promotes	 myoblast	 differentiation	 by	 repressing	 the	 mRNA	 of	 transcription	
factor	 Ying	 Yang	 1	 (YY1),	 which	 functions	 as	 a	 gene	 transcription	 silencer	 (via	 chromatin	
modification)	(Wang	et	al.	2008).	On	the	other	hand,	miR-181	targets	Hox-A11,	a	homeobox	protein	
that	represses	MyoD	transcription	(Yamamoto	&	Kuroiwa	2003;	Naguibneva	et	al.	2006).			
Due	to	myogenesis	being	a	stepwise	process	requiring	an	intricate	cooperation	between	positive	and	
negative	regulators	of	gene	expression,	it	comes	as	no	surprise	that	miRNAs,	both	specific	to	muscle	
tissue	 and	 ubiquitously	 expressed,	 play	 important	 roles	 in	 mediating	 key	 events	 of	 myogenesis.	
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miRNAs	can	selectively	repress	specific	genes	 involved	 in	the	myogenic	programme,	either	directly	
by	 inhibiting	 their	mRNA	 translation,	or	 indirectly	by	 repressing	 their	 activators.	Recently,	miRNAs	
have	been	discovered	 to	 regulate	different	 stages	of	 satellite	 cell	 activity	 -	 quiescence,	 activation,	
proliferation	and	differentiation.	
1.4.2 MICRO	RNAs	IN	SATELLITE	CELLS	
In	2009,	Crist	et	al.	discovered	a	novel	miRNA	(miR-27)	present	in	Pax3	expressing	satellite	cells	and	
showed	that	 it	 regulates	the	 initiation	of	 the	myogenic	programme	(Crist	et	al.	2009).	The	authors	
demonstrated	 that	 miR-27	 expression	 was	 concomitant	 with	 the	 downregulation	 of	 Pax3	 in	
activated	satellite	cells		(Crist	et	al.	2009).	Further	analysis	revealed	that	miR-27,	negatively	regulates	
Pax3	protein	expression	by	binding	to	a	single	target	site	on	the	3’-UTR	of	Pax	3	mRNA	(Crist	et	al.	
2009).	Pax3	and	Pax7	downregulation	is	required	for	differentiation	to	proceed	(Boutet	et	al.	2012;	
Olguín	 et	 al.	 2011).	 miRNA	 regulation	 of	 Pax7	 has	 also	 been	 shown	 at	 the	 time	 of	 satellite	 cell	
differentiation:	miR-1	and	miR-206	expression	 is	upregulated	and	target	Pax7	 that	 in	 turn	 leads	 to	
cell	cycle	exit	(Chen	et	al.	2010).	The	predicted	binding	sites	for	miR-1	and	miR-206	are	also	present	
on	the	3’UTRs	of	Pax	3	variants	(Blake	&	Ziman	2005),	indicating	that	in	satellite	cells	as	in	muscles	a	
single	miRNA	can	regulate	different	genes	in	a	specific	gene	network.	Furthermore,	miR-146a	(Kuang	
et	al.	2009)	miR-21	(Tatsuguchi	et	al.	2007;	Thum	et	al.	2008)	and	miR-489	(Cheung	et	al.	2012)	have	
been	found	to	be	expressed	in	satellite	cells.	
It	is	therefore	clear	that	there	are	several	miRNAs	present	in	satellite	cells	and	they	may	well	operate	
in	a	coordinated	fashion	to	either	promote	satellite	cell	quiescence,	or	activation	or	differentiation.	
Interestingly,	miR-31	has	been	shown	to	play	an	important	role	in	the	former	and	it	has	been	shown	
to	target	Myf-5	in	quiescent	satellite	cells,	thereby	potentially	maintaining	quiescence.	
1.4.3 miR-31	AND	MYF-5	
Maintaining	 satellite	 cells	 in	 a	 quiescent	 state,	 in	 the	 absence	 of	 muscle	 regeneration,	 is	
fundamental	to	ensure	the	survival	of	the	satellite	cell	pool.	As	mentioned	before,	satellite	cells	are	
incredibly	 responsive	 to	 the	 plethora	 of	 molecules	 present	 in	 their	 niche	 and	 other	 endocrine	
factors.	Mechanisms	regulating	the	effetcs	of	these	external	stimuli	are	thus	crucial	to	prevent	hyper	
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activation	and	to	keep	satellite	cells	dormant	within	their	niche.	The	notion	that	quiescent	cells	(G0	
phase)	are	actively	being	maintained	 in	a	dormant	state	 is	 starting	 to	gain	ground	as	more	 insight	
into	miRNA	functions	is	obtained.		
Since	quiescent	cells	display	condensed	chromatin	and	overall	 less	gene	activation	 it	was	assumed	
that	 they	 are	 completely	 transcriptionally	 inactive	 (Schultz	 et	 al.	 1978).	 It	 is	 however	 now	 known	
that	even	quiescent	 cells	need	 intrinsic	and	extrinsic	 cues	 to	maintain	 them	 in	 their	 current	 state.	
Maintaining	 satellite	 cells	 in	 a	 G0	 state,	 is	 thus	 an	 active	 process.	 Recently,	 it	 was	 observed	 that	
quiescent	satellite	cells	were	expressing	Myf-5	mRNA,	without	activating	the	myogenic	programme	
(Crist	 et	 al.	 2012).	 Further	 analysis	 revealed	 that,	 although	 these	 satellite	 cells	 were	 indeed	
expressing	Myf-5	mRNA,	 no	Myf-5	 protein	 was	 detectable	 (Crist	 et	 al.	 2012).	 These	 observations	
could	 be	 explained	 by	 a	 prior	 study	 done	 by	 Daubas	 et	 al.	 (2009),	 who	 discovered	 that	 a	 target	
sequence	 for	 miR-31	 was	 present	 in	 the	 3’-UTR	 of	 Myf-5	 (Daubas	 et	 al.	 2009).	 In	 a	 subsequent	
investigation,	 Crist	 et	 al.	 (2012)	 set	 out	 to	 determine	 if	 miR-31	 was	 indeed	 targeting	 Myf-5	 in	
quiescent	satellite	cells,	and	by	doing	so	preventing	the	accumulation	of	Myf-5	protein.	Not	only	did	
the	authors	observe	higher	 levels	of	miR-31	 in	the	quiescent	cells	compared	to	activated	cells,	but	
they	 also	 showed	 that	 miR-31	 was	 targeting	 Myf-5	 mRNA	 and	 maintaining	 it	 transcriptionally	
inactive.	 The	 authors	 furthermore	 showed	 that	 miR-31	 was	 sequestered	 with	 Myf-5	 transcripts	
inside	messenger	 ribonucleoprotein	 (mRNP)	 granules	 in	 the	 cytoplasm	 of	 quiescent	 satellite	 cells,	
whereas	association	of	Myf-5	mRNA	with	the	mRNP	granules	was	not	evident	 in	activated	satellite	
cells.	Upon	 activation	 the	mRNP	 granules	were	 shown	 to	 dissociate	 and	 release	Myf-5	 transcripts	
which	 then	 allowed	 for	 the	 translation	 and	 Myf-5	 protein	 accumulation	 and	 activation	 of	 the	
myogenic	programme	(Crist	et	al.	2012).	Quiescent	satellite	cells	therefore	seem	to	be	maintained	in	
a	 ‘halted’	 or	 intermediate	 state,	 where	 cells	 are	 quiescent,	 but	 ‘primed’	 for	 myogenesis,	 since	
relevant	mRNA	has	already	been	transcribed.	
1.4.4 SATELLITE	CELLS	AND	THEIR	‘PRIMED’	STATE	
The	concept	of	an	alternate	or	intermediate	state	between	G0	and	proliferating	was	first	put	forward	
by	Rodgers	et	al.	(2014).	Using	an	animal	model	of	unilateral	muscle	injury,	the	authors	noticed	that	
quiescent	 satellite	 cells	 in	 the	 muscle	 contralateral	 to	 the	 injured	 limb	 displayed	 unique	 cycling	
properties	that	are	different	from	activated	satellite	cells	or	quiescent	satellite	cells	(Rodgers	et	al.	
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2014).	These	contralateral	 satellite	 cells	displayed	a	propensity	 to	 cycle	and	when	explanted	were	
able	 to	 re-enter	 the	 cell	 cycle	 far	 quicker	 than	 fully	 quiescent	 satellite	 cells	 and	 took	 less	 time	 to	
complete	a	full	G1-S-G2-M	cycle	(Rodgers	et	al.	2014).	Phenotypically,	these	satellite	cells	resembled	
quiescent	satellite	cells	more	than	activated	satellite	cells,	and	their	ability	to	self-renew	and	engraft	
was	 unaltered,	 thus	 ruling	 out	 the	 possibility	 that	 these	 satellite	 cells	 were	 actually	 already	
committed	cells	(Rodgers	et	al.	2014).	In	contrast,	these	satellite	cells	displayed	enrichment	in	genes	
regulating	cells	cycle	(Rodgers	et	al.	2014).	These	contralateral	satellite	cells	seemed	to	represent	an	
intermediate	 state,	 displaying	 similarities	 with	 both	 quiescent	 and	 activated	 satellite	 cells:	 they	
possessed	all	the	abilities	and	characteristics	of	a	true	unipotent	stem	cell,	but	were	more	‘alert’	as	
they	displayed	increased	transcriptional	activity	and	accelerated	cell	cycle	re-entry	and	cycling.		
The	characteristics	displayed	by	these	contralateral	satellite	cells	described	by	Rodgers	et	al.	(2014)	
are	very	alike	to	cells	under	mTOR	signaling	reviewed	by	(Laplante	&	Sabatini	2012).	Rodgers	et	al.	
(2014)	showed	that	mTORC1	signaling	was	present	in	the	‘alert’	contralateral	satellite	cells	and	that	
HGF/c-Met	 signaling	 was	 regulating	 mTORC1	 activity	 via	 PI3K-Akt	 signaling.	 Indeed	 mTORC1	
signaling	was	 shown	 to	 be	 responsible	 for	 the	 functional	 and	 transcriptional	 changes	 seen	 in	 this	
‘alert’	state	and	that	once	mTORC1	signaling	subsides	this	‘alert’	state	is	lost.	The	authors	therefore	
concluded	that	this	 ‘alert’	state	 is	reversible	 (Rodgers	et	al.	2014).	Finally,	 it	was	shown	that	these	
‘alert’	 satellite	cells	were	primed	 into	 this	 state	 in	 response	 to	multiple	 types	of	unrelated	 injuries	
(skin	wounds,	bone	 injuries,	muscle	 injuries),	and	 in	response	to	subsequent	 injury,	 they	displayed	
enhanced	muscle	regenerative	capacity.		
In	summary	the	data	present	by	Rodgers	et	al.	(2014)	show	that	quiescent	stem	cells	have	the	ability	
to	transition	to	a	‘primed’	state,	which	they	termed	GAlert,	whereby	they	are	primed	to	re-enter	the	
cell	cycle	and	proliferate	more	profusely.	It	is	tempting	to	speculate	that	the	capacity	of	these	GAlert
satellite	cells	to	elicit	enhanced	muscle	regeneration	may	not	only	be	due	to	their	 increased	ability	
to	 proliferate,	 but	 also	 due	 to	 their	 ‘priming’	 to	 enter	 the	 myogenic	 differentiation	 programme	
(achieved	by	prescence	of	MRF	mRNA’s	albeit	translationally	repressed	by	myo-miRs).	
Careful	 scrutiny	 of	 the	 currently	 available	 literature	 has	 highlighted	 several	 gaps	 in	 the	
understanding	 of	 how	 HGF	 causes	 differential	 levels	 of	 MyoD	 and	 Myf-5	 in	 recently	 activated	
satellite	cells.	Some	data	points	to	different	concentrations	of	HGF	leading	to	changes	in	regulation	
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of	MyoD	and	Myf-5	at	the	mRNA	level,	resulting	in	more	or	 less	expression	of	one	or	the	other.	 In	
addition,	 it	 is	 though	 that	 different	 intracellular	 levels	 of	MyoD	 and	Myf-5	 protein	 elicit	 different	
responses	in	satellite	cells,	ultimately	guiding	their	fate.	Understanding	the	mechanistic	regulation	of	
satellite	cells	is	now	further	complicated	with	the	introduction	of	miRNAs	and	their	role	as	powerful	
regulators	of	gene	expression.	 It	has	been	shown	 that	 intermediate	 satellite	 cells	upregulate	gene	
transcription	 and	 re-enter	 the	 cell	 cycle	 far	 too	 quickly	 for	 de	 novo	 gene	 expression,	 further	
implicating	 miRNAs	 as	 actively	 playing	 a	 role	 in	 maintaining	 satellite	 cells	 in	 a	 ‘primed’	 or	 ‘GAlert’	
state.	 This	 new	understanding	 opens	 the	way	 to	 reinterpretation	 of	 earlier	 studies,	 particularly	 in	
relation	to	the	effects	of	factors	present	in	the	satellite	cell	niche.	
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1.5 HYPOTHESIS,	AIMS	AND	OBJECTIVES	
We	hypothesize	that	the	known	effect	of	HGF	on	the	expression	of	MyoD	and	Myf-5	which	differs	
depending	on	its	concentration	is	in	part	due	to	an	effect	HGF	may	have	on	miR-31	expression	and	
satellite	cell	exit	from	quiescence.		
The	central	focus	of	this	study	is	thus	to	understand	how	different	concentrations	of	HGF	affect	the	
expression	 and	 translation	 of	 MyoD	 and	Myf-5,	 along	 with	 the	 expression	 of	 miR-31,	 in	 primary	
human	myoblasts.		
In	this	study	we	aim	to:	
• Drive	primary	human	myoblasts	(PHM)	into	a	quiescent	state	(G0/G1)	in	vitro	and	re-activate
them	by	addition	of	low	or	high	concentrations	of	exogenous	rh-HGF.
• Investigate	the	time	and	concentration	dependent	effects	of	HGF	on	MyoD	and	Myf-5	mRNA
and	protein	levels	and	the	expression	of	miR-31.
We	have	set	out	the	following	objectives	to	satisfy	out	aims.	
Firsty	to:	
• Expand	previously	isolated	Primary	Human	Myoblast	(PHM)	cells.
• Drive	PHMs	 into	a	quiescent	state,	via	FBS	removal	and	supplementation	with	a	synthetic,
growth	factor-free	serum	replacement:	KnockOut™	Serum	Replacement	(KOSR).
• Determine	the	state	(quiescent,	activated	or	proliferating)	of	the	PHMs	before	and	after	10
days	in	KOSR.
- To	ascertain	the	state	 in	which	PHMs	find	themselves,	multi-colour	flow	cytometry	
and	cell	cycle	analysis	will	be	employed.	
Secondly	 to	 determine	 the	 effects	 of	 different	 concentrations	 of	 rh-HGF	 (2	 ng/mL	 and	 10	 ng/mL)	
after	24	h	and	48	h	on	cell	cycle	progression	in	PHMs.	
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Thirdly	to	determine	the	effects	of	different	concentrations	of	rh-HGF	(2	ng/mL	and	10	ng/mL)	after	
24	h	and	48	h	on	the:	
• Expression	of	MyoD	and	Myf-5	mRNA	in	PHMs.
• Synthesis	of	MyoD	and	Myf-5	protein	in	PHMs.
• Expression	of	miR-31	in	PHMs.
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CHAPTER	2	
MATERIALS	AND	METHODS	
All	 experimental	 procedures	 that	 formed	 part	 of	 this	 research	 study	 were	 performed	 in	 vitro	 on	
previously	 isolated	 primary	 human	 myoblasts	 (PHM)	 (Steyn	 2015).	 This	 research	 study	 and	 the	
associated	 experimental	 protocols	 were	 approved	 by	 the	 Committee	 for	 Human	 Research	 at	
Stellenbosch	University	(Ethics	reference	#:N12/08/051).	Experiments	were	conducted	according	to	
the	ethical	guidelines	and	principles	of	the	International	Declaration	of	Helsinki.	
All	chemicals	used	were	of	analytical	grade.	
2.1 PRIMARY	HUMAN	MYOBLAST	CELL	CULTURE	
2.1.1 ISOLATION	OF	PRIMARY	HUMAN	MYOBLAST	CULTURE	(MICROEXPLANT	TECHNIQUE)	
The	 isolation	and	expansion	of	primary	human	myoblasts	 (PHM)	 from	healthy	male	 subjects	 (n=8)	
were	 performed	 by	 a	 former	 Ph.D.	 student	 (Dr	 P.	 Steyn)	 (Steyn	 2015)	 using	 the	 micro-explant	
technique	(Smith	&	Merrick	2010).	Briefly,	a	qualified	medical	doctor	performed	the	needle	biopsy	
procedures	 (5	 mm	 trephine	 biopsy	 needle	 with	 assisted	 suction)	 on	 the	 vastus	 lateralis	 of	 the	
subjects	 to	 harvest	 approximately	 50-100	 mg	 of	 skeletal	 muscle.	 The	 muscle	 sample	 was	
immediately	transferred	to	a	harvesting	1x	phosphate	buffered	saline	(PBS)	solution	containing	10%	
(v/v)	penicillin/streptomycin	 (P/S)	 (Sigma-Aldrich,	Germany,	P43333)	and	1%	(v/v)	gentamicin	 (Cf	=	
0.5	mg/mL)	(GIBCO™,	Paisley,	Scotland,	50	mg/mL,	15750-060).	Muscle	samples	were	then	removed	
from	 the	 harvesting	 PBS	 and	 washed	 with	 1x	 PBS	 before	 being	 transferred	 into	 a	 96-well	 tissue	
culture	plate	(Corning,	USA,	#3595).	Prior	to	that	the	wells	were	coated	overnight	at	37	°C	with	an	
entactin-collagen	IV-laminin	(ECL)	cell	attachment	matrix	(Merck,	USA,	08-110).	Each	individual	piece	
of	muscle	was	transferred	into	a	well	in	a	96-well	plate	containing	media	ideal	for	the	proliferation	
of	PHM.	The	proliferation	media	consisted	of	Ham’s	F-10	Nutrient	Mixture	Medium	(Sigma-Aldrich,	
Germany,	 N6908)	 that	 was	 supplemented	 with	 20%	 (v/v)	 foetal	 bovine	 serum	 (FBS)	 (Life	
Technologies,	 USA,	 10499-044),	 2%	 (v/v)	 P/S	 (Sigma-Aldrich,	 Germany,	 P43333),	 0.1%	 (v/v)	
gentamicin	 (Cf	 =	 0.05	mg/mL)	 (GIBCO™,	 Paisley,	 Scotland,	 50	mg/mL,	 15750-060),	 6.8%	 (v/v)	 (200	
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mM,	 100x)	 L-glutamine	 (Sigma-Aldrich,	 Germany,	 G7513)	 and	 10	 ng/mL	 rh-FGF	 (Promega,	 USA,	
G5071).	 The	muscle	 samples	were	maintained	 in	 a	 semi-conditioned	media	 by	 regularly	 removing	
half	of	the	old	media	in	each	well	and	replacing	it	with	fresh	proliferation	media	every	48	hours	(h).	
The	myoblast	cells	started	to	migrate	off	the	muscle	fibers	approximately	10	days	(d)	post	transfer.	
The	biopsy	samples	were	removed	from	the	culture	dish	14	d	post	transfer	and	then	transferred	to	a	
new	ECL-coated	well	so	as	to	allow	more	PHMs	to	migrate	off	and	generate	a	larger	population.	The	
adherent	cells	were	then	cryo-preserved	in	liquid	nitrogen	(LN2)	(-195	°C)	for	long	term	storage	at	a	
p0	 state/stage.	 The	 freezing	 media	 consisted	 of	 Ham’s	 F-10	 Nutrient	 Mixture	 Medium	 (Sigma-
Aldrich,	 Germany,	 N6908)	 that	 was	 supplemented	 with	 20%	 (v/v)	 FBS	 (Life	 Technologies,	 USA,	
10499-044),	2%	(v/v)	P/S	(Sigma-Aldrich,	Germany,	P43333),	0.1%	(v/v)	gentamicin	(Cf	=	0.05	mg/mL)	
(GIBCO™,	Paisley,	Scotland,	50	mg/mL,	15750-060),	6.8%	(v/v)	(200	mM,	100x)	L-glu	(Sigma-Aldrich,	
Germany,	G7513)	and	5%	(v/v)	dimethyl	sulphoxide	(DMSO)	(Sigma-Aldrich,	Germany,	D2650)	Prior	
to	 storage	 in	 LN2,	 the	 identity	 of	 the	 subcultured	 cells	 were	 confirmed	 using	 flow	 cytometry	 as	
previously	described	 (Steyn	2015).	Cells	were	analysed	 for	Pax7/desmin	expression	 to	confirm	 the	
presence	 of	 a	 homogeneous	 population	 of	 PHMs	 and	 to	 determine	 the	 extent	 of	 fibroblast	
contamination.	 The	 flow	 cytometric	 analysis	 confirmed	 that	 the	 isolation	 of	 PHMs	 from	 all	 eight	
donors	 were	 successful	 and	 yielded	 a	 highly	 pure	 population	 of	 PHMs,	 with	 an	 average	 of	
93.4±1.71%	cells	positive	 for	Pax7.	Refer	to	Table	2.1	 for	detailed	 information	on	the	purity	of	 the	
PHM	populations	derived	from	each	of	the	individual	donors.	
Table	2.1:	Percentage	values	of	PAX7+	and	Desmin+	cells	isolated	from	the	various	donors.	
DONOR	#	 PAX7+	 DESMIN+	 Pax7/Desmin+	 Desmin	Only	
1	 97.4	 65.9	 65.6	 0.3	
2	 82.6	 61	 59.8	 1.2	
3	 92.5	 62.9	 62.1	 0.8	
4	 95	 63.2	 62.9	 0.3	
5	 91.7	 80.1	 79.2	 0.9	
6	 95.8	 75.6	 74.9	 0.7	
7	 97.5	 79.6	 78.8	 0.8	
8	 95	 83.7	 81.6	 2.1	
AVERAGE	 93.4±1.71	 71.5±3.25	 70.6±3.15	 0.89±0.20	
Footnote:	Data	obtained	from	(Steyn	2015).	Donor	6	is	in	bold	as	this	subject’s	cells	were	expanded	and	used	
for	all	experimental	procedures	in	this	study.	
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2.1.2 PHM	EXPANSION	AND	STORAGE	
PHMs	 from	subjects	1,	2,	4,	6	and	9	were	 selected	 randomly	and	expanded	 in	 vitro	 to	generate	a	
large	working	stock	of	PHMs.	For	initial	expansion,	a	T25	cell	culture	flask	(NEST	Biotechnology,	USA,	
707003)	was	coated	with	ECL	matrix	(Millipore,	USA,	08-110)	and	placed	at	37	°C	for	1	h.	A	cryovial	
containing	3	x	105	PHMs	was	then	removed	from	LN2	storage	and	placed	in	37	°C	waterbath	to	thaw	
for	approximately	2	minutes	(min).	The	cell	suspension	was	transferred	to	a	15	mL	centrifuge	tube	
(NEST	Biotechnology,	USA,	601002)	containing	5	mL	of	pre-warmed	(37	°C)	primary	human	myoblast	
proliferation	 media	 (PHM-PM).	 To	 make	 PHM-PM,	 Ham	 F-10	 Nutrient	 Mixture	 Medium	 (Sigma-
Aldrich,	Germany,	N6908)	was	supplemented	with	20%	(v/v)	foetal	bovine	serum	(Life	Technologies,	
USA,	10499-044),	1%	(v/v)	PenStrep	(Life	Technologies,	USA,	15140-122),	6.8%	(v/v)	(200	mM,	100x)	
L-glutamine	(Life	Technologies,	USA,	25030-081)	and	10	ng/mL	rh-FGF	(Promega,	USA,	G5071).	Cells	
were	centrifuged	for	3	min	at	1500	RPM	at	room	temperature	(20-25	°C).	After	centrifugation,	the	
media	was	aspirated	to	remove	all	 traces	of	DMSO	(Sigma-Aldrich,	Germany,	D2650).	The	pelleted	
cells	were	resuspended	in	warm	PHM-PM	and	triturated.	The	cell	suspension	was	then	transferred	
to	the	ECL-coated	T25	cell	culture	flask,	and	the	cells	were	 incubated	at	37	°C	 	with	a	constant	5%	
CO2	(ESCO,	Singapore,	CCL-170B-8-UV).	The	cells	plated	initially	were	assigned	a	p1	passage	number	
and	coded	 ‘PHM’	along	with	 the	donor	 subject	number	 (e.g	PHM	6	 -	p1).	Refer	 to	Appendix	A	 for	
detailed	information	on	cell	culture	reagents	used	and	for	media	recipies.	
PHMs	were	subcultured	in	T75	cell	culture	flasks	(NEST	Biotechnology,	USA,	708003)	to	obtain	a	high	
yield	of	cell	stocks	for	future	experiments.	A	full	media	change	(PHM-PM)	was	performed	every	48	h	
until	 cells	 covered	 70-80%	 of	 the	 cell	 culture	 flask	 growth	 surface.	 To	 perform	 cell	 passaging	 old	
media	 was	 removed	 and	 cells	 were	 rinsed	 twice	 with	 pre-warmed	 1x	 sterile	 PBS	 (Sigma-Aldrich,	
Germany,	 P4417).	 0.25%	Trypsin-EDTA	 (1x)	 (Life	 Technologies,	USA,	 25200-072)	was	 added	 to	 the	
culture	flask	and	the	cells	 incubated	in	a	heated	shaking	 incubator	set	at	37	°C	for	5	min.	This	was	
essential	to	dislodge	the	adherend	cells	from	the	flask	surface.	After	5	min,	an	equal	volume	of	warm	
PHM-PM	was	 added	 to	 the	 flask	 and	 the	 cell	 suspension	 transferred	 to	 a	 15	mL	 centrifuge	 tube	
(NEST	Biotechnology,	USA,	601002).	 The	culture	 flask	was	 rinsed	with	PHM-PM	 in	order	 to	 collect	
remaining	cells.	The	centrifuge	tube	containing	the	PHM	cell	suspension	was	centrifuged	(Eppendorf,	
Germany,	5810R)	at	1500	RPM	for	3	min	at	 room	temperature.	The	media	was	discarded	and	 the	
pelleted	cells	were	resuspended	in	1	mL	warm	PHM-PM	and	then	transferred	into	a	new	tissue	ECL-
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coated	 culture	 flask.	 Cells	 were	 passaged	 until	 p4	 and	 then	 cryopreserved	 in	 freezing	media	 and	
stored	 in	 LN2.	 Freezing	 media	 consisted	 of	 Ham	 F-10	 Nutrient	 Mixture	 Medium	 (Sigma-Aldrich,	
Germany,	N6908)	was	 supplemented	with	 20%	 (v/v)	 foetal	 bovine	 serum	 (Life	 Technologies,	USA,	
10499-044),	 1%	 (v/v)	 P/S	 (Life	 Technologies,	 USA,	 15140-122),	 6.8%	 (v/v)	 (200	 mM,	 100x)	 L-
glutamine	 (Life	 Technologies,	 USA,	 25030-081)	 and	 5%	 (v/v)	 DMSO	 (Sigma-Aldrich,	 Germany,	
D2650).	 Refer	 to	 Appendix	 B	 for	 more	 detailed	 protocols	 on	 cell	 passaging,	 thawing	 and	
cryopreservation.	
For	the	purpose	of	this	study	only	PHMs	expanded	from	subject	6,	were	used,	as	they	proliferated	
rapidly	and	generated	a	large	working	stock.	For	all	experimental	procedures	performed	on	subject	
6’s	PHMs,	only	cells	between	passage	6	(p6)	and	8	(p8)	were	used.			
Prior	 to	 cryopreservation	 and	 subsequent	 experimental	 procedures,	 cells	 were	 checked	 for	 both	
bacterial	and	fungal	contamination	(Refer	to	Appendix	C).		
2.1.3 KNOCKOUT	SERUM	REPLACEMENT	TREATMENT	TO	INDUCE	CELLULAR	QUIESCENCE	
To	 stimulate	 PHMs	 to	 return	 to	 a	 quiescent	 state,	 FBS	 (Life	 Technologies,	 USA,	 10499-044)	 was	
removed	 from	 the	 culture	 media	 and	 substituted	 with	 a	 synthetic,	 growth	 factor	 free	 serum	
replacement	known	as	KnockOut™	Serum	Replacement	(KOSR)	(Life	Technologies,	USA,	10828-010).	
The	 resulting	 media	 was	 termed	 quiescence	 media	 and	 contained	 Ham’s	 F-10	 Nutrient	 Mixture	
Medium	 (Sigma-Aldrich,	 Germany,	 N6908),	 supplemented	 with	 20%	 (v/v)	 KnockOut™	 Serum	
Replacement	 (KOSR)	 (Life	 Technologies,	 USA,	 10828-010),	 1%	 (v/v)	 P/S	 (Life	 Technologies,	 USA,	
15140-122)	and	6.8%	(v/v)	 (200	mM,	100x)	L-glutamine	(Life	Technologies,	USA,	25030-081)	(Refer	
to	Appendix	A).	Cells	were	cultured	for	10	days	in	this	media,	with	daily	media	changes,	in	order	to	
induce	cellular	quiescence.	
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2.2 FLOW	CYTOMETRIC	ANALYSIS	OF	THE	PRIMARY	HUMAN	MYOBLASTS	
2.2.1 DETERMINING	 THE	 STATE	 OF	 PHMs	 AFTER	 10	 DAYS	 OF	 CULTURE	 IN	 QUIESCENCE	
MEDIA	
Cells	were	trypsinized	and	pelleted	as	described	in	Section	2.1.2.	Cell	numbers	were	quantified	using	
a	 haemocytometer	 (Neubauer-improved,	 Marienfeld,	 Germany,	 #0640010)	 and	 resuspended	 at	 a	
concentration	of	1	x	106	cells/100	μL	of	1x	PBS	(Sodium	Azide,	Tris	and	Protein	Free).	To	differentiate	
between	live	and	dead	cells	a	Zombie	Aqua™	Fixable	viability	kit	(BioLegend,	USA,	423101)	was	used.	
1	 μL	 of	 Zombie	 dye	was	 added	 to	 the	 cell	 suspension	 followed	 by	 30	min	 of	 incubation	 at	 room	
temperature	in	the	dark.	Following	incubation,	cells	were	washed	with	2	mL	1x	PBS	and	then	fixed	in	
500	μL	of	4%	paraformaldehyde	for	10	min.	Cells	were	then	washed	twice	with	1	mL	of	freshly	made	
staining	buffer	(1x	PBS,	2%	(w/v)	Bovine	Serum	Albumin	(BSA)	(Roche,	Germany,	10735086001)).	To	
permeabilize	cells,	3	mL	of	ice-cold	(-20	°C)	70%	Ethanol	(EtOH)	was	added	and	the	cell	suspension	
placed	in	a	freezer	(-20	°C)	for	1	h.	After	permeabilization,	cells	were	washed	three	times	with	1	mL	
staining	buffer	and	resuspended	at	a	concentration	of	2	x	105	cells	in	staining	buffer.	Each	antibody	
(Refer	to	Table	2.2)	was	added	proportional	to	the	number	of	cells	and	the	final	volume	was	brought	
to	100	μL.	Cells	were	incubated	at	room	temperature	in	the	dark	for	30	min	and	then	washed	twice	
with	staining	buffer.	Prior	to	flow	cytometric	analysis	(BD	FACSAria™	Cell	Sorter,BD	Biosciences,	San	
Jose,	CA	95133,	USA),	cells	were	filtered	through	a	50	μm	nylon	mesh.	A	minimum	of	1	x	105	cells	
were	 acquired	 and	 analysed.	 Compensation	 was	 performed	 with	 BD™	 CompBead	 Plus	 (BD	
Biosciences,	 USA,	 560497)	 and	 data	 analyses	 was	 performed	 on	 the	 FACSDiva™	 software	 v6.1.3.	
Refer	 to	Appendix	D	 for	detailed	 information	on	 the	 setup	and	antibody	optimization	 for	 titration	
curve	analysis	and	FMO	optimization.	
Stellenbosch University  https://scholar.sun.ac.za
50	
Table	2.2:	Multicolour	Flow	cytometry	antibodies.	
Antibody	 Volume	
(µL/1	x	106	cells)	 Manufacturer	 Fluorophore	 Host	 Reactivity	 Reference	
Pax7	 10	 Novus	Biological	 PE	 Mouse	 Human	 NBP2-34706	
MyoD	 10	 Novus	Biological	 APC	 Mouse	 Human	 NBP2-34772	
Myf-5	 5	 Novus	Biological	 ALEX	488	 Mouse	 Human	 IC4027G	
CD56	 2.5	 BioLegend	 PE/Dazzle	 Mouse	 Human	 363544	
CD34	 2.5	 BioLegend	 APC/Cy7	 Mouse	 Human	 350526	
Ki-67	 5	 BioLegend	 PE/Cy7	 Mouse	 Human	 343514	
Footnote:	 Antibody	 optimization	 was	 performed	 via	 titration	 experiments.	 Fluorescence-minus-one	 (FMO)	
analysis	 was	 performed	 to	 ascertain	 the	 presence	 of	 any	 spectral	 overlap	 of	 the	 fluorophores	 in	 different	
channels.	Refer	to	Appendix	D	for	Flow	cytometry	setup	and	antibody	optimization	for	titration	curve	analysis	
and	FMO	optimization	data.	
2.2.2 CELL	CYCLE	ANALYSIS	AFTER	10	DAYS	IN	QUIESCENCE	MEDIA	
Cells	were	trypsinized	and	pelleted	as	described	in	Section	2.1.2.	To	study	the	phase	of	the	cell	cycle	
the	BD	Cycletest™	Plus	DNA	Reagent	Kit	was	employed	 (BD	Biosciences,	USA,	340242),	 that	 stains	
the	DNA	with	Propidium	Iodide,	a	fluorescent	dye.	Pelleted	cells	were	washed	twice	with	1	mL	of	the	
Wash	Buffer	 supplied	 in	 the	 kit.	 The	Wash	Buffer	was	 removed	and	250	μL	of	 Solution	A	 (Trypsin	
Buffer)	was	added	and	left	for	10	min.	200	μL	of	Solution	B	(Trypsin	inhibitor	and	RNase	buffer)	was	
then	added	and	left	for	another	10	min.	Finally,	200	μL	of	ice-cold	Solution	C	(PI	Stain	solution)	was	
added	to	the	cell	suspension	and	cells	were	incubated	in	the	dark	on	ice	for	a	further	10	min.	Cells	
were	 filtered	 through	a	 50	μm	nylon	mesh	and	 immediately	 analysed	using	 a	 flow	 cytometer	 (BD	
FACSAria™	Cell	Sorter,	BD	Biosciences,	San	Jose,	CA	95133,	USA)	to	determine	the	DNA	ploidy.	BD™	
DNA	QC	 Particles	 (BD	 biosciences,	 USA,	 349523)	was	 used	 to	 verify	 the	 instruments	 performance	
and	 quality	 control	 according	 to	 manufacturer’s	 instructions.	 Cell	 cycle	 fractions	 were	 quantified	
with	ModFitL	3.0	(Verity	Software).	A	minimum	of	3	x	104	cells	were	acquired	and	analysed	for	each	
sampling	 group.	 Refer	 to	 Figure	 2.1	 below	 for	 graphical	 illustration	 demonstrating	 the	 different	
phases	of	the	cell	cycle	as	determined	using	this	technique.		
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Figure	2.1:	Graphical	illustration	of	the	phases	of	the	cell	cycle	as	assessed	using	flow	cytometry.	
Panel	 A:	 Depicts	 the	 various	 phases	 of	 the	 cell	 cycle	 composed	 of	 Interphase	 and	 Mitosis.	 Interphase	 is	
composed	of	3	separate	stages:	G1,	S	and	G2.	In	the	G1-phase	the	cell	has	1	copy	of	each	chromosome	(n).	In	
S-phase	the	DNA	is	replicated.	In	the	G2-phase	the	cell	has	2	copies	of	each	chromosome	(2n).	Mitosis	is	where	
the	mother	cell	divides	to	form	2	daughter	cells.	Panel	B:	Depicts	a	typical	DNA	content	histogram	generated	
with	 ModFitL	 3.0	 (Verity	 Software).	 Here	 the	 different	 cell	 cycle	 phases	 are	 distinguished	 by	 fluorescence	
intensity.	The	G0/G1	peak	represents	cells	with	n	amount	of	chromosomes.	The	G2/M	peak	represents	cells	
with	2n	amount	of	chromosomes.	The	S-phase	peak	represents	cells	with	n	to	2n	amounts	of	DNA.	The	Sub-G1	
phase	 represents	a	population	of	 cellular	debris	or	apoptotic	 cells.	 Image	modified	and	 reproduced	without	
permission	from	(Tabll	&	Ismail	2011).	
A.	 B.	 G0/G1	
S-phase	
G2/M	
Sub-G1	
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2.3 HEPATOCYTE	GROWTH	FACTOR	TREATMENT	
2.3.1 PREPARATION	OF	RH-HGF	
Lyophilized	recombinant	human	hepatocyte	growth	factor	(rh-HGF)	(5	μg)	(R&D	Systems,	USA,	294-
HG)	 was	 reconstituted	 at	 50	 μg/mL	 in	 sterile	 1x	 PBS	 with	 0.1%	 (w/v)	 of	 BSA	 (Roche,	 Germany,	
10735086001).	The	reconstituted	rh-HGF	(50	μg/mL)	was	then	diluted	by	a	factor	of	10,	to	yield	a	5	
μg/mL	 working	 stock,	 which	 was	 aliquoted	 and	 stored	 at	 -20	 °C	 (Refer	 to	 Appendix	 A).	 For	 all	
subsequent	experiments	using	either	a	high	or	low	concentration	of	rh-HGF,	the	working	stock	was	
diluted	as	follows:			
• High	concentration	of	rh-HGF	(10	ng/mL)	-	30	μL	of	stock	rh-HGF	(5	μg/mL)	added	to	14.97
mL	of	quiescence	media.
• Low	concentration	of	rh-HGF	(2	ng/mL)	-	3	mL	of	High	concentration	(10	ng/mL)	added	to	12
mL	of	quiescence	media.
2.3.2 RH-HGF	TREATMENT	
Before	rh-HGF	treatment,	PHMs	were	cultured	in	6-well	cell	culture	plates	(Corning,	USA,	#3516)	in	
quiescence	 media	 for	 10	 days	 in	 order	 to	 induce	 a	 quiescent	 state	 (refer	 to	 Section	 2.1.3).	 The	
quiescent	PHMs	were	then	treated	with	either	low	(2	ng/mL)	or	high	(10	ng/mL)	dose	of	rh-HGF	for	a	
period	of	24	h	and	48	h	respectively.	The	48	h-low	and	-high	rh-HGF	treatment	groups	were	treated	
with	freshly	made	media	at	an	initial	time	point	(Time	0)	and	then	again	exactly	24	h	later.	The	24	h-
low	and	-high	rh-HGF	groups	were	also	treated	at	the	initial	(Time	0)	time	point,	but	after	24	h,	the	
rh-HGF	containing	media	was	removed.	The	cells	were	washed	twice	with	1x	sterile	PBS	and	cultured	
for	a	further	24	h	in	quiescence	media.	The	purpose	for	this	was	to	see	whether	brief	exposure	to	rh-
HGF	was	enough	to	stimulate	and	maintain	gene	expression.	After	48	h	in	culture,	protein	and	RNA	
from	the	low	(24	h	rh-HGF	and	48	h	rh-HGF)	and	high	(24	h	rh-HGF	and	48	h	rh-HGF)	were	isolated	
and	stored	at	-80	°C	for	subsequent	analysis.	The	rh-HGF	was	added	freshly	to	all	quiescence	media	
for	 all	 treatment	 groups.	 Refer	 to	 Appendix	 E	 for	 detailed	 information	 on	 the	 rh-HGF	 treatment	
tissue	culture	plate	setup.	
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2.4 WESTERN	BLOTTING	
2.4.1 PROTEIN	HARVESTING	FROM	CULTURED	CELLS	
Media	 was	 removed	 and	 cells	 were	 washed	 twice	 with	 ice-cold	 1x	 PBS.	 100	 μL	 of	 RIPA-buffer	
containing	 50	 mM	 Tris	 (hydroxymethyl)	 aminomethane	 (NH2C(CH2OH)3,	 (MW	 =	 121.14)	 (Sigma-
Aldrich,	 Germany,	 201-064-4),	 2.5	mM	TRIS-HCl	 pH	 7.8	 1	M	 (Sigma-Aldrich,	 Germany,	 T2913),	 1%	
(v/v),	Triton	X-100	(Sigma-Aldrich,	Germany,	X100),	0.5%	(v/v)	sodium	deoxycholate	(MW	=	414.55)	
(Sigma-Aldrich,	 Germany,	 DA5670),	 0.25%	 (w/v)	 ethylenediaminetetraacetic	 acid	 disodium	 salt	
dihydrate	 (EDTA,	M	 =	 372.24)	 (Sigma-Aldrich,	 Germany,	 205-358-3),	 2x	 protease	 inhibitor	 cocktail	
(Roche,	Germany,	04-693-116-001)	and	1x	phosphatase	inhibitor	cocktail	(Roche,	Germany,	04-906-
837-001)	was	added	to	each	culture	well	(Refer	to	Appendix	F).	Culture	plates	were	kept	on	ice	and	
cells	 were	 harvested	 from	 the	 culture	 surface	 with	 a	 cell	 scraper	 (NEST,	 USA,	 710001)	 and	
transferred	 into	 a	 1.5	 mL	 Eppendorf	 tube.	 The	 collected	 cell	 suspension	 was	 sonicated	 for	 15	
seconds	and	centrifuged	at	14,000	RPM	for	10	min	at	4	°C.	The	supernantant	was	transferred	into	a	
new	1.5	mL	Eppendorf	tube	and	protein	concentrations	were	determined	spectrophotometrically	via	
the	 Direct	 Detect®	 infrared	 spectrophotometer	 (EDM	 Millipore,	 USA,	 DDHW00010-00).	 Samples	
were	stored	at	-80	°C.	Refer	to	Appendix	F	for	detailed	information	on	protein	lysate	preparation	and	
quantification	for	raw	protein	concentration	readouts.	
2.4.2 POLYACRYLAMIDE	GEL	ELECTROPHORESIS	AND	WESTERN	BLOTTING	PROTOCOL	
Protein	 lysates	were	thawed	on	 ice	and	a	specific	volume	of	 the	sample	was	aliquoted	 in	order	 to	
contain	a	total	of	10	μg	of	protein.	A	pre-made	5x	Laemmli	sample	buffer	containing	a	10%	(v/v)	of	
2-mercaptoethanol	(Bio-Rad,	USA,	161-0710)	was	added	to	the	proteins	and	the	lysates	placed	in	a	
heating	block	at	95	 °C	 for	5	min	 to	denature	 the	proteins.	Cell	 lysates	containing	10	µg	of	protein	
were	 loaded	 and	 separated	 on	 a	 polyacrylamide	 gel	 by	 sodium	dodecyl	 sulfate	 polyacylamide	 gel	
electrophoresis	 (SDS-PAGE).	 A	 TGX	 Stain-Free™	 FastCast™	Acrylamide	 kit,	 12%	 (BioRad,	USA,	 161-
0185)	 was	 used	 to	 separate	 proteins.	 Refer	 to	 Appendix	 G	 -	Western	 blot	 reagents,	 for	 detailed	
recipies.		
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For	 electrophoresis	 run,	 power	was	 set	 at	 a	 constant	 voltage	 of	 120V	 for	 10-15	min	 to	 allow	 the	
protein	samples	to	pass	into	the	resolving	gel	and	then	increased	to	200V	for	1	h	or	until	satisfactory	
separation	was	observed	(Bio-Rad	PowerPac	1000,	Bio-Rad	Laboratories,	USA).	Gels	were	placed	in	a	
ChemiDoc™	 MP	 Imaging	 System	 (Bio-Rads	 Laboratories,	 USA)	 and	 activated	 for	 total	 protein	
visualization	 and	 quantification.	 After	 activation,	 proteins	 samples	were	 transferred	 to	 a	 0.45	 μm	
low-autofluorescence	 polyvinylidene	 difluoride	 (LF	 PVDF)	 membrane	 using	 a	 Trans-Blot®	 Turbo™	
RTA	 Transfer	 Kit,	 LF	 PVDF	 (Bio-Rad,	 USA,	 170-4274)	 and	 a	 Bio-Rad	 Trans-Blotv®	 Turbo™	 Transfer	
system.	The	apparatus	was	run	according	to	Bio-Rad’s	standard	protocol	for	1.5	mm	gels	(25V	and	
1.3A	 for	 10	 min),	 to	 ensure	 maximal	 protein	 transfer	 onto	 the	 membrane.	 After	 proteins	 were	
successfully	 transferred	 to	 the	 LF	 PVDF	 membrane,	 it	 was	 washed	 three	 times	 in	 1x	 TBS-Tween	
buffer	for	5	min.	The	membrane	was	then	blocked	with	5%	(v/v)	fat	free	milk	(Parmalat)	in	1x	TBS-
Tween	buffer	for	1	h,	to	prevent	non-specific	binding.	The	membrane	was	then	washed	three	times	
in	1x	TBS-tween	buffer	for	5	min	to	remove	traces	of	milk.		
Primary	antibody	was	added	to	1x	TBS-Tween	with	2%	(w/v)	BSA	(Roche,	Germany,	10735086001)	
buffer	 at	 a	 1:1000	dilution	and	 incubated	overnight	 at	 4	 °C	with	 constant	 agitation.	After	primary	
antibody	incubation	was	complete	the	membrane	was	washed	six	times	in	1x	TBS-Tween	buffer	for	5	
min	 and	 then	 incubated	with	 secondary	 HRP-linked	 (horse	 radish	 peroxidase)	 antibodies	 at	 room	
temperature	for	1	h	with	constant	agitation.	Finally,	the	membrane	was	washed	again	six	times	in	1x	
TBS-Tween	buffer	 for	5	min	 to	 remove	any	non-specific	binding.	Proteins	were	visualized	with	 the	
aid	 of	 chemiluminescence	 SuperSignal®	 West	 Femto	 Maximum	 Sensitivity	 Substrate	 Kit	 (Thermo	
Scientific,	USA,	34096)	and	imaged	using	the	ChemiDoc™	MP	Imaging	system	(Bio-Rad	Laboratories,	
USA).	 Densitometric	 analysis	 of	 the	 protein	 samples	was	 performed	 on	 the	 Image	 Lab™	 Software	
(Bio-Rad	Laboratories,	USA)	and	normalized	to	total	protein.	Refer	to	Appendix	H	for	more	detailed	
protocols	on	polyacrylamide	gel	electophoresis	and	Western	blotting.	
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Table	2.3:	Primary	antibodies	used	for	Western	blotting.	
1°	
Antibody	 Clonality	
Host	
Species	 Reactivity	 IsoType	 MW	(kDa)	 Dilution	
Product	
Reference	
MyoD1	 Monoclonal	 Rabbit	 H	 IgG	 ±	45	 1:1000	 D8G3	
Myf-5	 Polyclonal	 Rabbit	 H,M,R	 N/A	 ±	29	 1:2000	 ABD19	
c-Met	 Monoclonal	 Rabbit	 H	 IgG	 ±	160	 1:1000	 Ab51067	
HGF	 Monoclonal	 Rabbit	 H	 IgG	 ±	83	 1:1000	 Ab178395	
Footnote:	The	table	demonstrates	the	optimal	dilution	of	primary	antibodies	used	for	Western	blotting.	These	
concentrations	are	based	on	the	manufacturer’s	recommendations	and	optimization	experiments.	MyoD1	was	
purchased	 from	 Cell	 Signaling	 Technologies.	 Myf-5	 was	 purchased	 from	 Merck.	 C-Met	 and	 HGF	 were	
purchased	from	Abcam.	H	-	Human;	M	-	Mouse;	R	-	Rabbit.	IgG	-	Immunoglobulin	G.	MW	-	Molecular	weight.			
Table	2.4:	Secondary	antibodies	used	for	Western	blotting.	
2°	Antibody	 Product	Reference	 MyoD1	 Myf-5	 c-Met	 HGF	
Anti-Rabbit	IgG	 7074	 1:10000	 1:15000	 1:15000	 1:10000	
Footnote:	Optimal	dilution	of	secondary	anti-rabbit	IgG	antibody	used.	These	concentrations	are	based	on	the	
manufacturer’s	recommendations	and	optimization	experiments.	Secondary	Anti-rabbit	IgG	was	conjugated	to	
horse	radish	peroxidase	(HRP)	and	purchased	from	Cell	Signaling	Technologies.	
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2.5 RNA	ANALYSIS	
2.5.1 RNA	EXTRACTION	
Media	was	 removed	 and	 cells	were	washed	 twice	with	 ice-cold	 1x	 PBS	 and	placed	on	 ice.	 300	μL	
TriPure	Isolation	Reagent	(Roche,	USA,	11667157001)	was	added	and	cells	were	harvested	from	the	
culture	surface	via	the	aid	of	a	cell	scraper.	Cell	suspensions	were	placed	in	a	1.5	mL	Eppendorf	tube	
and	placed	at	-80	°C.		The	lysates	were	thawed	and	left	at	room	temperature	for	5	min.	Chloroform	
(0.2	 mL/1	 mL	 of	 TriPure	 reagent)	 was	 added	 and	 the	 tubes	 shaken	 vigorously	 and	 allowed	 to	
incubate	for	15	min.	The	tubes	were	the	centrifuged	at	12,000	x	g	 for	15	min	at	2-8	°C.	The	upper	
aqueous	phase	was	collected	and	mixed	with	an	equal	volume	of	70%	Ethanol.	The	entire	solution	
was	transferred	to	a	High	Pure	Filter	Tube,	which	was	placed	in	a	2	mL	Collection	Tube,	supplied	in	
the	 kit.	 The	 High	 Pure	 Filter	 Tube	 assembly	 was	 centrifuged	 at	 8000	 x	 g	 for	 1	 min	 at	 room	
temperature.	Each	sample	was	then	DNase	treated,	with	10	μL	of	DNase	I	mixed	with	90	μL	of	DNase	
I	 Incubation	 Buffer	 and	 allowed	 to	 incubate	 for	 15	 min	 at	 room	 temperature.	 After	 the	 DNase	
treatment,	500	μL	of	Wash	Buffer	I	was	added	to	the	upper	reservoir	of	the	Filter	Tube	assembly	and	
centrifuged	at	8,000	x	g	for	1	min.	This	wash	step	was	performed	twice	to	further	decrease	280	nm	
contamination.	Wash	buffer	II	(500	μL)	was	added	and	the	Filter	Tube	assembly	centrifuged	at	8,000	
x	g	for	1	minute	at	room	temperature.	Wash	Buffer	II	was	added	a	second	time,	albeit	only	200	μL,	
and	centrifuged	at	13,000	x	g	for	2	min	to	remove	any	residual	Wash	Buffer.	RNA	was	then	eluted	by	
adding	30	μL	of	pre-warmed	 (45	 °C)	Elution	Buffer	and	centrifuging	 the	Filter	Tube	assembly	 for	1	
min	at	8,000	x	g.	RNA	yield	and	purity	was	quantified	by	spectrophotometry	using	a	NanoDrop	Lite	
(Thermo	 Scientific,	 USA).	 An	 A260/A280	 ratio	 of	 ~2.0	 is	 accepted	 as	 ‘pure’	 for	 RNA.	 Refer	 to	
Appendix	I	for	RNA	quantification,	raw	RNA	concentration	and	purity	readouts.		
2.5.2 cDNA	SYNTHESIS	
Reverse	transcription	(RT)	of	the	isolated	RNA	to	obtain	cDNA	was	performed	with	a	High	Capacity	
RNA-to-cDNA	 kit	 (Roche,	 USA,	 4387406).	 The	 RNA	 sample	 was	 added	 to	 the	 RT	 reaction	 mix	
composed	of	10	μL	of	2x	RT	Buffer	and	1	μL	of	20x	RT	Enzyme	Mix.	Nuclease-free	H2O	was	used	to	
bring	the	total	reaction	volume	to	20	μL	in	each	tube.	The	tubes	were	mixed,	and	placed	in	a	thermal	
cycler	(Applied	Biosystems	2720	Thermal	Cycler,	USA).	The	Thermal	cycler	was	programmed	for	a	3-
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Step	cycling	condition	optimized	for	the	High	Capacity	RNA-to-cDNA	Kit	according	to	manufacturer’s	
instructions.	Refer	to	Table	2.5	for	optimized	cycling	conditions.	
Table	2.5:	Optimized	cycling	conditions	for	the	High	Capacity	RNA-to-cDNA	Kit.	
STEP	1	 STEP	2	 STEP	3	
Temperature	(°C)	 37	 95	 4	
Time	(min)	 60	 5	 ∞	
Footnote:	 3-Step	 cycling	 condition	 optimized	 for	 the	 High	 Capacity	 RNA-to-cDNA	 Kit	 according	 to	
manufacturer’s	instructions.	
2.5.3 QUANTITATIVE	POLYMERASE	CHAIN	REACTION	
Samples	 were	 loaded	 in	 duplicate	 into	 MicroAmp®	 Fast	 optical	 96-well	 reaction	 plates	 (Applied	
biosystems,	USA,	4346907).	Each	well	 contained	10	μL	of	2x	TaqMan	Gene	Expression	Master	mix	
(Applied	biosystems,	USA,	4369016),	1	μL	of	20x	TaqMan	gene	expression	assays	(probe	(5	μM)	and	
primer	 (18	μM))	and	10-100	ng	of	cDNA	template.	Samples	were	 run	on	a	StepOnePlus™	realtime	
PCR	machine	 (Life	Technologies,	USA)	with	the	 following	cycling	conditions	optimized	according	to	
manufacturer’s	instructions	(Refer	to	Table	2.6).	
Table	2.6:	qPCR	thermal	cycling	conditions	for	TaqMan	gene	expression	master	mix	and	assays.	
Step	
UDG	Incubation	
AmpliTaq	Gold,	
UP	Enzyme	
Activation	
PCR	
CYCLE	(40	Cycles)	
HOLD	 HOLD	 Denature	 Anneal/Extend	
Time	 2	min	 10	min	 15	sec	 1	min	
Temp	 50	°C	 95	°C	 95	°C	 60	°C	
Footnote:	 The	 cycling	 conditions	 are	 optimized	 for	 use	 with	 the	 TaqMan	 gene	 expression	master	 mix	 and	
TaqMan	gene	expression	assays	according	to	manufacturer’s	instructions.	The	2-minute,	50	°C	step	is	required	
for	 Uracil-DNA	 Glycosylase	 (UDG)	 enzyme	 activity.	 UDG	 prevents	 the	 reamplification	 of	 carryover-PCR	
products	 by	 removing	 any	 uracil	 incorporated	 into	 the	 single-	 or	 double-stranded	 amplicons	 (Longo	 et	 al.	
1990).	The	10-minute,	95	°C	is	required	to	activate	the	AmpliTaq	Gold®	DNA	polymerase,	Ultra	Pure	(UP).	The	
AmpliTaq	Gold®	DNA	polymerase,	UP,	is	a	chemically	modified	form	of	AmpliTaq	Gold®	DNA	polymerase,	that	
is	only	active	at	temperatures	where	the	DNA	is	fully	denatured.	
Each	sample	was	run	in	duplicate	and	the	resultant	CT	was	calculated	by	the	the	software	(StepOne™	
Software	v2.2.2,	Life	Technologies,	USA)	and	a	mean	CT	value	was	calculated	for	each	sample.	The	CT	
value	represents	the	cycle	number,	at	which	the	amplification	plot	crosses	a	threshold,	for	which	the	
fluorescent	signal	generated	is	significant	with	regards	to	the	background	levels.	The	18	S	ribosomal	
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sunbunit	 was	 used	 as	 endogenous	 reference	 gene	 (Goidin	 et	 al.	 2001).	 This	 allowed	 for	 the	
normalization	 of	 gene	 expression	 for	 each	 target	 gene,	 to	 the	 amount	 of	 input	 cDNA.	 Briefly,	
calculation	of	ΔΔCT	was	obtained	first	by	subtracting	the	mean	CT	value	for	each	target	gene,	to	the	
mean	CT	value	for	the	reference	gene	(CT	target	gene	-	CT	endogenous	reference	gene).	The	obtained	
value,	 termed	ΔCT,	was	 then	used	to	determine	the	ΔΔCT	value.	The	ΔΔCT	describes	 the	difference	
between	the	average	ΔCT	value	of	the	sample	of	 interest	and	the	average	ΔCT	value	of	a	reference	
sample.	 This	 sample,	 known	 as	 the	 calibrator	 sample,	 is	 usually	 obtained	 from	 unstimulated	 or	
untreated	 cells	 and	 is	 used	 to	 normalize	 all	 other	 (stimulated)	 samples.	 Thus,	ΔΔCT	 =	 average	ΔCT
(sample	 of	 interest)	 -	 average	 ΔCT	 (reference	 sample).	 Finally,	 relative	 expression	 levels	 for	 each	
target	gene	were	calculated	by	the	following	formula	(2-ddCT).	Refer	to	Appendix	J	 -	qPCR	raw	data,	
for	raw	CT	readouts.	
Table	2.7:	TaqMan	Probes	utilized	for	qPCR.	
TaqMan	Probe	 Amplicon	Length	(bp)	 Catalogue	#	 Reference	
MyoD1	 87	 4331182	 Hs02330075_g1	
Myf-5	 114	 4331182	 Hs00929416_g1	
Pax7	 73	 4331182	 Hs00242962_m1	
18S	 187	 4331182	 Hs99999901_s1	
Footnote:	TaqMan	Probes	were	purchased	from	Applied	Biosystems.	
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2.6 MICRORNA	ANALYSIS	
2.6.1 miRNA	EXTRACTION	
Media	was	 removed	and	cells	were	washed	 twice	with	 ice-cold	1x	PBS	and	placed	on	 ice.	QIAzol®	
lysis	 reagent,	 included	 in	 the	miRNeasy®	mini	kit	 (Qaigen,	Germany,	217004),	was	added	and	cells	
were	harvested	from	the	culture	surface	via	the	aid	of	a	cell	scraper.	Cell	suspensions	were	placed	in	
a	 1.5	mL	 Eppendorf	 tube	 and	placed	 at	 -80	 °C.	 Samples	were	 thawed	 and	 allowed	 to	 incubate	 at	
room	temperature	for	5	min.	Chloroform	(0.2	mL/1	mL	of	QIAzol®	reagent)	was	added	to	the	tubes	
and	shaken	vigorously	for	15	seconds.	The	tubes	were	left	to	stand	for	2-3	min	after	which	they	were	
centrifuged	at	12,000	x	g	at	4	°C	for	15	min.	The	upper	aqueous	phase	was	placed	in	a	new	collection	
tube	and	1.5	volumes	of	100%	ethanol	was	added	and	mixed.	The	sample	was	transferred	 into	an	
RNeasy	mini	spin	column	and	 inserted	 into	a	2	mL	collection	tube,	supplied	 in	 the	kit.	The	RNeasy	
mini	spin	column	was	centrifuged	at	8000	x	g	for	15	seconds	at	room	temperature.	700	μL	of	Buffer	
RWT	was	added	to	the	column	and	centrifuged	at	8000	x	g	for	15	seconds,	followed	by	two	separate	
additions	of	500	μL	of	Buffer	RPE.	Finally,	30	μL	of	RNase-Free	water	was	added	directly	onto	 the	
RNeasy	Mini	column	membrane	and	centrifuged	for	1	min	at	8,000	x	g	to	elute	the	RNA.	RNA	yield	
and	purity	was	quantified	by	 spectrophotometry	using	a	NanoDrop™	Lite	 (Thermo	Scientific,	USA,	
ND-LITE).	An	A260/A280	ratio	of	~2.0	is	accepted	as	‘pure’	for	RNA.	Refer	to	Appendix	I	for	raw	RNA	
concentration	and	purity	readouts.	
2.6.2 cDNA	SYNTHESIS	
Isolated	miRNA	was	 reverse	 transcribed	 into	 cDNA	using	 the	miScript	 II	 RT	 Kit	 (Qiagen,	Germany,	
218161),	which	allows	for	the	selective	reverse	transcription	of	mature	miRNAs.	The	miRNA	sample	
was	 added	 to	 the	 RT	 reaction	mixed	 composed	 of	 4	 μL	 of	 5x	miScript	 HiSpec	 Buffer,	 2	 μL	 of	 10x	
miScript	Nucleics	mix	and	2	μL	of	miScript	reverse	transcriptase	mix.	Nuclease-free	H2O	was	used	to	
bring	the	total	reaction	volume	to	20	μL	 in	each	tube.	The	tubes	were	then	mixed	and	centrifuged	
and	 then	placed	 in	 a	 thermal	 cycler	 (Applied	Biosystems	 2720	 Thermal	 Cycler,	USA).	 The	 Thermal	
cycler	 was	 programmed	 for	 a	 3-Step	 cycling	 condition,	 optimized	 according	 to	 manufacturer’s	
instructions	(see	Table	2.8).	
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Table	2.8:	Cycling	condtions	for	the	miScript	II	RT	Kit.	
STEP	1	 STEP	2	 STEP	3	
Temperature	(°C)	 37	 95	 4	
Time	(min)	 60	 5	 ∞	
Footnote:	 3-Step	 cycling	 condition	 for	 the	 miScript	 II	 RT	 Kit,	 optimized	 according	 to	 manufacturer’s	
instructions.	
2.6.3 QUANTITATIVE	POLYMERASE	CHAIN	REACTION	
Samples	 were	 loaded	 in	 triplicate	 into	 MicroAmp®	 Fast	 optical	 96-well	 reaction	 plates	 (Applied	
biosystems,	USA,	4346907).	Each	well	contained	12.5	μL	of	2x	QuantiTect®	SYBR	Green	PCR	Master	
mix,	 2.5	 μL	 of	 10x	miScript	Universal	 Primer,	 2.5	 μL	 of	 10x	miScript	 primer	 assay	 and	 ≤	 2.5	 μL	 of	
template	 cDNA.	 RNase-Free	water	was	 used	 to	 bring	 the	 final	 reaction	 volume	 to	 25	μL.	 Samples	
were	 run	 on	 a	 StepOnePlus™	 realtime	 PCR	 machine	 (Life	 Technologies,	 USA)	 with	 the	 following	
setup	(see	Table	2.9).	
Table	2.9:	qPCR	thermal	cycling	conditions	for	SYBR®	Green	master	mix	and	primer	assays.	
STEP	 PCR	Initial	activation	step	
3-Step	Cycling	(40	Cycles)	 Dissociation/Melt	
curve	analysis	Denaturation	 Annealing	 Extension	
Temperature	 95°C	 94°C	 55°C	 70°C	 55	-	95°C	
Time	 15	min	 15	sec	 30	sec	 30	sec	 NA	
Footnote:	The	15-minute,	95	 °C	step	 is	 required	 to	activate	 the	HotStarTaq®	DNA	Polymerase.	Fluorescence	
data	 collection	was	 performed	 at	 the	 extension	 stage.	Melt	 curve	 analysis	was	 performed	 to	 ascertain	 that	
only	the	desired	PCR	product	was	amplified.	
Relative	target	miRNA	expression	levels	were	calculated	by	the	2-ddCT	formula	as	described	in	section	
2.5.3.	For	normalization	RNU6-2	was	used	as	an	endogenous	miRNA	control,	while	a	miRTC	control	
was	used	to	confirm	successful	cDNA	systhesis.	Refer	 to	Appendix	 J	 for	qPCR	raw	data	and	raw	CT	
readouts.	
Table	2.10:	miScript	primer	assays	utilized	for	qPCR.	
miScript	primer	 Catalogue	#	 Lot	#	
Hs_miR-31_1	 MS00003290	 20160303132	
Ctrl_miRTC_1	 MS00000001	 20160122129	
Hs_RNU6-2_11	 MS00033740	 20160505112	
Footnote:	 miScript	 primer	 assays	 were	 reconstituted	 in	 550	 μL	 TE	 Buffer	 (pH	 8.0)	 as	 per	 manufacturer’s	
instructions.	miScript	primer	assays	were	purchased	from	Qaigen.		
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2.7 STATISTICAL	ANALYSES	
Statistical	 analyses	 of	 the	 obtained	 data	 were	 performed	 with	 Graphpad	 Prism	 5	 (GraphPad	
Software,	 Inc.,	 La	 Jolla,	 CA,	 92037,	 USA).	 One-way	 ANOVA	 (analysis	 of	 variance),	 with	 Bonferroni	
post	hoc	test,	was	used	to	 infer	statistical	significance	between	each	treatment	groups.	Values	are	
expressed	as	mean	±	standard	error	of	the	mean	(S.E.M).	Statistical	significance	was	accepted	at	p	<	
0.05.	
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CHAPTER	3	
RESULTS	
3.1 OPTIMIZATION	OF	CULTURE	CONDITIONS	TO	INDUCE	A	QUIESCENT	STATE	
IN	PRIMARY	HUMAN	MYOBLASTS	
The	first	objective	of	this	project	was	to	drive	activated	and	proliferating	primary	human	myoblasts	
(PHMs)	into	a	quiescent	state.	These	PHMs	had	previously	been	cultured	and	expanded	in	Ham’s	F-
10	nutrient	medium	mixture	supplemented	with	20%	(v/v)	foetal	bovine	serum	(FBS),	10	ng/mL	rh-
FGF,	 1%	 (v/v)	 P/S	 and	 6.8%	 (v/v)	 (200	 mM,	 100x)	 L-glutamine.	 Henceforth	 this	 culture	 media	 is	
referred	 to	 as	 PHM-PM	 and	 only	 to	 describe	 the	 expansion	 conditions	 prior	 to	 day	 0	 of	
experimentation.	 For	 the	 series	 of	 experiments	 described	 in	 this	 thesis	 FBS	 and	 rh-FGF	 were	
replaced	with	20%	(v/v)	of	KnockOut™	Serum	Replacement	(KOSR)	in	the	culture	media.	
3.1.1 COMPARISON	OF	KNOCKOUT	DMEM	vs.	HAM’s	F-10	CULTURE	
Two	nutrient	media	mixtures	were	selected:	Ham’s	F-10	nutrient	medium	mixture	and	KnockOut™	
DMEM	(KO-DMEM)	 (Life	Technologies,	USA,	10829-018).	These	were	selected	as	 the	 former	 is	 the	
standard	media	used	for	PHM	culture	in	vitro	(Motohashi	et	al.	2014;	Liu	et	al.	2015),	while	the	latter	
is	specifically	formulated	for	serum	free	culture	supplemented	with	KnockOut™	Serum	Replacement	
(KOSR).	
For	 the	 first	 series	 of	 experiments	 KOSR	was	 added	 to	 the	 two	 choice	media	 (Ham’s	 F-10	 or	 KO-
DMEM)	 to	 determine	 if	 this	 affected	 PHM	 survival	 and	morphology	 over	 a	 10	 day	 culture	 period.	
Furthermore,	 to	 observe	 the	 effects	 of	 cell	 to	 cell	 proximity	 on	morphology	 and	 alignment,	 each	
culture	plate	contained	different	amounts	of	cells	on	day	0	(50	x	103,	75	x	103,	100	x	103,	125	x	103,	
150	x	103,	200	x	103).	The	effects	of	different	plating	densities	was	observed	10	days	later	(see	Figure	
3.1).	
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Observations	
After	10	days	in	culture	cells	were	in	very	close	proximity	(90%-100%	confluency)	and	began	showing	
morphological	 changes	 (Figure	 3.1,	 Panels	 A-F),	 namely	 elongation	 (yellow	 arrow)	 and	 alignment	
(red	arrow),	similar	to	differentiating	myoblasts.	These	changes	became	more	prominent	on	plates	
seeded	with	 higher	 cell	 numbers	 (Figure	 3.1,	 Panels	 B-F).	 Figure	 3.1,	 Panel	 A,	 indicates	 that	 even	
plating	50	x	103	cells	on	day	0	resulted	in	a	high	degree	of	confluency	in	the	culture	plates	after	10	
days	of	culture,	with	confluency	even	greater	with	75	x	103	-	200	x	103	cell	plating	densities.		
Consequently,	these	results	suggested	that	plating	fewer	cell	numbers	than	50	x	103	on	day	0	would	
be	worth	investigating	to	determine	if	the	morphological	changes	suggestive	of	early	differentiation	
would	 be	 reduced	 when	 cells	 are	 plated	 at	 a	 lower	 seeding	 density.	 This	 prompted	 the	 next	
experiments,	with	results	presented	in	Figure	3.2.	Plating	density	was	decreased	so	that	the	number	
of	cells	plated	on	day	0	was	either	20	x	103,	30	x	103	or	40	x	103	(Figure	3.2,	Panels	A,	C,	E).	Not	only	
plating	density	but	also	the	culture	media	was	changed.	It	was	also	decided	to	culture	PHMs	in	their	
typical	media,	Ham’s	F-10,	supplemented	with	20%	(v/v)	KOSR,	instead	of	KO-DMEM	supplemented	
with	20%	(v/v)	KOSR.		
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Figure	3.1:	PHM	morphology	after	a	10	day	period	of	culture	in	KO-DMEM	and	20%	KOSR,	plated	
at	different	confluencies.	
Cells	were	plated	into	6-well	tissue	culture	plates	(35	mm).	Plating	densities	on	day	0:	Panel	A	-	50	x	103	cells.	
Panel	B	-	75	x	103		cells.	Panel	C	-	100	x	103		cells.	Panel	D	-	125	x	103		cells.	Panel	E	-	150	x	103		cells.	Panel	F	-	
200	x	103		cells.	The	culture	media	was	changed	daily	and	cells	were	washed	once	with	1x	PBS.	Red	arrows	-	
aligned	PHMs.	Yellow	arrows	-	elongated	PHMs.	Green	arrows	-	Normal	PHM	morphology	in	vitro.	
KO-DMEM	50	x	103	 KO-DMEM	75	x	103	
KO-DMEM	100	x	103	 KO-DMEM	125	x	103	
KO-DMEM	150	x	103	 KO-DMEM	200	x	103	
A.	 B.	
C.	 D.	
E.	 F.	
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Observations	
Both	 KO-DMEM	 and	 Ham’s	 F-10,	 each	 supplemented	 with	 20%	 (v/v)	 KOSR,	 maintained	 cellular	
viability	 over	 the	 10	 day	 culture	 period	 (Figure	 3.2,	 Panels	 A-F)	 and	 reduced	 cellular	 proliferation	
(KO-DMEM	 from	 5	 days	 onwards	 and	 Ham’s	 F-10	 from	 3	 days	 onwards	 -	 qualitative	 assessment	
only).	Specifically,	after	10	days	 in	culture,	Ham’s	F-10	seemed	to	reduce	cellular	proliferation	to	a	
greater	 extent	 than	 KO-DMEM	 as	 evident	 from	 visibly	 less	 confluent	 culture	 surfaces	 (Figure	 3.2,	
Panels	A	vs.	B,	C	vs.	D	and	E	vs.	F).	It	was	then	noted	that	the	cell	culture	media	choice	(KO-DMEM)	
not	only	did	not	 rapidly	 reduce	proliferation,	but	 favoured	PHM	growth	 (more	elongated	and	 less	
spindle-like	morphology),	whereas	Ham’s	F-10	allowed	for	maintainance	of	typical	PHM	morphology	
in	 vitro	 (Figure	3.2,	Panels	A	vs.	B,	C	 vs.	D	and	E	 vs.	 F).	 Specifically,	PHMs	cultured	 in	Ham’s	 F-10,	
maintained	a	single	cell	spindle-shaped	morphology.	The	fact	that	plating	densities	ranged	from	20	x	
103	 -	 40	 x	 103	 	 all	maintained	 the	 typical	morphology,	 suggests	 the	 effect	 can	 be	 ascribed	 to	 the	
Ham’s	F-10	media	(Figure	3.2,	Panels	B,	D	and	F).	
Based	on	these	observations,	it	was	decided	that	for	all	subsequent	experiments,	PHMs	were	to	be	
cultured	in	Ham’s	F-10,	supplemented	with	20%	(v/v)	KOSR.	Since	the	objective	of	expsoure	to	KOSR	
is	to	promote	quiescence,	the	culture	media	was	called	quiescence	media	from	this	point	forward.		
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Figure	3.2:	PHM	morphology	after	a	10	day	period	of	culture	in	either	KO-DMEM	and	20%	KOSR	or	
quiescence	media	(Ham’s	F-10	and	20%	KOSR),	plated	at	different	low	confluencies.	
Cells	were	plated	into	6-well	tissue	culture	plates	(35	mm).	Plating	densities	on	day	0:	Panel	A	-	20	x	103	cells	
plated	on	day	0	 in	KO-DMEM	and	20%	KOSR.	Panel	B	 -	20	x	103	 	cells	plated	on	day	0	 in	quiescence	media.	
Panel	C	-	30	x	103		cells	plated	on	day	0	in	KO-DMEM	and	20%	KOSR.	Panel	D	-	30	x	103		cells	plated	on	day	0	in	
quiescence	media.	Panel	E	-	40	x	103		cells	plated	on	day	0	in	KO-DMEM	and	20%	KOSR.	Panel	F	-	40	x	103		cells	
plated	on	day	0	in	quiescence	media.	The	culture	media	was	changed	daily,	and	cells	were	washed	once	with	
1x	 PBS.	 Red	 arrows	 -	 aligned	 PHMs.	 Yellow	 arrows	 -	 elongated	 PHMs.	 Green	 arrows	 -	 Normal	 PHM	
morphology	in	vitro.	
KO-DMEM	20	x	103	
KO-DMEM	30	x	103	
KO-DMEM	40	x	103	
Ham’s	F10	30	x	103	
Ham’s	F10	20	x	103	
Ham’s	F10	40	x	103	
A.	
F.	E.	
D.	C.	
B.	
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3.1.2 	THE	 EFFECT	 OF	 QUIESCENCE	 MEDIA	 ON	 THE	 EXPRESSION	 OF	 SATELLITE	 CELL	
MARKERS	
Criteria	 to	 confirm	 that	 culturing	 PHMs	 in	 Ham’s	 F-10	 supplemented	with	 20%	 KOSR	 (quiescence	
media)	 induced	the	cells	to	exit	the	cell	cycle	and	return	to	a	quiescent	state,	 included	multicolour	
flow	cytometry	and	 cell	 cycle	 analysis.	 Specifically,	multicolour	 flow	cytometry	was	used	 to	assess	
the	 expression	 of	 key	 satellite	 cell	 markers.	 The	 markers	 selected	 are	 known	 to	 be	 differentially	
expressed	 depending	 on	 the	 state	 of	 the	 satellite	 cell	 (quiescent,	 activated	 or	 proliferating).	
Furthermore,	the	selected	markers	were	used	to	confirm	the	identity	of	the	cells	used	for	this	study	
and	 to	 accurately	 determine	 their	 state	 before	 and	 after	 culturing	 in	 quiescence	 media.	 Marker	
expression	was	analysed	at	day	0,	3,	5,	7	and	10.		
Several	 multicolour	 flow	 cytomety	 experiments	 were	 run	 for	 this	 study	 in	 order	 to	 optimise	 the	
technique.	 Flow	 cytometry	 settings	 were	 modified	 for	 each	 new	 optimization	 experiment.	 PHMs	
from	subjects	1,	2,	4,	6,	and	9	were	expanded	and	used	during	optimization	experiments.	Cells	were	
not	 pooled,	 rather	 PHMs	 from	 a	 different	 subject	 were	 used	 for	 each	 optimization	 experiment.	
Optimization	 included	 for	 example	 adjustments	 to	 cytometer	 voltages,	 and	 compensation	 for	
fluorophore	 spectral	overlaps	as	well	 as	background	 fluorescence.	 Since	 several	 variables	 changed	
each	 time,	 data	 cannot	 be	 compared	 between	 the	 different	 optimization	 experiments.	 The	 first	
experiment	 after	 optimization	was	 completed,	 compared	 PHMs	 from	 four	 subjects.	Unfortunately	
between	the	final	optimizations	and	the	real	experiment,	the	violet	 laser	malfunctioned	causing	all	
optimized	 setting	 to	 be	 obsolete.	 The	 only	 observation	 that	 could	 be	made	was	 that	 CD34	was	 a	
consistant	marker	and	 its	expression	was	always	seen	 in	all	subjects	and	at	all	 time	points	(day	0	 -	
10).	
PHMs	 harvested	 from	 different	 subjects	 had	 differing	 expansion	 capabilities	 and	 only	 substantial	
cellular	stocks	were	generated	for	subject	6.		Therefore,	a	further	two	experiments	were	done	using	
PHMs	from	subject	6	only.	These	PHMs	were	in	passage	6-7.	The	first	experiment	was	performed	in	
exactly	the	same	way	as	the	final	optimization	in	terms	of	culture	conditions	and	cell	harvest	ie:	cells	
were	 cultured	 in	 35mm	wells	 and	 trypsynized	 for	 harvest.	 Results	 presented	 in	 Table	 3.1	 indicate	
once	 again,	 the	 high	 expression	 of	 CD34.	 Also,	 Myf-5	 and	 Ki-67	 were	 highly	 expressed.	 A	 third	
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observation	was	 an	 unexpected	 lack	 of	 Pax7	 on	 day	 0	 in	 the	 culture.	 These	 observations	 did	 not	
change	for	the	first	7	days.	However,	by	day	10,	it	seemed	that	Pax7	expression	was	responding.		
Table	3.1:	Summary	of	marker	expression	as	analysed	in	flow	cytometry	in	PHMs	from	subject	6,	
cultured	in	35mm	wells	in	quiescence	media	for	10	days.	
M
ar
ke
r	
Days	
0	 3	 5	 7	 10	
Cells	
counted	 %	(+)	
Cells	
counted	 %	(+)	
Cells	
counted	 %	(+)	
Cells	
counted	 %	(+)	
Cells	
counted	 %	(+)	
Ce
ll	
Su
rf
ac
e	
CD34	 7,346	 98.6	 15,582	 99.0	 9,588	 99.6	 21,998	 97.7	 19,749	 98.7	
CD56	 2,747	 36.9	 11,831	 75.2	 6,556	 68.1	 9,540	 42.4	 5,811	 29.1	
N
uc
le
ar
	 Pax7	 59	 0.8	 286	 1.8	 210	 2.2	 522	 2.3	 6,874	 34.4	
Myf-5	 7,387	 99.2	 15,631	 99.3	 9,597	 99.7	 22,145	 98.3	 19,996	 100	
MyoD	 146	 2.0	 1,314	 8.3	 782	 8.1	 840	 3.7	 1,178	 5.9	
Ki-67	 7,297	 98.0	 15,399	 97.8	 9,569	 99.4	 21,489	 95.4	 19,115	 95.8	
Footnote:	Satellite	cell	events:	Day	0	-	7,447,	Day	3	-	15,739,	Day	5	-	9,626,	Day	7	-	22,518,	Day	10	-	20,000.	
Only	live	satellite	cells	were	analysed.	PHMs	from	subject	6	were	used	at	p6.	PHMs	were	cultured	in	6-well	(35	
mm)	plates	for	10	days	in	quiescence	media.	40	x	103	cells	were	plated	on	day	0	in	each	sampling	well.	PHMs	
used	for	day	0	sampling	time	point	were	cultured	in	PHM-PM.	The	culture	media	was	changed	daily,	and	cells	
were	washed	once	with	1x	PBS.	%	(+)	=	Percentage	of	expressing	cells	for	that	marker.	
As	per	protocol,	 preparation	of	 cells	 for	 flow	 cytometry	 includes	 a	 substantial	 number	of	washing	
steps.	 It	 was	 observed	 that	 a	 significant	 proportion	 of	 cells	 were	 lost	 during	 the	 preparation	
procedure	 for	 flow	cytometric	analysis,	which	prompted	a	change	 in	culture	conditions.	 Instead	of	
repeating	 the	 experiment	 using	 6-well	 (35	 mm)	 plates	 which	 would	 have	 allowed	 for	 direct	
comparison	 between	 the	 two	 flow	 cytometry	 result	 sets	 of	 subject	 6,	 the	 decision	 was	 taken	 to	
culture	cells	 in	T75	flasks	with	seeding	densities	similar	to	that	used	for	the	wells.	This	allowed	for	
greater	 cell	 numbers	 at	 the	 start	 of	 the	 preparation	 procedure	 for	 flow	 cytometric	 analysis.	 To	
further	mitigate	 the	 loss	 of	 cells	 the	 speed	 (RPM)	 at	which	 the	 cells	were	 spun	down	 in	 between	
wash	steps	was	increased,	from	1500	RPM	for	3	min	to	3000	RPM	for	3	min.	This	was	due	to	the	fact	
that	 the	 permeabilization	 procedure	made	 the	 cells	more	 buoyant.	 Furthermore	 the	wash	 buffer	
used	 for	wash	 steps	 in	 the	 preparation	 procedure,	 composed	 of	 1x	 PBS	 and	 2%	 (w/v)	 BSA,	 has	 a	
different	 density	 than	 normal	 culture	 media	 (DMEM	 or	 Ham’s	 F-10),	 causing	 cells	 to	 be	 more	
buoyant	when	placed	 in	 it.	Furthermore,	 the	staining	protocol	was	also	slightly	altered.	Since	both	
CD34	and	CD56	are	cell	 surface	markers	and	were	present	 in	a	high	proportion	of	PHMs,	whereas	
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Pax7	and	MyoD	are	nuclear	transcription	factors,	a	 longer	time	period	for	antibody	incubation	was	
introduced	for	the	final	experiment	(1	h	rather	than	30	min).	
Table	3.2	presents	the	flow	cytometry	data	for	PHMs	isolated	from	subject	6	at	p7.	These	cells	were	
cultured	in	T75	flasks	and	incubated	with	antibodies	for	1	h.	Refer	to	Appendix	K	for	detailed	data.	
Similar	 to	 the	 first	 data	 set,	 the	 expression	 of	 the	 stem	 cell	marker,	 CD34	was	 constant	 over	 the	
entire	10	day	culture	period,	with	the	entire	PHM	population	(>	97%)	expressed	CD34	on	their	cell	
surfaces	(Table	3.2	and	Figure	3.3,	Panels	B-F).	However,	protocol	adjustments	appeared	to	alter	the	
Pax7	 data:	 Before	 culturing	 in	 quiescence	 media	 (day	 0)	 61.1%	 of	 the	 PHM	 population	 were	
expressing	 Pax7	 (Figure	 3.4,	 Panel	 B).	 Over	 the	 10	 day	 culture	 period	 the	 percentage	 of	 PHMs	
expressing	Pax7	steadily	decreased	(Figure	3.4,	Panel	B-F).	On	the	 last	day	of	culture	(day	10)	only	
32.6%	of	PHMs	were	expressing	Pax7,	suggesting	that	prolonged	culturing	in	quiescence	media	may	
cause	 Pax7	 expression	 in	 PHMs	 to	 decrease	 over	 time.	 Virtually	 all	 Pax7	 positive	 PHMs	 also	
expressed	CD34	 (Figure	3.5,	 Panel	 F).	 Taken	 together,	 although	 the	population	of	Pax7	expressing	
cells	decreased,	the	fact	that	CD34	is	expressed	in	the	entire	population,	signified	that	the	PHMs	had	
not	differentiated,	as	they	did	not	lose	their	stem	cell	status.		
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Figure	3.3:	CD34	expression	in	PHMs	over	a	10	day	culture	period	in	quiescence	media.	
Cells	were	plated	into	a	T75	tissue	culture	flask.	Panel	A:	Unstained	control	(US).	Panel	B:	Percentage	of	CD34	
expressing	PHMs	prior	to	quiescence	media	exposure.	Panel	C	-	F	:	Percentage	of	CD34	expressing	PHMs	after	
3	days	(Panel	C),	after	5	days	(Panel	D),	after	7	days	(Panel	E),	after	10	days	(Panel	F).	The	culture	media	was	
changed	daily,	and	cells	were	washed	once	with	1x	PBS.	A	minimum	of	1	x	105	satellite	cells	were	analysed	for	
each	time	point.	Data	analyses	were	performed	on	the	FACSDiva™	software	v6.1.3.	
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Figure	3.4:	Pax7	expression	in	PHMs	over	a	10	day	culture	period	in	quiescence	media.	
Cells	were	plated	into	a	T75	tissue	culture	flask.	Panel	A:	Unstained	control	(US).	Panel	B:	Percentage	of	CD34	
expressing	PHMs	prior	to	quiescence	media	exposure.	Panel	C	-	F	:	Percentage	of	Pax7	expressing	PHMs	after	3	
days	(Panel	C),	after	5	days	(Panel	D),	after	7	days	(Panel	E),	after	10	days	(Panel	F).	The	culture	media	was	
changed	daily,	and	cells	were	washed	once	with	1x	PBS.	A	minimum	of	1	x	105	satellite	cells	were	analysed	for	
each	time	point.	Data	analyses	were	performed	on	the	FACSDiva™	software	v6.1.3.	
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Figure	3.5:	Pax7	vs.	CD34	expression	in	PHMs	over	a	10	day	culture	period	in	quiescence	media.	
Cells	were	plated	into	a	T75	tissue	culture	flask.	Panel	A:	Unstained	control	(US).	Panel	B:	Percentage	of	CD34	
and	Pax7	co-expressing	PHMs	prior	to	quiescence	media	exposure.	Panel	C	-	F	:	Percentage	of	CD34	and	Pax7	
co-expressing	PHMs	after	3	days	(Panel	C),	after	5	days	(Panel	D),	after	7	days	(Panel	E),	after	10	days	(Panel	
F).	 The	 culture	media	was	 changed	 daily,	 and	 cells	 were	washed	 once	with	 1x	 PBS.	 A	minimum	 of	 1	 x	 105	
satellite	cells	were	analysed	 for	each	time	point.	Data	analyses	were	performed	on	the	FACSDiva™	software	
v6.1.3.	
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The	expression	of	the	cell	surface	marker,	CD56,	which	is	typically	expressed	on	‘activated’	satellite	
cells,	consistently	decreased	over	the	10	day	culture	period.	Before	culturing	 in	quiescence	media,	
25.8%	 of	 the	 PHM	 population	 was	 actively	 expressing	 it	 (Figure	 3.6,	 Panel	 B).	 This	 population	
dropped	 to	 only	 2.1%	 by	 day	 10	 (Figure	 3.6,	 Panel	 F).	 The	 expression	 of	 Ki-67	 is	 normally	 only	
present	in	the	nucleus	of	cells	that	are	in	the	cell	cycle	and	undergoing	proliferation.	PHMs	cultured	
in	 PHM-PM	 had	 high	 expression	 of	 the	 nuclear	 antigen,	 with	 84.5%	 of	 the	 entire	 population	
expressing	 it	before	KOSR	exposure	 (Figure	3.7,	Panel	B).	Throughout	 the	10	day	culture	period	 in	
quiescence	media,	however,	the	percentage	of	PHMs	expressing	Ki-67	dropped,	until	 less	than	half	
of	 the	 PHM	 population	 were	 expressing	 Ki-67	 on	 day	 7	 and	 day	 10	 (Figure	 3.7,	 Panels	 E	 and	 F).	
Therefore,	 culturing	 the	 PHMs	 in	 the	 quiescence	 media	 reduced	 cellular	 proliferation,	 but	
quiescence	was	not	achieved	in	all	PHMs.	In	order	to	make	use	of	subject	6’s	expanded	PHM	stocks	
to	investigate	the	effects	of	HGF	on	a	population	of	PHMs	that	were	at	least	substantially	quiescent,	
it	 was	 decided	 not	 to	 try	 a	 KOSR	 exposure	 of	 even	 longer	 than	 10	 days	 to	 determine	 if	 greater	
proportion	of	quiescence	might	have	been	achieved.		
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Figure	3.6:	CD56	expression	in	PHMs	over	a	10	day	culture	period	in	quiescence	media.	
Cells	were	plated	into	a	T75	tissue	culture	flask.	Panel	A:	Unstained	control	(US).	Panel	B:	Percentage	of	CD34	
expressing	PHMs	prior	to	quiescence	media	exposure.	Panel	C	-	F	:	Percentage	of	CD56	expressing	PHMs	after	
3	days	(Panel	C),	after	5	days	(Panel	D),	after	7	days	(Panel	E),	after	10	days	(Panel	F).	The	culture	media	was	
changed	daily,	and	cells	were	washed	once	with	1x	PBS.	A	minimum	of	1	x	105	satellite	cells	were	analysed	for	
each	time	point.	Data	analyses	were	performed	on	the	FACSDiva™	software	v6.1.3.	
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Figure	3.7:	Ki-67	expression	in	PHMs	over	a	10	day	culture	period	in	quiescence	media.	
Cells	were	plated	into	a	T75	tissue	culture	flask.	Panel	A:	Unstained	control	(US).	Panel	B:	Percentage	of	CD34	
expressing	PHMs	prior	to	quiescence	media	exposure.	Panel	C	-	F	:	Percentage	of	Ki-67	expressing	PHMs	after	
3	days	(Panel	C),	after	5	days	(Panel	D),	after	7	days	(Panel	E),	after	10	days	(Panel	F).	The	culture	media	was	
changed	daily,	and	cells	were	washed	once	with	1x	PBS.	A	minimum	of	1	x	105	satellite	cells	were	analysed	for	
each	time	point.	Data	analyses	were	performed	on	the	FACSDiva™	software	v6.1.3.	
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3.1.3 THE	 EFFECT	 OF	 QUIESCENCE	 MEDIA	 ON	 THE	 EXPRESSION	 OF	 MYOGENIC	
REGULATORY	FACTORS	
To	 ascertain	 whether	 the	 quiescence	 media	 could	 prevent	 PHMs	 from	 entering	 the	 myogenic	
programme,	the	expression	of	the	myogenic	regulator	factors,	MyoD	and	Myf-5,	were	assessed.	Like	
Pax7,	 MyoD	 expression	 steadily	 decreased	 over	 the	 10	 day	 culture	 period.	 Only	 20.1%	 of	 PHMs	
expressed	the	myogenic	regulatory	factor	before	culturing	in	quiescence	media	(Figure	3.8,	Panel	B)	
and	after	7	and	10	days	in	culture	only	just	over	9%	of	the	population	was	positive	for	MyoD	(Figure	
3.8,	Panels	E	and	F).	This	confirms	that	the	quiescence	media	did	not	induce	the	expression	of	MyoD	
and	 therefore	 did	 not	 stimulate	myogenesis.	Myf-5	 expression	 remained	 constant	 throughout	 the	
entire	 10	 day	 culture	 period	 in	 quiescence	 media	 (Figure	 3.9,	 Panels	 B-F)	 and	 no	 changes	 in	
expression	were	noticed	between	PHMs	cultured	 in	proliferation	media	 (PHM-PM)	and	quiescence	
media	 (Figure	 3.9,	 Panels	 B	 and	 F),	 suggesting	 that	 the	 culture	 conditions	 did	 not	 affect	 Myf-5	
expression	in	the	PHMs.		
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Figure	3.8:	MyoD	expression	in	PHMs	over	a	10	day	culture	period	in	quiescence	media.	
Cells	were	plated	into	a	T75	tissue	culture	flask.	Panel	A:	Unstained	control	(US).	Panel	B:	Percentage	of	CD34	
expressing	PHMs	prior	to	quiescence	media	exposure.	Panel	C	-	F	:	Percentage	of	MyoD	expressing	PHMs	after	
3	days	(Panel	C),	after	5	days	(Panel	D),	after	7	days	(Panel	E),	after	10	days	(Panel	F).	The	culture	media	was	
changed	daily,	and	cells	were	washed	once	with	1x	PBS.	A	minimum	of	1	x	105	satellite	cells	were	analysed	for	
each	time	point.	Data	analyses	were	performed	on	the	FACSDiva™	software	v6.1.3.	
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Figure	3.9:	Myf-5	expression	in	PHMs	over	a	10	day	culture	period	in	quiescence	media.	
Cells	were	plated	into	a	T75	tissue	culture	flask.	Panel	A:	Unstained	control	(US).	Panel	B-F:	Proportion	of	cells	
expressing	Myf-5,	after	compensation	for	auot-fluorescence	indicated	in	Panel	A.	Panel	B:	Percentage	of	Myf-5	
expressing	PHMs	prior	to	quiescence	media	exposure.	Panel	C	-	F	:	Percentage	of	Myf-5	expressing	PHMs	after	
3	days	(Panel	C),	after	5	days	(Panel	D),	after	7	days	(Panel	E),	after	10	days	(Panel	F).	The	culture	media	was	
changed	daily,	and	cells	were	washed	once	with	1x	PBS.	A	minimum	of	1	x	105	satellite	cells	were	analysed	for	
each	time	point.	Data	analyses	were	performed	on	the	FACSDiva™	software	v6.1.3.	
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Table	3.2:	Summary	of	marker	expression	as	analysed	in	flow	cytometry	in	PHMs	from	subject	6,	
cultured	in	T75	flasks	in	quiescence	media	for	10	days,	for	the	final	flow	cytometry	experiment.	
Marker	
Days	
0	 3	 5	 7	 10	
Cells	
counted	 %	(+)	
Cells	
counted	 %	(+)	
Cells	
counted	 %	(+)	
Cells	
counted	 %	(+)	
Cells	
counted	 %	(+)	
Ce
ll	
Su
rf
ac
e	
CD34	 171,894	 99.7	 73,047	 97.8	 175,577	 98.3	 244,363	 97.8	 204,850	 98.6	
CD56	 44,520	 25.8	 13,533	 18.1	 34,034	 19.0	 10,822	 4.3	 4,456	 2.1	
N
uc
le
ar
	 Pax7	 105,289	 61.1	 46,534	 62.3	 87,416	 48.9	 98,767	 39.5	 67,711	 32.6	
Myf-5	 171,977	 99.8	 73,510	 98.5	 176,171	 98.6	 248,833	 99.6	 206,344	 99.4	
MyoD	 34,642	 20.1	 10,510	 14.1	 25,252	 14.1	 23,526	 9.4	 19,418	 9.3	
Ki-67	 145,691	 84.5	 68,148	 91.3	 97,847	 54.8	 107,256	 42.9	 95,643	 46.1	
Footnote:	 Satellite	cell	events:	Day	0	 -	172,351,	Day	3	 -	74,667,	Day	5	 -	178,691,	Day	7	 -	249,761,	Day	10	 -	
207,681.	Only	live	satellite	cells	were	analysed.	PHMs	from	subject	6	were	used	at	p7.	PHMs	were	cultured	in	
T75	flasks	for	10	days	in	quiescence	media.	500	K	cells	were	plated	on	day	0	in	each	T75	flask.	PHMs	used	for	
day	0	 sampling	 time	point	were	 cultured	 in	 PHM-PM.	 The	 culture	media	was	 changed	daily,	 and	 cells	were	
washed	 once	 with	 1x	 PBS.	 %	 (+)	 =	 Percentage	 of	 expressing	 cells	 for	 that	 marker.	 Staining	 procedure	 was	
adjusted	compared	to	data	presented	in	Table	3.1.	
When	analysing	pro-myogenesis,	pro-proliferation	and	pro-quiescence,	the	expression	of	 individual	
markers	should	be	supplemented	by	analysis	of	relevant	co-expression.	For	example,	MyoD	is	known	
to	be	a	 substantially	pro-differentiation	MRF,	whereas	Myf-5	positive	 cells	 are	 typically	orientated	
towards	 self-renewal	 and	 maintenance	 of	 the	 parent	 pool	 without	 necessarily	 being	 subject	 to	
further	proliferation.	Co-expression	of	MyoD	and	Myf-5	is	 indicative	of	cells	under	control	of	MRFs	
but	not	solely	pro-differentiation.	In	contrast,	co-expression	of	CD34	and	Myf-5	can	be	presented	to	
indicate	proportion	of	pro-quiescent	cells.		
As	can	be	seen	in	Figure	3.10,	the	increased	co-expression	of	Myf-5	and	CD34	from	day	0	(59.6%)	to	
day	7	(89.5%)	(Figure	3.10,	Panels	B	-	E)	during	culture	in	quiescence	media	substantiates	the	claims	
that	 PHMs	were	promoted	 to	 return	 to	 quiescence.	Myf-5	 vs.	 CD34	 co-expression	 results	 pointed	
toward	the	fact	that	culturing	PHMs	from	subject	6	in	quiescence	media	promoted	quiescence.	
Results	for	co-expression	of	MyoD	and	Myf-5	dropped	from	19.4%	(Figure	3.11,	Panel	B)	to	only	9%	
(Figure	3.11,	Panel	F),	over	the	10	day	culture	period.	This	suggested	that	the	culturing	of	PHMs	in	
quiescence	media	actively	reduces	the	pro-differentiation	environment.		
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Figure	3.10:	Myf-5	vs.	CD34	expression	in	PHMs	over	a	10	day	culture	period	in	quiescence	media.	
Cells	were	plated	into	T75	tissue	culture	plates.	Panel	A:	Unstained	control	(US).	Panel	B:	Percentage	of	Myf-5	
and	CD34	expressing	PHMs	in	PHM-PM.	Panel	C:	Percentage	of	Myf-5	and	CD34	expressing	PHMs	after	3	days.	
Panel	D:	Percentage	of	Myf-5	and	CD34	expressing	PHMs	after	5	days.	Panel	E:	Percentage	of	Myf-5	and	CD34	
expressing	 PHMs	 after	 7	 days.	Panel	 F:	Percentage	 of	Myf-5	 and	CD34	 expressing	 PHMs	 after	 10	 days.	 The	
culture	media	was	changed	daily,	and	cells	were	washed	once	with	1x	PBS.	A	minimum	of	1	x	105	satellite	cells	
were	analysed	for	each	time	point.	Data	analyses	was	performed	on	the	FACSDiva™	software	v6.1.3.	
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Figure	3.11:	MyoD	vs.	Myf-5	expression	in	PHMs	over	a	10	day	culture	period	in	quiescence	media.	
Cells	were	plated	into	a	T75	tissue	culture	flask.	Panel	A:	Unstained	control	(US).	Panel	B:	Percentage	of	Myf-5	
and	MyoD	 co-expressing	 PHMs	prior	 to	 quiescence	media	 exposure.	Panel	 C	 -	 F	 :	Percentage	 of	Myf-5	 and	
MyoD	co-expressing	PHMs	after	3	days	(Panel	C),	after	5	days	(Panel	D),	after	7	days	(Panel	E),	after	10	days	
(Panel	F).	The	culture	media	was	changed	daily,	and	cells	were	washed	once	with	1x	PBS.	A	minimum	of	1	x	105	
satellite	cells	were	analysed	 for	each	time	point.	Data	analyses	were	performed	on	the	FACSDiva™	software	
v6.1.3	
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3.1.4 PHMs	 DO	 NOT	 LOOSE	 THEIR	 DIFFERENTIATION	 ABILITY	 AFTER	 10	 DAYS	 IN	
QUIESCENCE	MEDIA	
It	was	important	to	ascertain	that	10	days	of	culturing	PHMs	in	Ham’s	F-10	supplemented	with	20%	
KOSR	 (quiescence	media)	 didn’t	 affect	 their	 inherent	 capabilities	 to	 become	 activated,	 proliferate	
and	differentiate	ie:	follow	the	myogenic	path.	Since	differentiation	is	the	final	step	in	the	myogenic	
path,	 it	 was	 elected	 to	 test	 the	 effect	 of	 quiescence	media	 on	 subsequent	 differentiation.	 PHMs	
were	 cultured	 for	 10	 days	 in	 quiescence	media,	 and	 then	 cultured	 for	 a	 further	 7	 days	 in	 culture	
media	 that	 promoted	 differentiation	 (PHM-DM,	 with	 addition	 of	 2%	 horse	 serum)	 (Refer	 to	
Appendix	 A).	 Myoblast	 fusion	 and	 myotube	 formation	 was	 first	 seen	 after	 2	 days.	 This	 process	
continued	 for	 the	 next	 5	 days,	 and	 after	 7	 days,	 almost	 no	 single	 cells	were	 visible	 in	 the	 culture	
wells.	These	data	suggested	that	prolonged	culture	of	PHMs	in	quiescence	media	did	not	affect	their	
subsequent	ability	to	differentiate	into	myotubes,	when	exposed	to	pro-differentiation	conditions.	It	
is	 not	 clear	 whether	 or	 not	 PHMs	 exposed	 for	 similar	 time	 period	 to	 these	 pro-differentiation	
conditions	 without	 prior	 quiescence	 media	 exposure	 would	 have	 exhibited	 more	 myotube	
formation.	Here	some	proliferative	myoblasts	are	still	observed.		
Figure	3.12:	PHMs	cultured	in	PHM-DM	after	10	days	in	quiescence	media.	
Cells	 were	 plated	 into	 6-well	 tissue	 culture	 plates	 (35	 mm)	 and	 cultured	 for	 10	 days	 quiescence	 media,	
followed	by	a	7	day	culture	in	differentiation	media	(PHM-DM).	The	culture	media	was	changed	daily,	and	cells	
were	washed	once	with	1x	PBS.	Panel	A:	Image	of	PHM	morphology	after	2	days	in	PHM-DM.	Panel	B:	Image	
of	PHM	morphology	after	7	days	in	PHM-DM.	Blue	arrows	-	Myotubes.	
PHM-DM	–	2	Days	 PHM-DM	–	7	Days	A.	 B.	
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3.1.5 THE	EFFECT	OF	QUIESCENCE	MEDIA	ON	THE	CELL	CYCLE	OF	PHMs	
To	corroborate	the	cell	surface	marker	data	obtained	with	multicolour	flow	cytometry	and	provide	
conclusive	evidence	toward	achieving	the	first	objective	of	the	project,	cell	cycle	analysis	was	used	to	
ascertain	whether	culturing	PHMs	in	quiescence	media	induced	them	to	exit	the	cell	cycle	and	return	
to	a	quiescent	state	(G1/G0).	Propidium	iodide	staining	of	DNA	was	used	to	determine	the	proportion	
of	cells	in	each	cell	cycle	stage	(G1/G0-phase,	S-phase,	G2-phase).		
As	was	 the	 case	 for	multicolour	 flow	 cytometry,	 several	 cell	 cycle	 optimisation	 experiments	were	
performed.	Firstly,	 the	effect	of	KO-DMEM	supplemented	with	20%	(v/v)	KOSR	on	the	cell	cycle	of	
PHMs	was	investigated.	The	optimisation	data	show	that	culturing	PHMs	in	this	media	over	a	10	day	
period	substantially	decreased	 the	number	of	 cells	 in	S-phase	and	G2/M-phase:	The	percentage	of	
PHMs	 in	 S-phase	 decreased	 from	 11.47%	 (in	 PHM-PM)	 to	 2.97%,	while	 the	 percentage	 of	 cells	 in	
G2/M-phase	decreased	from	5.57%	(in	PHM-PM)	to	1.14%.	The	decreased	percentages	of	cells	in	S-
phase	and	G2/M-phase	was	 reflected	 in	 the	 increased	numbers	of	 cells	 in	G0/G1	 -	 from	82.96%	 (in	
PHM-PM)	to	95.62%.	Refer	to	Appendix	L	for	detailed	information	on	the	cell	cycle	histograms	and	
population	 data.	 It	 thus	 seemed	 as	 though	 culturing	 cells	 in	 KO-DMEM	 supplemented	 with	 20%	
KOSR,	inhibited	cellular	proliferation,	as	>95%	of	the	PHM	population	was	arrested	in	G0/G1	after	10	
days	 of	 culture.	 However,	 due	 to	 the	 observations	made	 in	 Section	 3.1.1	 and	 Figure	 3.2	 and	 the	
results	 obtained	 via	 multicolour	 flow	 cytometry	 (for	 cells	 cultured	 in	 KO-DMEM/20%	 KOSR),	 the	
possibility	that	the	increased	numbers	of	PHMs	in	G0/G1	was	due	to	PHMs	differentiating	couldn’t	be	
excluded.		
Cell	 cycle	 analysis	 was	 thus	 performed	 on	 PHMs	 cultured	 in	 Ham’s	 F-10	 supplemented	with	 20%	
(v/v)	 KOSR	 (quiescence	 media),	 as	 previous	 results	 showed	 that	 quiescence	 media	 favoured	
proliferation	arrest	without	inducing	differentiation.		
The	effects	of	 culturing	PHM’s	 isolated	 from	several	different	 subjects	 (subject	1,	2,	4,	6	and	9)	 in	
quiescence	media	were	investigated	(data	not	shown).	Briefly,	the	optimisation	data	showed	similar	
effects	 of	 quiescence	 media,	 on	 the	 cell	 cycle	 of	 PHMs	 (isolated	 from	 different	 subjects).	 This	
signified	 that	 culturing	 in	 quiescence	 media	 was	 inducing	 the	 same	 effects	 on	 different	 PHM	
populations.	These	data	are	not	presented,	however,	due	to	the	extensive	optimization	and	differing	
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expansion	 capabilities	 of	 PHMs	 harvested	 from	 different	 subjects,	 which	 ultimately	 caused	
insufficient	 cell	 stocks	 to	 enable	 running	 the	 final	 cell	 cycle	 analysis.	 Due	 to	 the	 fact	 that	 enough	
cellular	stocks	were	generated	for	subject	6,	the	final	cell	cycle	analysis	optimisation	experiment	was	
performed	only	on	PHMs	 isolated	from	subject	6.	The	following	qualitative	data	 is	presented	from	
the	final	cell	cycle	analysis	experiment,	which	was	performed	after	the	final	optimization	experiment	
using	PHMs	from	subject	6	cultured	in	quiescence	media	for	10	days.	
The	majority	 (>50%)	of	PHMs	were	 in	the	G1-phase	throughout	the	entire	culture	period,	however	
the	percentage	of	PHMs	actively	 in	 the	cell	 cycle	varied	between	the	sampling	 time	points	 (Figure	
3.13,	 Panels	 A-D).	 A	 high	 proportion	 of	 cells	 in	 the	 S-phase	 were	 observed	 in	 both	 the	 PHM-PM	
(36.11%)	and	day	3	group	 (42.87%).	There	was	a	noticeable	G2-phase	decrease	 from	the	PHM-PM	
group	(5.1%)	to	the	day	3	group	(0.17%)	(Figure	3.13,	Panels	A	and	B).	The	percentage	of	cells	in	S-
phase	substantially	decreased	on	day	7	 (9.23%)	and	day	10	 (10.09%)	 (Figure	3.13,	Panels	C	and	D)	
compared	to	the	day	3	group	(42.87%)	(Figure	3.13,	Panel	B).	The	decreased	proportion	of	cells	the	
S-phase	was	reflected	in	the	increased	proportion	of	G0/G1-phase	cells	(Figure	3.13,	Panels	C	and	D).	
The	percentage	of	cells	in	G2/M-phase	was	relatively	constant	in	each	sampling	time	point.	
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Figure	3.13:	Cell	cycle	analysis	of	PHMs	cultured	in	quiescence	media	for	10	days.	
Single	cells	were	selected	based	on	the	size	(FSC-A)	and	granularity	(SSC-A).	The	propidium	Iodide	(PI)	stained	
(PE-Texas	Red-A)	nuclei	of	 the	PHMs	were	analysed	 for	 cell	 cycle	proportions	by	 the	ModfitLT	3.0	 software.	
The	software	assumes	a	Gaussian	distribution	 (bell-shaped	curve).	The	G0/G1	Proportion	 is	 first	 identified	by	
the	peak	with	single	copies	of	DNA	(n)	and	shows	lower	PI	staining	(around	45).	The	S-phase	ranges	from	45	to	
90,	as	cells	will	contain	a	range	of	DNA	from	n	 to	2n.	Cells	 in	G2	will	have	a	peak	doule	to	that	of	G1	as	they	
have	diploid	nuclei	(2n).	
Taken	 together,	 the	data	obtained	 for	both	cell	 cycle	analysis	 (Section	3.1.5)	and	multicolour	 flow	
cytometer	 (Sections	 3.1.2	 and	 3.1.3)	 demonstrated	 that	 culturing	 PHMs	 in	 quiescence	 media	
induced	 quiescence	 without	 promoting	 differentiation	 nor	 affecting	 their	 intrinsic	 functions	
(differentiation	abilities,	Section	3.1.4,	Figure	3.12,	Panels	A	and	B).	The	first	objective	of	the	project	
was	thus	achieved.	
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3.2 RH-HGF	TREATMENT	DOESN’T	STIMULATE	PHMS	TO	RE-ENTER	THE	CELL	
CYCLE	
The	second	objective	of	the	project	was	to	treat	quiescent	PHMs	with	rh-HGF	and	reactivate	them,	
thereby	stimulating	cell	cycle	re-entry.	
The	subsequent	experiments	were	done	to	determine	whether	treament	with	low	(2	ng/mL)	or	high	
(10	 ng/mL)	 concentrations	 of	 rh-HGF	 had	 any	 effect	 on	 stimulating	 the	 PHMs	 to	 re-enter	 the	 cell	
cycle	after	10	days	 in	quiescence	media.	Four	conditions	were	tested.	Regardless	of	dose	and	time	
period,	treatment	with	rh-HGF	similarly	affected	the	percentage	of	PHMs	in	either	the	S-phase	or	G2-
phase	(Figure	3.14,	Panels	A	-	D).	However,	when	the	proportion	of	cells	in	S	and	G2-phase	in	these	
rh-HGF-treated	 groups	 are	 compared	 to	 that	 of	 cells	 cultured	 in	 quiescence	 media	 for	 10	 days	
(Figure	 3.13,	 Panel	 D),	 a	 small	 increase	 of	 G2-phase	 cells	 is	 noticable	 in	 the	 treated	 groups.	 This	
increase	in	G2/M-phase	cells	from	2.79%	pre-treatment	(Figure	3.13,	Panel	D)	to	>4%	in	the	treated	
groups	 (Figure	 3.14,	 Panels	 A	 -	 D),	 is	 reflected	 in	 a	 decreased	 proportion	 of	 S-phase	 cells	 (10.1%	
KOSR	10	days	vs.	±7.5%	 in	 the	 rh-HGF	 treated	groups).	This	 could	be	due	 to	 the	effects	of	 rh-HGF	
treatment	which	re-activated	PHMs	arrested	in	S-phase,	and	stimulated	them	to	progress	to	a	G2/M-
phase.	
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Figure	3.14:	Cell	 cycle	analysis	of	PHMs	treated	with	different	concentrations	of	 rh-HGF	 for	24	h	
and	48	h.	
Single	cells	were	selected	based	on	the	size	(FSC-A)	and	granularity	(SSC-A).	The	propidium	Iodide	(PI)	stained	
(PE-Texas	Red-A)	nuclei	of	 the	PHMs	were	analysed	 for	 cell	 cycle	proportions	by	 the	ModfitLT	3.0	 software.	
The	software	assumes	a	Gaussian	distribution	 (bell-shaped	curve).	The	G0/G1	Proportion	 is	 first	 identified	by	
the	peak	with	single	copies	of	DNA	(n)	and	shows	lower	PI	staining	(around	45).	The	S-phase	ranges	from	45	to	
90,	as	cells	will	contain	a	range	of	DNA	from	n	 to	2n.	Cells	 in	G2	will	have	a	peak	doule	to	that	of	G1	as	they	
have	diploid	nuclei	(2n).	
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3.3 THE	EFFECTS	OF	RH-HGF	TREATMENT	ON	THE	EXPRESSION	OF	SELECTED	
GENES	
The	third	objective	of	the	project	was	to	treat	quiescent	PHMs	with	rh-HGF	and	study	its	effects	on	
expression	 of	 various	 genes	 under	 the	 four	 different	 conditions	 described	 below.	 Genes	 to	
investigate	were	selected	on	the	basis	of	their	importance	in	satellite	cell	biology.	
PHMs	were	cultured	for	10	days	in	quiescence	media	and	then	treated	with	either	low	(2	ng/mL)	or	
high	 (10	 ng/mL)	 concentrations	 of	 rh-HGF	 for	 either	 24	 h	 followed	 by	 a	 period	 of	 24	 h	 without	
treatment	or	for	a	period	of	48	h	with	treatment	(24	h	followed	immediately	by	a	second	dose	for	24	
h).	After	48	h	protein	and	RNA	were	collected	 from	cell	 lysates	of	each	treatment	group.	Western	
blotting	 and	 qPCR	 were	 used	 to	 investigate	 protein	 levels	 and	mRNA	 expression,	 respectively,	 in	
PHMs	treated	with	either	low	(2	ng/mL)	or	high	(10	ng/mL)	rh-HGF	for	24	h	or	48	h.	These	data	were	
compared	to	protein	levels	and	mRNA	expression	in	PHMs	cultured	in	quiescence	media	for	10	days	
(control).	 Refer	 to	 Appendix	 E	 for	 the	 rh-HGF	 treatment	 tissue	 culture	 plate	 setup	 and	 refer	 to	
Appendix	J	for	qPCR	raw	data	and	CT	values	for	mRNA	and	miRNA	expression.	
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3.3.1 PAX7	EXPRESSION	DECREASES	UPON	RH-HGF	TREATMENT	IN	PHMs	
The	 results	 obtained	 from	 qPCR	 analysis	 of	 relative	 expression	 showed	 a	 tendency	 towards	
decreased	Pax7	mRNA	levels	following	rh-HGF	treatment.	Both	 low	(24	h	and	48	h)	and	high	(24	h	
and	48	h)	treatment	groups	had	almost	50%	less	expression	of	Pax7	mRNA	when	compared	to	the	
control	 (KOSR	 10	 d).	 However,	 relative	 to	 each	 other,	 Pax7	 expression	 did	 not	 differ	 between	
treatment	groups	(Figure	3.15).	
Figure	3.15:	Pax7	mRNA	expression	levels	in	PHMs	treated	with	rh-HGF	at	two	different	doses	for	
24	h	or	48	h.	
Cells	were	cultured	in	6-well	(35	mm)	plates.	A	total	of	3	(n=3)	experimental	repeats	were	used	for	statistical	
analysis	for	each	treatment	group.	Within	each	treatment	group	3	wells	were	pooled	to	gain	sufficient	RNA	for	
extraction.	qPCR	analyses	of	relative	expression	 levels	of	Pax7	mRNA	in	PHMs	treated	with	 low	(2	ng/mL)	or	
high	(10	ng/mL)	of	rh-HGF	for	24	h	or	48	h.	Samples	were	run	on	a	StepOnePlus™	realtime	PCR	machine.	The	
resultant	CT	was	calculated	by	the	the	StepOne™	software	v2.2.2.	After	normalization	to	a	housekeeping	gene	
(18	S	ribosomal	subunit),	each	treatment	group	was	normalized	to	a	reference	sample	(PHM	from	subject	6	at	
p7	cultured	in	PHM-PM).	Fold	changes	in	Pax7	mRNA	expression	are	relative	to	that	of	the	reference	sample.	
Values	reported	as	mean	±	S.E.M.	
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3.3.2 RH-HGF	TREATMENT	INDUCES	ELEVATED	HGF	PROTEIN	IN	PHMs	
Exposure	 to	 rh-HGF	 was	 repeated	 on	 3	 occasions	 (passages	 6	 to	 8)	 for	 each	 of	 the	 4	 rh-HGF	 treatment	
conditions.	On	each	occasion	each	treatment	was	done	in	3	wells	which	were	pooled	to	gain	sufficient	protein	
for	 extraction.	 The	 control	 group	 (KOSR	 10	 d)	 had	 minimal	 levels	 of	 endogenous	 HGF.	 All	 rh-HGF	
treated	 groups	 had	 increased	 HGF	 protein	 when	 compared	 to	 the	 control	 group	 (Figure	 3.16).	
Although	treatment	with	2	ng/mL	rh-HGF	for	both	24	h	and	48	h	significantly	changed	the	 level	of	
HGF	compared	to	control,	an	even	greater	increase	in	HGF	levels	was	evident	following	10	ng/mL	rh-
HGF	treatment	(Figure	3.16),	especially	after	continuous	treatment	with	a	high	concentration	of	rh-
HGF	for	a	period	of	48	h.	This	was	despite	washing	of	cells	to	remove	exogenously	added	rh-HGF.	
Figure	3.16:	HGF	levels	in	PHMs	treated	with	rh-HGF	at	two	different	doses	for	24	h	or	48	h.	
Three	experimental	 repeats	 (done	on	PHMs	from	passages	6	 to	8)	were	used	 for	statistical	analysis	 (n=3	 for	
each	 treatment	 group).	 Cells	were	 cultured	 in	6-well	 (35	mm)	plates.	Relative	HGF	protein	was	 assessed	by	
means	 of	 Western	 blotting.	 Blots	 were	 imaged	 using	 the	 ChemiDoc™	 MP	 Imaging	 system.	 Densitometric	
analysis	of	the	protein	samples	was	performed	on	the	Image	Lab™	Software	and	normalized	to	total	protein.	
After	 total	 protein	normalization,	 each	 treatment	 group	was	normalized	 to	 a	 reference	 sample	 (PHMs	 from	
subject	 6	 at	 p7	 cultured	 in	 PHM-PM).	 Arbitrary	 levels	 of	 HGF	 protein	 are	 relative	 to	 that	 of	 the	 reference	
sample.	Values	reported	as	mean	±	S.E.M.	n=3;	**p<0.01;	***p<0.0001.	
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3.3.3 c-MET	LEVELS	AFTER	RH-HGF	TREATMENT	IN	PHMs	
Exposure	 to	a	 ligand	may	 induce	 regaulation	of	 its	 receptor.	The	receptor	 for	HGF	 is	 c-Met.	 c-Met	
protein	 was	 relatively	 constant	 when	 comparing	 the	 rh-HGF	 treated	 groups,	 with	 no	 statistically	
significant	variations,	between	treatment	groups.	Compared	to	the	control,	a	significant	increase	in	
c-Met	levels	was	noticed	in	the	PHMs	treated	with	a	high	dose	of	rh-HGF	for	a	period	of	24	h	(Figure	
3.17).	
Figure	3.17:	c-Met	protein	in	PHMs	treated	with	rh-HGF	at	two	different	doses	for	24	h	or	48	h.	
Three	experimental	 repeats	 (done	on	PHMs	from	passages	6	 to	8)	were	used	 for	statistical	analysis	 (n=3	 for	
each	 treatment	 group).	 Cells	were	 cultured	 in	 6-well	 (35	mm)	 plates.	Within	 each	 treatment	 group	 3	wells	
were	 pooled	 to	 gain	 sufficient	 protein	 for	 extraction.	 Relative	 c-Met	 protein	 was	 assessed	 by	 means	 of	
Western	blotting.	Blots	were	imaged	using	the	ChemiDoc™	MP	Imaging	system.	Densitometric	analysis	of	the	
protein	 samples	 was	 performed	 on	 the	 Image	 Lab™	 Software	 and	 normalized	 to	 total	 protein.	 After	 total	
protein	normalization,	each	treatment	group	was	normalized	to	a	reference	sample	(PHMs	from	subject	6	at	
p7	cultured	in	PHM-PM).	Arbitrary	levels	of	c-Met	protein	are	relative	to	that	of	the	reference	sample.	Values	
reported	as	mean	±	S.E.M.	n=3;	**p<0.01.	
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3.3.4 	MYOD	mRNA	AND	PROTEIN	VARY	IN	PHMs	AFTER	RH-HGF	TREATMENT	
Since	MyoD	is	the	master	MRF	it	was	important	to	consider	effects	of	rh-HGF	on	MyoD	at	mRNA	and	
protein	 levels.	 MyoD	 protein	 levels	 did	 not	 differ	 between	 the	 control	 group	 and	 the	 treatment	
groups	(Figure	3.18).		
qPCR	analyses	of	MyoD	mRNA	showed	a	roughly	3-fold	decrease	in	the	expression	levels	in	the	rh-
HGF	treated	samples,	compared	to	the	non-treated	control.	Due	to	variability,	significant	differences	
in	mRNA	expression	was	however	only	detected	between	the	non-treated	control	and	the	high	24	h	
treated	 sample	 (Figure	 3.19).	 Within	 the	 rh-HGF	 treated	 groups,	 the	 24	 h	 treated	 samples	 did	
however	seem	to	have	lower	levels	of	mRNA	compared	to	the	48	h	treated	samples	(Figure	3.19).	
Figure	3.18:	MyoD	protein	in	PHMs	treated	with	rh-HGF	at	two	different	doses	for	24	h	or	48	h.	
Three	experimental	 repeats	 (done	on	PHMs	from	passages	6	 to	8)	were	used	 for	statistical	analysis	 (n=3	 for	
each	 treatment	 group).	 Cells	were	 cultured	 in	 6-well	 (35	mm)	 plates.	Within	 each	 treatment	 group	 3	wells	
were	 pooled	 to	 gain	 sufficient	 protein	 for	 extraction.	 Relative	 MyoD	 protein	 was	 assessed	 by	 means	 of	
Western	blotting.	Blots	were	imaged	using	the	ChemiDoc™	MP	Imaging	system.	Densitometric	analysis	of	the	
protein	 samples	 was	 performed	 on	 the	 Image	 Lab™	 Software	 and	 normalized	 to	 total	 protein.	 After	 total	
protein	normalization,	each	treatment	group	was	normalized	to	a	reference	sample	(PHMs	from	subject	6	at	
p7	cultured	in	PHM-PM).	Arbitrary	levels	of	MyoD	protein	are	relative	to	that	of	the	reference	sample.	Values	
reported	as	mean	±	S.E.M.	n=3.	
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Figure	3.19:	MyoD	mRNA	expression	levels	in	PHMs	treated	with	rh-HGF	at	two	different	doses	for	
24	h	or	48	h.	
Three	experimental	 repeats	 (done	on	PHMs	from	passages	6	 to	8)	were	used	 for	statistical	analysis	 (n=3	 for	
each	 treatment	 group).	 Cells	were	 cultured	 in	 6-well	 (35	mm)	 plates.	Within	 each	 treatment	 group	 3	wells	
were	pooled	to	gain	sufficient	RNA	for	extraction.	qPCR	analyses	of	relative	expression	levels	of	MyoD	mRNA	
in	PHMs	 treated	with	 low	 (2	ng/mL)	or	high	 (10	ng/mL)	of	 rh-HGF	 for	24	h	or	48	h.	 Samples	were	 run	on	a	
StepOnePlus™	realtime	PCR	machine.	The	resultant	CT	was	calculated	by	 the	 the	StepOne™	software	v2.2.2.	
After	normalization	to	a	housekeeping	gene	(18	S	ribosomal	subuint),	each	treatment	group	was	normalized	to	
a	reference	sample	(PHM	from	subject	6	at	p7	cultured	in	PHM-PM).	Fold	changes	in	MyoD	mRNA	expression	
are	relative	to	that	of	the	reference	sample.	Values	reported	as	mean	±	S.E.M.	n=3;	*p<0.05.	
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3.3.5 MYF-5	mRNA	AND	PROTEIN	IS	UNCHANGED	IN	PHMs	AFTER	RH-HGF	TREATMENT	
Myf-5	 protein	 levels	 were	 constant	 in	 all	 rh-HGF	 treatment	 groups	 and	 did	 not	 differ	 from	 the	
control	 at	 any	 time	 point.	 There	 was	 however	 a	 trend	 towards	 decreased	Myf-5	 protein	 in	 both	
groups	treated	with	10	ng/mL	rh-HGF	(Figure	3.20).		
Similarly,	a	moderate	non-significant	decrease	was	evident	in	Myf-5	mRNA	expression	in	the	treated	
samples	compared	to	the	control.	All	4	treatment	groups	did	however	have	similar	expression	levels	
of	Myf-5	mRNA	(Figure	3.21).		
Figure	3.20:	Myf-5	protein	in	PHMs	treated	with	rh-HGF	at	two	different	doses	for	24	h	or	48	h.	
Three	experimental	 repeats	 (done	on	PHMs	from	passages	6	 to	8)	were	used	 for	statistical	analysis	 (n=3	 for	
each	 treatment	 group).	 Cells	were	 cultured	 in	 6-well	 (35	mm)	 plates.	Within	 each	 treatment	 group	 3	wells	
were	 pooled	 to	 gain	 sufficient	 protein	 for	 extraction.	 Relative	 Myf-5	 protein	 was	 assessed	 by	 means	 of	
Western	blotting.	Blots	were	imaged	using	the	ChemiDoc™	MP	Imaging	system.	Densitometric	analysis	of	the	
protein	 samples	 was	 performed	 on	 the	 Image	 Lab™	 Software	 and	 normalized	 to	 total	 protein.	 After	 total	
protein	normalization,	each	treatment	group	was	normalized	to	a	reference	sample	(PHM	from	subject	6	at	p7	
cultured	 in	 PHM-PM).	Arbitrary	 levels	 of	Myf-5	 protein	 are	 relative	 to	 that	 of	 the	 reference	 sample.	 Values	
reported	as	mean	±	S.E.M.	n=3.	
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Figure	3.21:	Myf-5	mRNA	expression	levels	in	PHMs	treated	with	rh-HGF	at	two	different	doses	for	
24	h	or	48	h.	
Three	experimental	 repeats	 (done	on	PHMs	from	passages	6	 to	8)	were	used	 for	statistical	analysis	 (n=3	 for	
each	 treatment	 group).	 Cells	were	 cultured	 in	 6-well	 (35	mm)	 plates.	Within	 each	 treatment	 group	 3	wells	
were	pooled	to	gain	sufficient	RNA	for	extraction.	qPCR	analyses	of	relative	expression	levels	of	Myf-5	mRNA	in	
PHMs	 treated	 with	 low	 (2	 ng/mL)	 or	 high	 (10	 ng/mL)	 of	 rh-HGF	 for	 24	 h	 or	 48	 h.	 Samples	 were	 run	 on	 a	
StepOnePlus™	realtime	PCR	machine.	The	resultant	CT	was	calculated	by	 the	 the	StepOne™	software	v2.2.2.	
After	normalization	to	a	housekeeping	gene	(18	S	ribosomal	subuint),	each	treatment	group	was	normalized	to	
a	reference	sample	(PHM	from	subject	6	at	p7	cultured	in	PHM-PM).	Fold	changes	in	Myf-5	mRNA	expression	
are	relative	to	that	of	the	reference	sample.	Values	reported	as	mean	±	S.E.M.	n=3.	
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3.3.6 A	COMPARISON	OF	MYOD	AND	MYF-5	AFTER	RH-HGF	TREATMENT	
MyoD	and	Myf-5	potein	was	relatively	unchanged	between	treatment	groups	and	compared	to	the	
control	(Figure	3.22,	Panel	A).	This	is	also	true	for	the	ratio	between	MyoD	and	Myf-5	protein	(Figure	
3.22,	 Panel	 C).	 The	 low	 (48	 h	 &	 24	 h)	 treatment	 groups	 do	 show	 more	 differences	 in	 protein	
compared	to	the	high	rh-HGF	treatment	groups,	suggesting	that	rh-HGF	stimulates	MyoD	protein	at	
higher	concentrations.	
When	analysing	mRNA	expression,	Myf-5	mRNA	levels	are	generally	higher	than	MyoD	levels	 in	all	
rh-HGF	 treated	 groups	 and	 the	 treated	 control	 groups.	 However,	 both	 genes	 showed	 similar	
patterns	 in	 relative	 expression	 changes	 upon	 exposure	 to	 HGF.	 Indeed,	 when	 compared	 to	 the	
controls,	all	the	treatment	groups	showed	decreased	mRNA	expression	for	MyoD	and	Myf-5	(Figure	
3.22,	 Panel	 B).	 Although	 there	 is	 too	 much	 variation	 in	 the	 samples	 to	 make	 accurate	 statistical	
assumptions,	it	is	worthy	to	note	that	MyoD	mRNA	expression	tended	to	be	higher	in	both	the	low	
and	high	48	h	groups	compared	to	their	24	h	counterparts.	The	ratio	of	Myf-5	mRNA	to	MyoD	mRNA	
expression	 indicate	a	substantial	difference	 in	expression	 levels	 in	the	treated	groups	compared	to	
the	control	(KOSR	10	day)	(Figure	3.22,	Panel	D).	Taken	together,	the	results	displayed	in	Figure	3.22,	
Panels	B	and	D,	indicate	that	rh-HGF	treatment	decreases	both	Myf-5	and	MyoD	mRNA	expression,	
however	its	effects	are	more	pronounced	on	MyoD	expression.	Consequently,	the	ratio	of	Myf-5	to	
MyoD	mRNA	is	increased	in	the	treated	groups	(Figure	3.22,	Panel	D).	
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Figure	3.22:	Comparison	of	MyoD	vs.	Myf5	mRNA	and	protein	levels	in	PHMs	treated	with	rh-HGF	
at	two	different	doses	for	24	h	or	48	h.	
Western	blot	and	qPCR	analyses	 for	 relative	MyoD	vs.	Myf-5	protein	and	mRNA	expression	 in	PHMs	treated	
with	 low	(2	ng/mL)	or	high	(10	ng/mL)	of	rh-HGF	for	24	h	or	48	h.	Panel	A:	Comparison	of	MyoD	protein	to	
Myf-5	 protein	 for	 each	 treatment	 group.	 Panel	 B:	 Comparison	 of	MyoD	mRNA	 expression	 levels	 to	 Myf-5	
mRNA	expressions	levels	for	each	treatment	group.	Panel	C:	Myf-5	to	MyoD	protein	ratio	for	each	treatment	
group.	Panel	D:	Myf-5	to	MyoD	mRNA	ratio	for	each	treatment	group.	Three	experimental	repeats	(done	on	
PHMs	 from	 passages	 6	 to	 8)	 were	 used	 for	 statistical	 analysis	 (n=3	 for	 each	 treatment	 group).	 Cells	 were	
cultured	in	6-well	(35	mm)	plates.	Blots	were	imaged	using	the	ChemiDoc™	MP	Imaging	system.	Densitometric	
analysis	of	the	protein	samples	was	performed	on	the	Image	Lab™	Software	and	normalized	to	total	protein.	
After	 total	 protein	 normalization,	 each	 treatment	 group	 was	 normalized	 to	 a	 reference	 samples.	 mRNA	
samples	 were	 run	 on	 a	 StepOnePlus™	 realtime	 PCR	 machine.	 The	 resultant	 CT	 was	 calculated	 by	 the	 the	
StepOne™	 software	 v2.2.2.	 After	 normalization	 to	 a	 housekeeping	 gene	 (18	 S	 ribosomal	 subuint),	 each	
treatment	 group	 was	 normalized	 to	 a	 reference	 sample	 (PHM	 from	 subject	 6	 at	 p7	 cultured	 in	 PHM-PM).	
Arbitrary	levels	of	MyoD	and	Myf-5	protein	along	with	the	fold	changes	in	MyoD	and	Myf-5	mRNA	expression	
are	relative	to	that	of	the	reference	sample.	Values	reported	as	mean	±	S.E.M.	n=3;	*p<0.05.	
A.	
D.	C.	
B.	
*	
KO
SR
 10
 d
LO
W 
48
 h
LO
W 
24
 h
HI
GH
 48
 h
HI
GH
 24
 h
0
5
10
15
MyoD
Myf-5
M
yf
-5
 v
s.
 M
yo
D
 (P
ro
te
in
 le
ve
ls
)
KO
SR
 10
 d
LO
W 
48
 h
LO
W 
24
 h
HI
GH
 48
 h
HI
GH
 24
 h
0.0
0.1
0.2
0.3
0.4
MyoD
Myf-5
M
yf
-5
 v
s 
M
yo
D
 m
R
N
A
 (F
ol
d 
ch
an
ge
)
KO
SR
 10
 d
LO
W 
48
 h
LO
W 
24
 h
HI
GH
 48
 h
HI
GH
 24
 h
0.0
0.5
1.0
1.5
2.0
M
yf
-5
 : 
M
yo
D
 (P
ro
te
in
 r
at
io
)
KO
SR
 10
 d
LO
W 
48
 h
LO
W 
24
 h
HI
GH
 48
 h
HI
GH
 24
 h
0
5
10
15
20
M
yf
-5
 : 
M
yo
D
 (m
R
N
A
 r
at
io
)
Stellenbosch University  https://scholar.sun.ac.za
98	
3.4 MICRORNA	ANALYSIS	
3.4.1 miR-31	EXPRESSION	IS	UNCHANGED	AFTER	EXPOSURE	TO	RH-HGF	
qPCR	 analyses	 for	 miR-31	 expression	 showed	 that	 rh-HGF	 treatment	 did	 not	 induce	 significant	
changes	in	relative	miR-31	levels.	It	was	however	noted	that	the	low	48	h	and	high	(48	h	and	24	h)	
treatment	groups	showed	an	almost	2-fold	decrease	 in	 the	miR-31	 levels	compared	to	 the	control	
group.	Due	to	variability	in	the	control	group	(KOSR	10	d),	statistical	significance	was	not	observed.	
Figure	3.23:	miR-31	expression	levels	in	PHMs	treated	with	rh-HGF	at	two	different	doses	for	24	h	
or	48	h.	
Three	experimental	 repeats	 (done	on	PHMs	from	passages	6	 to	8)	were	used	 for	statistical	analysis	 (n=3	 for	
each	 treatment	 group).	 Cells	were	 cultured	 in	 6-well	 (35	mm)	 plates.	Within	 each	 treatment	 group	 3	wells	
were	 pooled	 to	 gain	 sufficient	 RNA	 for	 extraction.	 qPCR	 analyses	 of	 relative	 expression	 levels	 of	miR-31	 in	
PHMs	 treated	 with	 low	 (2	 ng/mL)	 or	 high	 (10	 ng/mL)	 of	 rh-HGF	 for	 24	 h	 or	 48	 h.	 Samples	 were	 run	 on	 a	
StepOnePlus™	realtime	PCR	machine.	The	resultant	CT	was	calculated	by	 the	 the	StepOne™	software	v2.2.2.	
After	 normalization	 to	 an	 endogenous	 housekeeping	 miRNA	 gene	 (RNU6-2),	 each	 treatment	 group	 was	
normalized	 to	a	 reference	 sample	 (PHM	 from	subject	6	at	p7	 cultured	 in	PHM-PM).	 Fold	 changes	 in	miR-31	
expression	are	relative	to	that	of	the	reference	sample.	Values	reported	as	mean	±	S.E.M.	n=3.	
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CHAPTER	4	
DISCUSSION	
This	 study	aimed	 to	 improve	 the	understanding	of	how	different	concentrations	of	HGF	affect	 the	
expression	of	MyoD	and	Myf-5,	in	quiescent	primary	human	myoblasts	(PHMs).	This	is	important	as	
these	 two	 MRFs	 are	 upregulated	 after	 activation	 in	 vivo,	 but	 in	 vitro	 studies	 seldom,	 if	 ever,	
attempted	 to	 ensure	 quiescence	 prior	 to	 intervention.	 Furthermore,	 this	 study	 investigated	 the	
expression	 of	miR-31,	 a	microRNA	 known	 to	 target	Myf-5	mRNA	 and	maintain	 satellite	 cells	 in	 a	
quiescent,	but	primed	state,	known	as	GAlert.	To	accomplish	these	objectives,	PHM	cell	numbers	were	
expanded	 in	 culture	 and	 a	 quiescent	 state	 induced	 by	 FBS	 removal	 and	 supplementation	 of	 the	
culture	 media	 with	 a	 synthetic,	 growth	 factor-free	 serum	 replacement:	 KnockOut™	 Serum	
Replacement	(KOSR).	The	cell	cycle	analyses	and	multicolour	flow	cytometer	data	provided	evidence	
that	PHMs	were	driven	into	a	quiescent	state	and	light	microscopy	ascertained	that	culturing	PHMs	
in	quiescence	media	for	10	days	did	not	induce	any	morphological	changes	suggestive	of	activation.	
Full	functionality	of	PHMs,	despite	long	exposure	to	KOSR,	was	confirmed	when	it	was	subsequently	
established	that	it	did	not	affect	the	intrinsic	differentiation	capacity	of	PHMs.	
Once	 in	 a	 quiescent	 state	 the	 PHMs	 were	 treated	 with	 low	 (2	 ng/mL)	 or	 high	 (10	 ng/mL)	
concentrations	 of	 rh-HGF	 for	 24	 h	 and	 48	 h	 to	 investigate	 the	 effects	 of	 concentration	 and	 time	
effects	of	gene	expression.	Analysis	of	MyoD	and	Myf-5	protein	 levels	showed	that	rh-HGF	did	not	
affect	 protein	 synthesis	 significantly,	 regardless	 of	 concentration.	 Analysis	 of	mRNA	 levels	 for	 the	
two	MRFs	showed	that	Myf-5	expression	was	not	affected	by	rh-HGF	treatment,	while	MyoD	mRNA	
levels	greatly	decreased	upon	exposure	to	rh-HGF,	albeit	significant	differences	were	only	observed	
between	 the	 24	 h-high	 treatment	 group	 vs	 control.	 Pax7	 mRNA	 expression,	 was	 not	 statisticaly	
significantly	 changed	 throughout	 all	 rh-HGF	 treatments,	 confirming	 the	 cultured	 PHMs	 were	 not	
differentiating.	Since	light	microscopy	images	revealed	some	evidence	of	elongation	and	alignment	
(in	 KO-DMEM)	 this	 deserves	 further	 investigation.	 Due	 to	 variability,	 it	 was	 however	 inconclusive	
whether	miR-31	played	an	active	role	in	maintaining	PHMs	in	a	quiescent	state.	
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4.1 KNOCKOUT	 SERUM	 REPLACEMENT	 INDUCED	 A	 QUIESCENT	 STATE	 IN	
PRIMARY	HUMAN	MYOBLASTS	
It	has	been	reported	extensively	that	in	vitro	culture	of	animal	cells	requires	the	use	of	FBS	to	ensure	
cell	survival,	as	it	contains	a	vast	array	of	growth	factors	essential	for	supporting	cellular	processes	
(Brunner	et	al.	2010).	The	optimal	growth	and	survival	media	for	culturing	PHMs	or	isolated	muscle	
satellite	cells	 is	Ham’s	F-10	nutrient	medium	(Motohashi	et	al.	2014;	Liu	et	al.	2015),	which	is	then	
supplemented	with	a	variety	of	 sera,	 typically	20%	FBS.	The	media	of	choice	 routinely	used	 in	our	
laboratory,	consists	of	Ham’s	F-10	nutrient	medium	supplemented	with	FBS	(20%,	v/v),	L-glutamine	
(6.8%,	 v/v)	 and	 recombinant	 human	 fibroblast	 growth	 factor	 (rh-FGF)	 (10	 ng/mL).	 The	 essential	
amino	 acid,	 glutamine,	 supports	 the	 proliferation	 of	 cells	 that	 have	 high	 energy	 demands	 and	
synthesize	large	amounts	of	proteins	and	nucleic	acids	(Newsholme	et	al.	2003).	The	addition	of	rh-
FGF	 further	 promotes	 cell	 survival	 and	 stimulates	 cellular	 proliferation	 (Sheehan	 &	 Allen	 1999;	
Kästner	et	al.	2000).	The	present	study,	however,	required	the	PHMs	to	be	in	a	quiescent	state,	to	
enable	 re-activation	 with	 rh-HGF	 in	 order	 for	 investigation	 of	 the	 expression	 of	 myogenic	 genes	
during	the	initial	stages	of	satellite	cell	activation.		
To	induce	cellular	quiescence	the	FBS	and	rh-FGF	were	replaced	with	a	synthetic,	growth	factor-free	
serum	 known	 as	 KnockOut™	 Serum	Replacement	 (KOSR).	 Supplementing	 the	Ham’s	 F-10	 nutrient	
medium	with	 20%	 (v/v)	 of	 KOSR	 ensured	 the	 survival	 of	 PHMs	 over	 a	 10	 day	 culture	 period	 and	
promoted	cells	to	shift	into	a	G0/G1	state.	Other	techniques	have	been	used	with	success	to	induce	
isolated	 primary	 human	 myoblasts	 into	 a	 quiescent	 state	 (Sellathurai	 et	 al.	 2013).	 Instead	 of	
removing	mitogens	and	growth	factors	from	the	culture	media	of	adherent	cultures,	Sellathurai	et	al.	
(2013)	utilized	a	 suspension	culture	 technique	 to	 induce	cellular	quiescence,	which	had	previously	
been	reported	to	efficiently	arrest	C2C12	myoblasts	proliferation	and	maintain	cells	 in	a	quiescent	
(G0)	phase	(Milasincic	et	al.	1996).	These	studies	employed	a	semi-solid	suspension	medium	(DMEM	
supplemented	 with	 10%	 FBS,	 1%	 P/S	 and	 2%	 methylcellulose)	 to	 maintain	 PHMs	 in	 suspension,	
thereby	causing	the	loss	of	substrate	attachment,	which	triggered	the	‘suspended’	PHMs	to	become	
quiescent	 (G0)	 (Sellathurai	 et	 al.	 2013).	 However	 lack	 of	 attachement	 is	 not	 an	 inherent	 state	 for	
satellite	cells,	as	in	vivo	they	are	always	in	contact	with	the	basal	lamina,	the	sarcolemma	of	muscle	
fibres	and	other	ECM	components.	
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In	the	present	study	cell	cycle	analysis	showed	that	culturing	adherent	PHMs	in	a	growth	factor	free	
environment	 (quiescence	media)	 lead	 to	 a	 30%	 increase	 in	 the	 proportion	 of	 PHMs	 cells	 in	G0/G1	
state	and	a	32%	decrease	 in	 the	proportion	of	S-phase	cells,	 compared	to	PHMs	cultured	 in	PHM-
PM.	Cell	cycle	analysis	results	were	supported	by	the	multicolour	flow	cytometer	data	showing	that	
both	 Ki-67	 and	 CD56	 expression	 steadily	 decreased	 over	 the	 10	 day	 culture	 period	 in	 quiescence	
media.	 This	 reduction	 in	 proliferation	 marker	 was	 not	 due	 to	 PHM’s	 differentiation,	 as	 the	
expression	 of	 the	 stem	 cell	 marker,	 CD34,	 was	 maintained	 (stem	 cells	 that	 differentiate	 loose	
expression	of	this	marker).	Similarly,	Sellathurai	et	al.	(2013)	showed	that	when	PHMs	were	placed	
in	suspension	medium,	levels	of	Ki-67	and	BrdU	(pulse	labelling)	expression	steadily	decreased	over	
a	48	h	period	(12	h,	24	h,	48	h)	and	disappeared	after	96	h	 in	suspension	media	 (Sellathurai	et	al.	
2013).	 Thus	 both	 methodologies	 induce	 PHM	 quiescence	 effectively.	 Sellathurai	 et	 al.’s	 (2013)	
protocol	allows	for	a	more	rapid	induction	into	G0		(96	h	vs.	10	days)	and	induced	a	G0	state	in	the	
entire	cultured	population	of	PHMs	thus	enabling	synchronized	reactivation	of	a	homogeneous	PHM	
population	(Sellathurai	et	al.	2013).	Having	a	homogeneous	synchronized	population	is	an	advantage	
when	 performing	 MRF	 gene	 expression	 analysis,	 in	 satellite	 cell	 re-activation	 studies,	 as	 all	 cells	
‘have	 a	 common	 starting	 ground’.	 However,	 the	 decision	 to	 test	 the	 use	 of	 KOSR	 was	 in	 part	
motivated	by	the	fact	that	the	current	study	wished	to	assess	the	effect	of	a	growth	factor	and	the	
KOSR	conditions	allowed	for	absence	of	an	amorphous	FBS	environment.	With	these	observations,	it	
was	 confirmed	 that	 using	 KOSR	 with	 Ham’s	 F-10	 nutrient	 media	 mixture	 inhibited	 cellular	
proliferation	 to	 a	 certain	 extent	 without	 inducing	 differentiation.	 The	 lack	 of	 complete	 cell	 cycle	
arrest	could	potentially	be	explained	by	the	heterogeneity	of	the	PHM	population.	For	future	studies	
the	suspension	culture	 in	combination	with	the	KOSR	should	be	tested	to	 investigate	whether	 this	
combined	methodology	induces	cellular	quiescence	more	efficiently	than	simply	suspension	culture	
or	KOSR	culture	alone.	
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4.2 HETEROGENEOUS	 POPULATION	 OF	 MYOBLAST	 PRECURSOR	 CELLS:	
PAX7+/CD34+/MYF-5+	AND	PAX7-/CD34+/MYF-5+	
The	concept	of	satellite	cell	heterogeneity	and	the	existence	of	satellite	cell	subpopulations	has	been	
a	 topic	 of	 discussion	 over	 the	 past	 several	 years,	 and	mounting	 evidence	 has	 been	 presented	 in	
support	 of	 this	 (Schultz	 1996;	 Beauchamp	 et	 al.	 2000;	 Montarras	 et	 al.	 2005;	 Sacco	 et	 al.	 2008;	
Lindström	 et	 al.	 2010)	 Satellite	 cells	 differ	 in	 their	 gene	 expression	 patterns	 and	 myogenic	
differentiation	 predisposition	 (as	 described	 in	 Section	 1.1.4).	 In	 the	 present	 study,	 analysis	 of	 the	
expression	of	specific	satellite	cell	markers	revealed	that	the	PHMs	used,	despite	their	origin	from	a	
single	 muscle	 biopsy,	 was	 a	 heterogeneous	 population	 of	 satellite	 cells,	 with	 regards	 to	 marker	
expression.	
Only	 a	 subset	 of	 the	 PHM	population	 (61%)	were	 positive	 Pax7	 protein	when	 cultured	 in	 primary	
human	myoblast-proliferation	media	(PHM-PM)	with	even	fewer	of	the	PHMs	(32%)	expressing	Pax7	
following	 10	 days	 of	 culture	 in	 quiescence	 media.	 The	 entire	 population	 of	 PHMs	 however	
maintained	the	expression	of	Myf-5	(99.4%)	and	CD34	(98.6%)	over	the	entire	10-day	culture	period	
in	quiescence	media.	The	presence	of	CD34	and	Myf-5	expression	 in	 the	culture	model	 confirmed	
that	the	PHMs	were	undifferentiated	myoblast	precursor	cells	(MPCs).	The	high	levels	of	Myf-5,	but	
low	levels	of	MyoD	expression	is	furthermore	indicative	that	the	quiescence	media	reduced	the	pro-
differentiation	environment.	However,	the	decreases	in	Pax7	expression	in	the	PHM	population	used	
in	the	current	 investigation,	suggests	that	the	cell	population	 in	culture	are	no	longer	true	satellite	
cells,	which	 are	 defined	 as	 expressing	 Pax7	 in	 vivo	 (Seale	 et	 al.	 2000)	 but	 rather	MPCs.	 There	 are	
numerous	accounts	in	the	literature	of	satellite	cells	existing	as	a	heterogeneous	population	in	vivo,	
with	regards	to	gene	expression	patterns	and	myogenic	differentiation	predisposition	 	(Kallestad	&	
McLoon	2010;	Rossi	et	al.	2010).	
Kallestad	and	Macloon	(2010)	showed	that	ex	vivo	sorting	of	skeletal	muscle	derived	cells	exhibited	
heterogeneous	(with	regards	to	marker	expression)	and	overlapping	(with	regards	to	the	nature	of	
the	 cell)	 populations	 (Kallestad	 &	 McLoon	 2010).	 Sorted	 for	 accepted	 myogenic	 precursor	 cell	
markers	 (CD34,	 Sca-1,	 Pax7	 and	M-cadherin),	 FACS	 analysis	 showed	 that	 both	 a	 ‘side	 population’,	
thought	 to	 be	 progenitor	 enriched	 and	 a	 ‘main	 population’	 contained	 both	 satellite	 cells	 and	
multipotent	progenitor	cells	(Kallestad	&	McLoon	2010).	Similarly,	Rossi	et	al.	(2010),	identified	the	
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presence	 of	 two	 main	 satelllite	 cell	 populations	 on	 isolated	 single	 muscle	 fibres	 from	 rat	 flexor	
digitorum	 brevis	 (Rossi	 et	 al.	 2010).	 These	 two	 satellite	 cell	 populations	 were	 identified	 on	 the	
surface	of	the	muscle	fibres,	based	on	the	number	of	clones	the	parent	satellite	cell	generated	after	
5	 days	 in	 suspension	 culture	 (aka	 hanging	 drops).	Clonal	 characterization	 showed	 that	 these	 two	
subpopulations	 differed	 based	 on	 their	 proliferative	 abilites,	 with	 the	 ‘low-proliferative’	 clones	
present	 in	 major	 proportion	 (~75%)	 (Rossi	 et	 al.	 2010).	 The	 differences	 in	 proliferation	 potential	
between	 the	 two	 subpopulations	 were	 shown	 to	 be	 caused	 by	 innate	 differences	 in	 their	
mitochondrial	 membrane	 potential,	 ATP	 synthesis	 efficiency	 and	 Reactive	 Oxygen	 Species	 (ROS)	
generation:	 the	 ‘high-proliferative’	 clones	had	a	more	glycolytic	phenotype.	 The	 ‘low-proliferative’	
clones	 spontaneously	 differentiated	 and	 generated	 myotubes	 and	 thus	 had	 a	 higher	 myogenic	
potential	 than	 the	 ‘high-proliferative’	 clones.	 However,	 when	 co-cultured	 together,	 the	 ‘low-
proliferative’	 clones	 were	 able	 to	 induce	 the	 ‘high-proliferative’	 clones	 to	 express	 MyoD	 and	
differentiate	 into	 myoblasts	 (Rossi	 et	 al.	 2010).	 How	 isolated	 PHMs	 used	 in	 this	 study	may	 have	
influenced	each	other	during	their	expansion	is	not	known.	But	they	remain	heterogeneous	despite	
10	 d	 exposure	 to	 the	 same	 KOSR.	 The	 majority	 of	 PHMs	 in	 the	 current	 study	 represent	 a	 Pax7-
/CD34+/Myf-5+	 MPC	 population,	 with	 a	 small	 population	 of	 more	 ‘parent-like’	 satellite	 cells	 that	
expressed	both	Pax7	and	CD34.	Published	data	suggests	that	a	Pax7+/CD34+/Myf-5-	subpopulation	of	
PHMs	 would	 represent	 a	 more	 stem-like	 satellite	 cell	 population	 with	 self-renewal	 capabilities:	
Pax7+/Myf-5−	 and	 Pax7+/Myf-5+	 subpopulations	 have	 been	 shown	 to	 exist	 in	 vivo	 and	 the	 ‘less	
differentiated’	Pax7+/Myf-5−	satellite	cells	were	able	to	self-renew	better	than	Pax7+/Myf-5+	(Kuang	
et	al.	2007).		
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4.3 RH-HGF	TREATMENT	MODERATELY	STIMULATED	PHMS	TO	RE-ENTER	THE	
CELL	CYCLE	
Cell	cycle	analysis	of	PHMs	treated	with	low	(2	ng/mL)	or	high	(10	ng/mL)	rh-HGF	for	24	h	or	48	h,	
overall	 showed	 signs	 of	 cell	 cycle	 re-entry.	 Although	 the	G1	 fractions	 didn’t	 vary	 from	 the	 control	
(KOSR	10	d),	the	percentage	of	S-phase	cells	decreased	upon	exposure	to	all	rh-HGF	conditions.	This	
decrease	in	S-phase	was	mirrored	by	an	increased	percentage	of	G2-phase	cells.	No	decreases	in	G1	
cells	were	noted	for	either	low	or	high	rh-HGF	concentrations,	with	either	the	24	h	or	48	h	exposure.	
These	 results	 indicate	 that	 rh-HGF	was	 unable	 to	 effectively	 restimulate	 cells	 to	 re-enter	 the	 cell	
cycle.	 The	 lack	 of	 observable	 PHM	 re-activation	 is	 not	 in	 agreement	 with	 literature.	 One	 major	
difference	in	the	current	study	was	the	KOSR	media	condition	to	which	the	PHMs	had	been	exposed	
and	 in	which	 they	 remained	 during	 rh-HGF	 exposure.	 But	 the	 concentration	 of	 rh-HGF	 used	 in	 in	
different	studies	also	differs	significantly.	
Yamada	et	al.,	 (2010)	showed	that	rat	satellite	cells	cultured	in	extremely	high	doeses	of	HGF	(500	
ng/mL)	 to	 induce	 decreased	 proliferation,	were	 reactivated	 and	 showed	newly	 BrdU-positive	 cells	
after	48	h	of	culture	with	2.5	ng/mL	of	HGF	(Yamada	et	al.	2010).	The	media	used	to	culture	satellite	
cells	in	the	study	of	Yamada	et	al.	(2010)	contained	10%	horse	serum	(HS),	and	the	potential	effects	
of	HS	on	satellite	cell	reactivation	needs	to	be	taken	into	account.	Furthermore,	the	growth	factors	
contained	 in	 their	nutrient	media	 (DMEM)	may	have	contributed	to	 the	 increases	 in	BrdU	positive	
cells,	 or	 at	 least	 augmented	 the	effects	 elicited	by	 the	2.5	ng/mL	of	HGF	 treatment.	Walker	et	al.	
(2015)	reported	similar	results	to	the	ones	seen	by	Yamada	et	al.	(2010)	regarding	increased	cellular	
proliferation	upon	HGF	treatment.	In	their	study,	both	C2C12s	and	human	skeletal	muscle	myoblasts	
(HSkM)	showed	 increased	cellular	proliferation,	as	determined	by	cell	counts,	after	24	h	of	rh-HGF	
treatment	 (2	 ng/mL)	 (Walker	 et	 al.	 2015).	 In	 the	 study	 by	 Walker	 et	 al.	 (2015)	 the	 rh-HGF	
proliferation	 experiments	 were	 performed	 in	 media	 containing	 10%	 (v/v)	 and	 20%	 (v/v)	 FBS,	
respectively.		
Furthermore,	 in	 the	 published	 studies	 cellular	 quiescence	 was	 not	 induced	 prior	 to	 rh-HGF	
treatment.	 One	 hypothesis	 as	 to	 why	 the	 quiescent	 PHMs	 did	 not	 shown	 concrete	 signs	 of	 re-
established	proliferation,	even	after	48	h	of	rh-HGF	treatment	(2	ng/mL),	is	that	cell	cycle	analysis	is	
not	sensitive	enough.	Alternatively,	quiescent	PHMs	may	require	the	presence	of	mitogenic	factors	
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as	well	as	HGF	to	truly	become	re-activated.	Performing	qPCR	analysis	of	known	cell	cycle	inhibitors	
like	p27kip1	and	p57kip2	alongside	cell	cycle	promoters,	could	more	accurately	determine	the	influence	
of	rh-HGF	on	cell	cycle	parameters.	This	was	not	done	here	but	the	possibility	that	lack	of	significant	
effect	of	rh-HGF	may	have	been	related	to	available	receptor	was	investigated.		
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4.4 HGF	AND	C-MET	
c-Met	 is	 the	 recepetor	 for	 HGF.	 Binding	 of	 HGF	 to	 c-Met	 causes	 receptor	 dimerization	 and	
intracellular	signaling.	This	 in	turn	activates	specific	gene	expression,	mediated	by	the	activation	of	
different	intracellular	signaling	pathways.	Because	HGF	signaling	is	thought	to	also	promote	further	
expression	 of	 c-Met	 on	 satellite	 cells,	 changes	 in	 c-Met	 expression	 should	 be	 seen	with	 different	
concentrations	of	HGF	(Organ	&	Tsao	2011).	HGF	itself	is	normally	not	present	in	satellite	cells	but	it	
can	 be	 produced	 and	 secreted	 from	 them	 upon	 stimulation	 by	 exogenous	 HGF.	 This	 is	 part	 of	 a	
positive	 feedback	 mechanism	 that	 ensures	 that	 enough	 satellite	 cells	 get	 activated	 and	 begin	
proliferating.	
Western	blot	analysis	revealed	that	quiescent	satellite	cells	(KOSR	10	d)	did	not	express	endogenous	
HGF,	which	 is	 logical	as	 if	 they	did	 they	wouldn’t	be	 in	a	quiescent	state.	 In	vivo	endogenous	HGF	
production	is	stimulated	only	after	c-Met	activation	(Sheehan	et	al.	2000).	Here,	PHMs	were	treated	
in	vitro	with	either	low	(2	ng/mL)	or	high	(10	ng/mL)	concentrations	of	rh-HGF	for	24	h	or	48	h.	The	
data	suggests	that	endogenous	production	of	HGF	was	both	concentration	and	time	dependent.	24	h	
of	low	(2	ng/mL)	and	high	(10	ng/mL)	rh-HGF	treatment	stimulated	less	intracellular	HGF	production	
compared	to	the	48	h	treated	group.	Furthermore,	the	high	rh-HGF	concentration	stimulated	more	
endogenous	HGF	production	that	the	low	concentration.	
Western	 blot	 data	 for	 c-Met	 showed	 that	 treating	 PHMs	 with	 rh-HGF	 stimulated	 its	 expression.	
Furthermore,	 in	 accordance	 with	 literature,	 higher	 concentrations	 of	 rh-HGF	 stimulated	 more	
receptor	expression.	These	findings	are	similar	to	those	reported	by	Walker	et	al.	(2015)	in	C2C12s.	
There,	10	ng/mL	of	HGF	stimulated	greater	c-Met	expression	than	C2C12s	treated	with	only	2	ng/mL	
(Walker	et	al.	2015).	Although	the	signaling	pathways	that	HGF/c-Met	signaling	activates	are	known	
(Leshem	et	al.	2002;	Halevy	&	Cantley	2004;	Walker	et	al.	2015),	they	were	not	investigated	here.	A	
limitation	of	using	PHMs	is	that	expansion	of	stock	is	more	limited	than	is	possible	when	using	the	
C2C12	 line.	 The	decision	was	made	 for	 the	 current	 study	 to	 focus	 on	 the	 c-Met	 receptor	 and	 the	
MRFs,	Myf-5	and	MyoD.	
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4.5 MYF-5	AND	MYOD	EXPRESSION	IN	QUIESCENT	PHMS	
The	 vast	 array	 of	 literature	 around	 the	 expression	MyoD	 and	Myf-5	 point	 toward	 their	 different	
roles.	Proliferating	myoblast	precursor	cells	are	characterized	by	the	expression	of	Myf-5	and	MyoD.	
In	vivo	 studies	using	adult	mice,	 injured	with	cardiotoxin	 (10-5	M)	 (Cooper	et	al.	1999)	and	 in	vitro	
studies	 using	myofiber	 cultures	 isolated	 from	mice	 (Cornelison	&	Wold	1997;	 Zammit	 et	 al.	 2002)	
showed	that	most	satellite	cells	express	either	Myf-5	or	MyoD	after	24	h	and	co-express	them	by	48	
h	(Cornelison	&	Wold	1997;	Cooper	et	al.	1999).	The	current	study’s	data	show	that	MyoD	and	Myf-5	
expression	were	present	in	the	quiescent	PHMs	both	at	the	protein	and	mRNA	level.	
It	 has	 been	 shown	 that	 within	 the	 entire	 satellite	 cell	 population,	 there	 may	 also	 be	 a	 distinct	
subpopulation	of	more	‘committed’	satellite	cells.	These	cells	were	shown	to	express	MyoD,	desmin	
and	myogenin	already	only	12	h	after	 injury,	 indicating	these	cells	may	differentiating	without	first	
proliferating	 (Rantanen	 et	 al.	 1995).	 Although	 desmin	 and	 myogenin	 were	 not	 assessed	 in	 the	
current	study,	the	cultured	PHMs	didn’t	show	morphological	signs	of	differentiation.	However,	due	
to	the	presence	of	MyoD	and	Myf-5	protein	and	mRNA	in	the	quiescence	cells,	these	cells	can	also	
be	considered	committed	progenitor	cells	(aka	myoblast	precursor	cells).	It	is	a	possibility	that	these	
committed	 cells	 have	 expressed	 either	 MyoD,	 Myf-5	 or	 both	 during	 the	 course	 of	 their	 history:	
before	isolation,	during	expansion	or	before	the	actual	experiments.		
The	data	obtained	for	Myf-5	mRNA	expression	 in	quiescent	cells	 is	 in	agreement	with	Crist	et	al.’s	
(2012)	 findings,	 however,	 Crist	et	 al.	 (2012)	 didn’t	 report	 any	Myf-5	 protein	 presence.	 Crist	et	 al.	
hypothesized	that	the	reason	why	Myf-5	mRNA	was	observed	but	no	protein,	was	due	to	miR-31’s	
targeted	repression	of	Myf-5	mRNA	(Crist	et	al.	2012).	 In	 the	current	study	miR-31	was	present	 in	
the	quiescent	cells.	However,	no	co-localization	studies	were	performed	for	Myf-5	mRNA	and	miR-
31,	to	ascertain	whether	sufficient	miR-31	was	targeting	all	Myf-5	mRNA.	Thus,	due	to	the	fact	that	
Myf-5	 protein	 was	 shown	 in	 the	 quiescent	 PHMs	 and	 that	 the	 expression	 levels	 of	 Myf-5	 was	
relatively	similar	to	that	of	MyoD,	one	may	assume	that	the	PHMs	were	not	truly	quiescent	(in	G0-
phase)	or	 that	 the	 the	PHMs	expanded	 from	subject	6	 still	 contained	signatures	 from	that	period.	
Myf-5	 and	 MyoD	 protein	 levels	 were	 relatively	 similar	 in	 quiescent	 cells	 but	 their	 mRNA	 levels	
differed	by	a	greater	margin,	with	Myf-5	mRNA	levels	~2-	to	3-fold	higher	than	MyoD.	This	may	be	
due	to	the	fact	that	changes	in	mRNA	expression	are	generally	seen	before	that	of	protein,	as	there	
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is	 always	 a	 time	 lag	 between	 mRNA	 expression	 and	 protein	 sysnthesis.	 These	 data	 are	 not	
inconsistent	with	 the	 interpretation	 that	 the	 proteins	were	 still	 present	 from	 the	 expansion	 time	
period	or	that	myo-miRs,	likely	miR-31	was	suppressing	Myf-5	translation.	
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4.6 MYF-5	AND	MYOD	EXPRESSION	IS	VARIED	WITH	RH-HGF	TREATMENT	IN	
PHMS	
The	literature	is	generally	in	agreement	with	distinct	roles	assigned	to	MyoD	and	Myf-5.	The	former	
is	critical	for	myoblast	differentiation	while	the	latter	plays	a	bigger	role	in	maintaining	a	capacity	to	
proliferate.	These	distinct	roles	may	serve	to	establish	different	satellite	cell	fates	depending	on	the	
amount	of	either	transcription	factor	relative	to	the	other	present	in	the	satellite	cell	(Rudnicki	et	al.	
2008).	Decreases	 in	MyoD	expression	are	expected	 in	cultures	treated	with	2-2.5	ng/mL	of	HGF	as	
this	concentration	range	has	been	shown	to	maximally	stimulate	proliferation	(Yamada	et	al.	2010;	
Walker	 et	 al.	 2015).	Upon	 treatment	with	 rh-HGF,	MyoD	and	Myf-5	mRNA	expression	 responded,	
but	MyoD	and	Myf-5	intracellular	protein	levels	in	all	treatment	groups,	remained	similar	to	that	of	
the	control	 group.	Using	C2C12	cells	Walker	et	al.	 (2015)	 showed	 treatment	with	2	ng/mL	of	HGF	
decreased	MyoD	positive	cells,	while	treatment	with	10	ng/mL	of	HGF	increased	MyoD	positive	cells.	
These	results	were	also	seen	with	the	human	skeletal	muscle	myoblast	(HSkM)	cells	that	were	used	
(Walker	et	al.	2015).	The	data	obtained	here	indicated	that	MyoD	protein	did	not	vary	significantly	
between	 any	 treatment	 groups	 and	 the	 control	 group.	 However,	 when	 comparing	 the	 different	
treatments,	the	PHMs	group	treated	with	2	ng/mL	of	rh-HGF	for	48	h	did	show	the	most	decreased	
MyoD	expression	compared	to	all	 the	other	treatment	groups,	which	 is	 in	agreement	with	current	
literature	(Yamada	et	al.	2010;	Walker	et	al.	2015).	
Although	neither	Walker	et	al.	(2013)	nor	Yamada	et	al.	(2010)	assessed	Myf-5	expression	after	HGF	
treatment	 in	 their	 studies,	 one	 might	 expect	 Myf-5	 expression	 to	 be	 opposite	 to	 that	 of	 MyoD:	
higher	with	2-2.5	ng/mL	of	HGF	and	 lower	with	HGF	concentrations	>10	ng/mL	of	HGF.	The	Myf-5	
protein	data	instead	showed	no	differences	in	expression	at	this	low	concentration	compared	to	the	
control	 group.	Beauchamp	et	al.	 (2000)	 showed	 that	most	quiescent	 cells	 isolated	 from	uninjured	
mouse	muscle	express	Myf-5	(Beauchamp	et	al.	2000),	potentially	providing	a	reason	as	to	why	Myf-
5	 levels	 may	 not	 change	 too	 much	 between	 quiescent	 cells	 and	 ones	 treated	 with	 low	
concentrations	 of	 rh-HGF.	 The	 high	 (10	 ng/mL)	 treatment	 groups	 exhibited	 slightly	 lower	 Myf-5	
protein	levels,	which	would	be	a	logical	concequence	as	this	higher	concentration	of	HGF	is	thought	
to	stimulate	decreased	proliferation.	
Stellenbosch University  https://scholar.sun.ac.za
110	
Data	 for	Myf-5	mRNA	expression	was	 consistant	with	 the	Myf-5	 protein	 data:	 PHMs	 treated	with	
both	low	and	high	concentrations	of	rh-HGF	showed	no	significant	differences	between	treatments.	
But,	Myf-5	mRNA	expression	was	decreased	 in	all	 treated	groups	compared	to	the	control.	On	the	
other	hand,	the	MyoD	mRNA	expression	levels	dropped	more,	around	3-fold,	in	all	treatment	groups	
compared	to	control	PHMs.	Again,	these	results	are	in	disagreement	with	previously	published	data	
and	 the	 overall	 literature	 reporting	 HGF	 has	 different	 effects	 on	 Myf-5	 and	 MyoD	 regulation.	
Yamane	et	al.	(2004)	showed	that	exogenous	HGF	inhibited	myoblast	differentiation	by	inducing	the	
expression	of	Myf-5	mRNA,	while	at	the	same	time	inhibiting	MyoD	mRNA	expression	(Yamane	et	al.	
2004).	However,	 these	changes	 in	MyoD	and	Myf-5	mRNA	expression	were	seen	at	very	high	HGF	
concentrations	-	50	and	100	ng/mL	-	 in	an	organ	culture	system	of	embryonic	(E13)	mouse	tongue	
myoblasts,	cultured	in	BGJb	medium	for	8	d.	These	high	concentrations	of	HGF	are	thought	to	only	
induce	myoblast	proliferation	arrest	and	to	promote	differentiation.	Therefore,	the	current	study	is	
not	 the	 only	 one	 reporting	 results	 that	 are	 contrary	 to	 what	 has	 been	 reported	 or	 expected.	
Furthermore,	 Yamane	 et	 al.’s	 (2004)	 data	 cannot	 be	 directly	 compared	 to	 the	 mRNA	 data	 in	
literature	 or	 this	 study,	 as	 the	 type	 of	 cell	 culture,	 HGF	 concentrations	 and	 duration	 of	 HGF	
treatment	are	different.	Finally,	although	there	was	a	lot	of	variability	in	expression	levels	within	the	
treatment	groups	in	this	study,	it	was	observed	that	MyoD	mRNA	expression	was	overall	lower	in	the	
24	h	low	and	high	HGF	treatment	groups	compared	to	their	48	h	counterparts.	These	data	seem	to	
add	also	a	 time	component	 to	HGF’s	effects	on	mRNA	synthesis,	but	does	not	 support	 the	notion	
that	HGF’s	effects	on	gene	expression	in	satellite	cells,	are	mainly	at	the	earliest	stages	of	activation	
(Miller,	Thaloor,	Matteson	&	G	K	Pavlath	2000).	
In	conclusion,	although	the	trends	for	MyoD	and	Myf-5	mRNA	expression	that	were	seen	have	had	
some	 similarities	 to	 those	 reported	 in	 literature,	 the	 protein	 and	 mRNA	 data	 were	 generally	
inconclusive	 and	 cannot	 accurately	 elucidate	 the	 effects	 that	HGF	 has	 on	 PHMs	 exposed	 to	 KOSR	
prior	 to	 treatment.	 Furthermore	 conclusive	 evidence	 on	 miR-31	 and	 its	 role	 in	 satellite	 cells	 in	
quiescence	promoting	media	was	not	achieved.	Finally,	it	was	not	determined	whether	HGF	has	any	
effect	on	its	expression.		
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CHAPTER	5	
CONCLUSION	AND	FUTURE	PERSPECTIVES	
The	findings	presented	in	this	thesis	can	be	considered	as	preliminary	since	no	previous	studies	have	
subjected	PHMs	to	KOSR.	Nontheless	they	open	up	several	interesting	avenues	of	research	into	the	
promotion	of	quiescence	and	the	subsequent	activation	of	quiescent	satellite	cells,	along	with	their	
gene	expression	and	protein	contents.		
After	 careful	 consideration,	 certain	 recommendations	 for	 future	 experiments	 became	 apparent.	
Firstly	 repeating	 all	 the	 experiments	 performed	 here,	with	 PHMs	 from	 different	 subjects	 to	more	
accurately	determine	the	state	of	PHM	cultures	after	10	days	in	quiescence	media.	Analysis	of	cyclin-
dependent	kinase	inhibitors,	p21,	p27	and	p57,	which	are	known	to	be	expressed	in	cells	 in	G0	will	
help	 in	 ascertaining	 whether	 the	 PHMs	 are	 truly	 quiescent.	 Secondly,	 to	 obtain	 a	 greater	
understanding	 of	 how	 HGF	 affects	 satellite	 cell	 activation,	 we	 recommend	 the	 addition	 of	 two	
further	rh-HGF	treatment	groups:	i)	a	‘very-high’	(50	ng/mL)	rh-HGF	and	ii)	an	‘extremely	high’	(100	
ng/mL)	rh-HGF.	This	will	further	help	to	elucidate	the	effects	high	HGF	concentrations	have	on	PHM	
proliferation	and	MRF	expression,	when	treatment	is	administered	to	quiescent	cells.	In	addition	to	
more	rh-HGF	treatment	groups	the	addition	of	12	h	and	72	h	sampling	time	points,	would	elucidate	
whether	rh-HGF	treatment	affects	MyoD	and	Myf-5	expression	at	these	earlier	and	later	time	points.	
Furthermore,	with	regards	to	miRNA	expression,	performing	whole	miR-nome	analysis,	to	determine	
which	 known	 miRNAs	 are	 upregulated	 in	 quiescent	 PHMs	 and	 then	 determining	 their	 potential	
targets	using	 in	silico	databases.	This	would	not	only	help	elucidate	the	roles	of	miRNAs	in	satellite	
cell	quiescence,	but	also	identify	which	ones	play	a	role	in	‘priming’	satellite	cells	to	re-enter	the	cell	
cycle,	by	maintaining	 them	 in	 the	hypothesized	GAlert	 state.	However,	better	expansion	 techniques	
prior	 to	repeating	the	studies	must	be	 investigated	for	use	 in	PHMs	derived	from	muscle	biopsies,	
especially	when	 frozen	 stocks	 are	 to	 be	 re-utilized.	 Otherwise	 insufficient	 cell	 numbers	will	 again	
hamper	the	study.	
In	 conclusion,	 the	 preliminary	 data	 presented	 here	 adds,	 albeit	modestly,	 to	 the	 growing	 body	 of	
literature	 surrounding	 the	 responses	 of	 primary	 human	 myoblasts	 to	 differing	 concentrations	 of	
HGF.	Furthermore,	 it	sets	up	future	potential	avenues	of	research	 into	the	time	and	concentration	
dependent	 effects	 HGF	 has	 on	 satellite	 cell	 proliferation	 and	 MRFs.	 Finally,	 it	 introduces	 novel	
insights	into	HGF’s	effects	on	miRNA	expression.	
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APPENDIX	A	- CELL	CULTURE	REAGENTS	
PRIMARY	HUMAN	MYOBLAST	PROLIFERATION	MEDIA	(PHM-PM):	A	solution	of	361	mL	of	Ham	F-10	
Nutrient	Mixture	Medium	(Sigma-Aldrich,	Germany,	N6908)	was	supplemented	with	100	mL	foetal	
bovine	 serum	 (Life	Technologies,	USA,	10499-044),	5	mL	Penicillin	 (10,000	units/mL)/Streptomycin	
(10,000	μg/mL)	(Cf	Penicillin	=	100	units/mL)	(Cf	Streptomycin	=	100	μg/mL)	(Life	Technologies,	USA,	
15140-122),	34	mL	L-glutamine	(200	mM,	100x)	(Cf	=	13.6	mM)	(Life	Technologies,	USA,	25030-081).	
49.95	 mL	 was	 filtered	 through	 a	 0.22	 μm	 PVDF	 membrane	 (Merck,	 Germany,	 SLGV033RB)	 and	
aliquoted	into	50	mL	centrifuge	tubes	(NEST	Biotechnology,	USA,	602072)	and	stored	at	4	°C.	Prior	to	
use,	50	μL	of	10	μg/mL	of	rh-FGF	(Promega,	USA,	G5071)	was	added	fresh	to	to	each	centrifuge	tube	
to	obtain	a	final	concentration	of	10	ng/mL	rh-FGF.	
PRIMARY	 HUMAN	 MYOBLAST	 QUIESCENCE	 MEDIA:	 A	 solution	 of	 361	 mL	 of	 Ham	 F-10	 Nutrient	
Mixture	 Medium	 (Sigma-Aldrich,	 Germany,	 N6908)	 was	 supplemented	 with	 100	 mL	 KnockOut™	
Serum	 Replacement	 (Life	 Technologies,	 USA,	 10828-010),	 5	 mL	 Penicillin	 (10,000	 units/mL)/	
Streptomycin	 (10,000	 μg/mL)	 (Cf	 Penicillin	 =	 100	 units/mL)	 (Cf	 Streptomycin	 =	 100	 μg/mL)	 (Life	
Technologies,	 USA,	 15140-122),	 34	 mL	 L-glutamine	 (200	 mM,	 100x)	 (Cf	 =	 13.6	 mM)	 (Life	
Technologies,	USA,	25030-081).	The	media	was	filtered	through	a	0.22	μm	PVDF	membrane	(Merck,	
Germany,	 SLGV033RB)	 and	 aliquoted	 into	 50	 mL	 centrifuge	 tubes	 (NEST	 Biotechnology,	 USA,	
602072)	and	stored	at	4	°C.	
PRIMARY	 HUMAN	 MYOBLAST	 DIFFERENTIATION	 MEDIA	 (PHM-DM):	 A	 solution	 of	 451	 mL	 of	
Dulbecco’s	 modified	 Eagle’s	 medium	 (Sigma-Aldrich,	 Grmany,	 D5671),	 10	 mL	 Horse	 Serum	 (Life	
Technologies,	USA,	26-050-088),	5	mL	Penicillin	(10,000	units/mL)/Streptomycin	(10,000	μg/mL)	(Cf	
Penicillin	=	100	units/mL)	(Cf	Streptomycin	=	100	μg/mL)	(Life	Technologies,	USA,	15140-122),	34	mL	
L-glutamine	 (200	mM,	 100x)	 (Cf	 =	 13.6	mM)	 (Life	 Technologies,	 USA,	 25030-081).	 The	media	was	
filtered	through	a	0.22	μm	PVDF	membrane	(Merck,	Germany,	SLGV033RB)	and	aliquoted	into	50	mL	
centrifuge	tubes	(NEST	Biotechnology,	USA,	602072)	and	stored	at	4	°C.	
PRIMARY	HUMAN	MYOBLAST	FREEZING	MEDIA:	A	solution	of	33.6	mL	of	Ham	F-10	Nutrient	Mixture	
Medium	(Sigma-Aldrich,	Germany,	N6908)	was	supplemented	with	10.0	mL	foetal	bovine	serum	(Life	
Technologies,	USA,	10499-044),	0.5	mL	Penicillin	(10,000	units/mL)/Streptomycin	(10,000	μg/mL)	(Cf	
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Penicillin	=	100	units/mL)	(Cf	Streptomycin	=	100	μg/mL)	(Life	Technologies,	USA,	15140-122),	34	mL	
L-glutamine	 (200	 mM,	 100x)	 (Cf	 =	 13.6	 mM)	 (Life	 Technologies,	 USA,	 25030-081),	 2.5	 mL	 DMSO	
(Sigma-Aldrich,	 Germany,	 D2650).	 The	 medium	 was	 filtered	 through	 a	 0.22	 μm	 PVDF	 membrane	
(Merck,	Germany,	SLGV033RB)	and	aliquoted	into	50	mL	centrifuge	tubes	(NEST	Biotechnology,	USA,	
602072)	and	stored	at	4	°C.	
rh-HGF	TREATMENT	MEDIA:	High	concentration	of	rh-HGF	(10	ng/mL)	was	made	from	30	μL	of	stock	
rh-HGF	(5	μg/mL)	added	to	14.97	mL	of	quiescence	media.	Low	concentration	of	rh-HGF	(2	ng/mL)	
was	made	from	3	mL	of	High	concentration	(10	ng/mL)	added	to	12	mL	of	quiescence	media.	
rh-HGF	RECONSTITUTION:	5	μg	of	lyophilized	rh-HGF	(R&D	Systems,	USA,	294-HG)	was	reconstituted	
at	50	μg/mL	by	adding	100	μL	of	sterile	1x	PBS	(Sigma-Aldrich,	Germany,	P4417)	with	0.1%	(w/v)	of	
BSA	 (Roche,	 Germany,	 10735086001).	 To	 make	 the	 0.1%	 BSA,	 0.05	 g	 of	 Bovine	 serum	 albumin	
fraction	 V	 (Roche,	 Germany,	 10735086001)	 was	 dissolved	 in	 50	mL	 1x	 sterile	 PBS	 (Sigma-Aldrich,	
Germany,	 P4417).	 This	 solution	 was	 then	 filtered	 through	 a	 0.22	 μm	 PVDF	 membrane	 (Merck,	
Germany,	SLGV033RB).	The	50	μg/mL	rh-HGF	was	then	diluted	10-fold	in	the	PBS	solution	to	obtain	a	
5	μg/mL	working	solution.	This	was	aliquoted	and	stored	at	-20	°C.	
rh-FGF	RECONSTITUTION:	25	μg	of	 lyophilized	rh-FGF	 (Promega,	USA,	G5071)	was	reconstituted	at	
10	μg/mL	by	adding	2.5	mL	of	 sterile	1x	PBS	 (Sigma-Aldrich,	Germany,	P4417).	This	was	aliquoted	
and	stored	at	-20°C.	
STERILE	 PHOSPAHTE	 BUFFERED	 SALINE:	 To	 prepare	 1x	 PBS,	 5	 tablets	 of	 Sigma-Aldrich	 P4417	 pre-
made	 PBS	 tablets	 were	 dissolved	 in	 1	 L	 of	 ddH20	 to	 yield	 a	 0.01	M	 phosphate	 buffer,	 0.0027	M	
potassium	 chloride	 and	 0.137	 M	 sodium	 chloride,	 pH	 7.4	 solution	 at	 25	 °C.	 This	 solution	 was	
autoclaved	to	ensure	sterility	and	aliquoted	into	50	mL	centrifuge	tubes	(NEST	Biotechnology,	USA,	
602072)	and	stored	at	4	°C.	
ENTACTIN-COLLAGEN	 IV-LAMININ	 (ECL)	 CELL	 ATTACHMENT	MATRIX:	 Stock	 ECL	 (5	 mg)	 (1	 mg/mL)	
(Merck,	USA,	08-110)	was	diluted	to	a	working	stock	of	20	μg/mL	in	250	mL	of	sterile	1x	PBS	(Sigma-
Aldrich,	 Germany,	 P4417).	 This	 solution	 was	 aliquoted	 into	 15	 mL	 centrifuge	 tubes	 (NEST	
Biotechnology,	USA,	601002)	and	stored	at	-20	°C.	
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APPENDIX	B	- CELL	PASSAGING,	THAWING	AND	CRYOPRESERVATION	
CELL	THAWING:	Cryovials	(Corning,	USA,	430487)	were	removed	from	LN2	storage	and	placed	in	37	
°C	 water	 to	 thaw.	 The	 cell	 suspension	 was	 then	 placed	 in	 a	 15	 mL	 centrifuge	 tube	 (NEST	
Biotechnology,	 USA,	 601002)	 containing	 5	 mL	 of	 pre-warmed	 (37	 °C)	 primary	 human	 myoblast	
proliferation	media	(PHM-PM).	Cells	were	placed	in	a	centrifuge	(Eppendorf,	Germany,	5810R)	and	
centrifuged	 for	 3	 min	 at	 1500	 RPM	 at	 room	 temperature.	 After	 centrifugation	 the	 media	 was	
aspirated	to	remove	all	traces	of	dimethyl	sulphoxide	(DMSO)	(Sigma-Aldrich,	Germany,	D2650).	The	
pelleted	 cells	 were	 resuspended	 in	 37	 °C	 PHM-PM	 and	 triturated.	 The	 cell	 suspension	 was	 then	
transferred	 to	 the	 ECL-coated	 (Millipore,	USA,	 08-110)	 T25	 cell	 culture	 flask	 (NEST	 Biotechnology,	
USA,	707003),	which	was	then	placed	in	a	temperature	controlled	incubator	with	a	constant	5%	CO2	
(ESCO,	Singapore,	CCL-170B-8-UV).	Coating	of	cell	culture	flasks	with	ECL	was	performed	prior	to	cell	
culturing.	Flasks	were	incubated	for	at	least	1	at	37	°C	with	ECL.		
CELL	 PASSAGING:	 Once	 PHMs	 covered	 70-80%	 of	 the	 cell	 culture	 flask	 growth	 surface	 cells	 were	
trypsinized	and	passaged.	To	perform	cell	passaging,	old	media	was	removed	and	cells	were	rinsed	
twice	 with	 pre-warmed	 1x	 sterile	 PBS	 (Sigma-Aldrich,	 Germany,	 P4417).	 0.25%	 Trypsin-EDTA	 (1x)	
(Life	Technologies,	USA,	25200-072)	was	then	added	to	the	culture	flask,	which	was	then	incubated	
in	a	heated	shaking	incubatore	set	at	37	°C	for	5	min,	to	dilodge	cells	from	the	flask	surface.	An	equal	
volume	of	warm	PHM-PM	was	then	added	to	the	flask	and	the	cell	suspension	was	transferred	to	a	
15	mL	centrifuge	tube	(NEST	Biotechnology,	USA,	601002).	The	culture	flask	was	then	rinsed	again	
with	PHM-PM	 in	order	 to	 collect	 remaing	 cells	 and	 transferred	 to	 the	15	mL	 centrifuge	 tube.	 The	
centrifuge	tube	was	then	placed	in	a	centrifuge	(Eppendorf,	Germany,	5810R)	was	spun	at	1500	RPM	
for	3	min.	After	centrifugation,	 the	media	 inside	the	15	mL	centrifuge	tube	was	discarded	and	the	
pelleted	 cells	were	 resuspended	 in	 1	mL	warm	PHM-PM.	Depending	on	 the	number	of	 cells,	 cells	
were	either	split	1:2	or	1:3	and	then	transferred	into	a	new	tissue	culture	flask.	
CRYOPRESERVATION:	Once	sufficient	expansion	of	cells	of	each	particular	subject	was	achieved,	cells	
were	cryopreserved	in	liquid	nitrogen	LN2	(-195	°C)	for	long	term	storage.	Cells	were	washed	with	1x	
PBS	 (Sigma-Aldrich,	 Germany,	 P4417)	 and	 trypsinized	 with	 0.25%	 (1x)	 Trypsin-EDTA	 (Life	
Technologies,	 USA,	 25200-072).	 Cells	 were	 pelleted	 and	 resuspended	 in	 ice-cold	 (1-4	 °C)	 primary	
human	myoblast	 freezing	media.	 The	 cell	 suspension	was	 then	 placed	 in	 cryovials	 (Corning,	 USA,	
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430487)	 in	 1	 mL	 aliquots,	 each	 containg	 ±	 5	 x	 105	 cells.	 Cryovials	 were	 placed	 in	 a	 Mr	 Frosty™	
freezing	 container	 (Thermo	Fischer,	Germany,	5100-0001)	 and	placed	 for	24	h	 in	 a	 -80	 °C	 freezer.	
Cryovials	were	then	moved	to	LN2	for	long	term	storage.		
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APPENDIX	C	- DETERMINATION	OF	CELL	CULTURE	CONTAMINATION	
Contamination	of	PHMs,	whether	 it	be	bacterial	or	 fungal,	was	determined	by	either	brightfield	or	
confocal	microscopy.		
BACTERIAL	OR	FUNGAL	CONTAMINATION:	All	cells	grown	in	flasks	or	plates	were	checked	on	a	daily	
basis	for	the	presence	of	any	possible	contamination.	Clear	see-through	media,	without	any	change	
in	colour	visually	confirmed	absence	of	contamination.	Cells	were	then	visualized	under	brightfield	
microscopy	at	4x,	10x	and	20x	to	look	for	fungal	spores	or	a	motile	particles	in	the	media,	generated	
by	bacterical	contamination.		
MYCOPLASMA	CONTAMINATION:	Mycoplasma	contamination	was	assessd	via	confocal	microscopy.	
Briefly,	cells	were	plated	on	a	cover	slips	and	incubated	for	24	h	at	37	°C.	Media	was	then	removed	
and	cells	were	washed	with	1x	PBS	twice.	Cells	were	the	fixed	 in	4%	paraformaldehyde	for	15	min	
and	stained	with	Hoechst	(1:2000)	for	5	min	in	the	dark.	Cover	slips	were	then	washed	with	1x	PBS	
several	 times	and	 then	mounted	with	4	μL	of	Moviol	onto	microscope	slides.	The	absence	of	blue	
string-like	particles	around	cellular	nuclei,	signified	the	absence	of	Mycoplasma	contamination.	
Figure	C.1:	Mycoplasma	contamination	assessement	in	PHM	cell	cultures.	
Confocal	 microscopy	 image	 of	 PHMs	 fixed	 in	 4%	 paraformaldehdye	 and	 stained	 with	 Hoescht	 (1:2000)	 to	
visualize	micoplasma	contamination	in	cell	cultures.	
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APPENDIX	D	- FLOW	CYTOMETRY	SETUP	AND	ANTIBODY	OPTIMIZATION	
Table	D.1:	Multicolour	flow	cytometry	antibody	panel.	
1	 2	 3	 4	 5	 6	 7	
Marker	 Ki-67	 CD56	 Myo-D	 Myf-5	 CD34	 Pax-7	 Zombie	Aqua	
Fluorochrome	 PE/Cy7	 PE/Dazzle	 APC	 Alex	488	 APC/Cy7	 PE	 Aqua	BV510	
Host	 Mouse	 Mouse	 Mouse	 Mouse	 Mouse	 Mouse	 Mouse	
Reactivity	 Human	 Human	 Human	 Human	 Human	 Human	 Human	
Application	 Flow	 Flow	 Flow	 Flow	 Flow	 Flow	 Flow	
Filter	 780/60	 610/20	 660/20	 530/30	 780/60	 585/42	 530/30	
Laser	 Blue	 Blue	 Red	 Blue	 Red	 Blue	 Violet	
Emmission	 785nm	 610nm	 660nm	 519nm	 785nm	 578nm	 516nm	
Concentration	
/		1	x	106	cells	 5	μL	 2.5	μL	 5	μL	 5	μL	 2.5	μL	 10	μL	 1	μL	
CYTOMETER	SETTINGS:	
Footnote:	Voltage	settings	used	on	the	FACS	Aria	for	the	multicolour	flow	cytometry	analyses	of	PHMs.	
SPECTRAL	OVERLAP:	
Footnote:	Spectral	overlap	of	the	different	fluorophores	used	for	the	multicolour	flow	cytometry	analyses	of	
PHMs.	
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ANTIBODY	TITRATIONS	AND	TITRATION	CURVES:	
Footnote:	Asterisk	indicates	optimal	concentration	of	antibody.	
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FLUORESCENCE	MINUS	ONE	(FMOs):	
Figure	D.1:	Unstained	FMO.	
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Figure	D.2:	Pax7	FMO.	
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Figure	D.3:	MyoD	FMO.	
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Figure	D.4:	Myf-5	FMO.	
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Figure	D.5:	Ki-67	FMO.	
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Figure	D.6:	CD34	FMO.	
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Figure	D.7:	CD56	FMO.	
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APPENDIX	E	- RH-HGF	TREATMENT	TISSUE	CULTURE	PLATE	SETUP	
Figure	E.1:	6-well	(35mm)	tissue	culture	plate	set	up	for	rh-HGF	treatment.	
PHMs	were	plated	onto	ECL-coated	plates	and	cultured	in	quiescence	media	(Ham’s	F-10	supplemented	with	
20%	KOSR,	1%	P/S	and	6.8	%	L-Glu)	for	10	days.	The	low	and	high	treatment	wells	were	then	further	cultured	
in	quiescence	media	containing	either	2	ng/mL	(low)	or	10	ng/mL	(high)	of	rh-HGF	for	24	h	or	48	h.	Once	the	
experiment	 reached	 completion,	 cells	 were	 lysed	 and	 protein,	 RNA	 and	 miRNA	 was	 isolated	 for	 further	
analysis.	
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APPENDIX	F	- PROTEIN	LYSATE	PREPARATION	AND	QUANTIFICATION	
RIPA	BUFFER:	50	mM	Tris	 (hydroxymethyl)	aminomethane	 (NH2C(CH2OH)3,	 (MW	=	121.14)	 (Sigma-
Aldrich,	 Germany,	 201-064-4),	 2.5	mM	TRIS-HCl	 pH	 7.8	 1	M	 (Sigma-Aldrich,	 Germany,	 T2913),	 1%	
(v/v),	Triton	X-100	(Sigma-Aldrich,	Germany,	X100),	0.5%	(v/v)	Sodium	deoxycholate	(MW	=	414.55)	
(Sigma-Aldrich,	 Germany,	 DA5670),	 0.25%	 (w/v)	 ethylenediaminetetraacetic	 acid	 disodium	 salt	
dihydrate	 (EDTA,	M	=	372.24)	 (Sigma-Aldrich,	Germany,	205-358-3)	The	buffer	was	 stored	at	4	 °C.	
Prior	 to	protein	harvesting,	80	μL	of	25x	protease	 inhibitor	cocktail	 (Roche,	Germany,	04-693-116-
001)	 and	 100	 μL	 of	 10x	 phosphatase	 inhibitor	 cocktail	 (Roche,	 Germany,	 04-906-837-001)	 were	
added	fresh	to	820	μL	of	RIPA	Buffer.		
PROTEIN	HARVESTING:	PHMs	were	cultured	 in	6-well	 tissue	culture	plates	 (Corning,	USA,	CR3516).	
Media	was	removed	and	cells	were	washed	with	cold	(4	°C)	1x	PBS	(Sigma-Aldrich,	Germany,	P4417)	
and	 trypsinized	 with	 0.25%	 (1x)	 Trypsin-EDTA	 (Life	 Technologies,	 USA,	 25200-072).	 Plates	 were	
placed	on	 ice	 and	100	μL	of	 RIPA	Buffer	was	placed	 into	 each	well.	 Cells	were	 removed	 from	 the	
culture	 surface	with	 a	 cell	 scraper	 (NEST,	 USA,	 710001)	 and	 transferred	 into	 a	 1.5	mL	 Eppendorf	
tube.	The	collected	cell	suspensions	were	kept	on	ice,	sonicated	for	15	seconds	and	then	centrifuged	
for	10	min	at	14,000	RPM	at	4	°C.	The	supernantant	was	transferred	 into	a	new	1.5	mL	Eppendorf	
tube	 and	 then	 protein	 concentrations	 were	 determined	 spectrophotometrically	 via	 the	 Direct	
Detect®	 infrared	spectrophotometer	(EDM	Millipore,	USA,	DDHW00010-00).	2	μL	of	cell	 lysate	was	
loaded	 onto	 Direct	 Detect	 cards	 and	 placed	 into	 the	 spectrophotometer.	 A	 pre-calibrated	 RIPA	
buffer	standard	curve	was	used	as	a	reference	and	a	sample	of	RIPA	buffer	used	to	harvest	cells	was	
used	to	blank	the	spectrophotometer.	Samples	were	then	stored	at	-80	°C.	
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DIRECT	DETECT	PROTEIN	CONCENTRATION	READ	OUTS:	
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APPENDIX	G	- WESTERN	BLOT	REAGENTS	
RUNNING	BUFFER	10X:	A	 solution	 containing	 30.3	 g	 0.25M	Tris	 (Merck,	Germany,	 648310),	144	 g	
1.92	 M	 Glycine	 (Merck,	 Germany,	 357002),	 10	 g	 10%	 (v/v)	 SDS	 (Merck,	 Germany,	 428023)	 was	
placed	into	a	beaker	and	made	up	to	1	L	with	ddH2O.	
TRANSFER	BUFFER:	200	mL	of	5x	Transfer	buffer	 supplied	 in	 the	Trans-Blot®	Turbo™	RTA	Transfer	
Kit,	LF	PVDF	(Bio-Rad,	USA,	170-4274)	was	mixed	with	200	mL	(95-99%)	EtoH,	and	600	mL	ddH2O.	
TBS-T	10X:	A	solution	containing	60	g	Tris	 (500mM),	87	g	NaCl	 (1.5M)	and	10	mL	Tween	 (1%)	was	
placed	into	a	beaker,	pH	to	8.3	and	made	up	to	1	L	with	ddH2O	
5%	MILK:	10	mL	of	fat	free	milk	(Parmalat)	was	mixed	with	190	mL	of	1x	TBS-Tween	for	blocking	and	
secondary	antibody	incubation.	
12%	 PAGE-GELS:	 A	 TGX	 Stain-Free™	 FastCast™	 Acrylamide	 kit,	 12%	 (BioRad,	 USA,	 161-0185)	 was	
used	to	separate	proteins.		
For	the	resolver	gel	4	mL	of	Resolver	A	solution	was	mixed	with	4	mL	of	Resolver	B	soultion.	40	μL	of	
10%	ammonium	persulfate	(APS)	was	then	added	along	with	15	μL	of	Tetramethylethylenediamine	
(TEMED)	(Sigma-Aldrich,	Germany,	T7024).	The	solution	was	mixed.	
For	the	Stacking	gel	1.5	mL	of	Stacker	A	solution	was	mixed	with	1.5	mL	of	Stacker	B	soultion.	10	μL	
of	 10%	 ammonium	 persulfate	 (APS)	 was	 then	 added	 along	 with	 5	 μL	 of	 TEMED	 (Sigma-Aldrich,	
Germany,	T7024).	The	solution	was	mixed.	
Both	 stacker	 and	 resolver	 soultions	 then	 pipetted	 in	 between	 two	 1.5	mm	 glass	 plates.	With	 the	
resolver	pipetted	first	followed	by	the	stacker.	The	gel	was	then	left	at	room	temperature	for	45	min	
to	allow	for	polymeriziation.	
10%	APS:	0.1	g	of	ammonium	persulfate	(APS)	(Sigma-Aldrich,	Germany,	A3678)	was	dissolved	in	1	
mL	of	ddH2O,	aliquoted	and	then	stored	at	-20	°C.	A	fresh	aliquot	was	thawed	and	used	every	time.	
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APPENDIX	H	- POLYACRYLAMIDE	GEL	ELECTROPHORESIS	&	WESTERN
BLOTTING	PROTOCOL	
POLYACRYLAMIDE	 GEL	 ELECTROPHORESIS:	 Cast	 gels	 were	 placed	 into	 a	 Bio-Rad	 Mini-PROTEAN®	
Tetra	 cell	 gel	 electrophoresis	 system.	 1x	 running	 buffer	 was	 poured	 into	 the	 inner	 and	 outer	
electrode	 compartments	 until	 the	 tank	 was	 full.	 10	 μL	 of	 Precision	 Plus	 Protein™	 Kaleidoscope™	
protein	marker	standard	(Bio-Rad,	USA,	161-0375)	was	added	along	with	protein	samples.	The	gels	
were	run	at	a	constant	voltage	of	120V	for	10-15	min	to	allow	the	protein	samples	to	pass	into	the	
resolving	gel	and	then	increased	to	200V	for	1	h	or	until	satisfactory	separation	was	observed.	(Bio-
Rad	PowerPac	1000,	Bio-Rad	Laboratories,	USA).	
WESTERN	BLOTTING:	Gels	were	placed	in	a	ChemiDoc™	MP	Imaging	System	(Bio-Rads	Laboratories,	
USA)	 and	 activated	 for	 total	 protein	 visualization	 and	 quantification.	 After	 activation,	 proteins	
samples	 were	 transferred	 to	 a	 0.45	 μm	 low-autofluorescence	 polyvinylidene	 difluoride	 (PVDF)	
membrane	 using	 a	 Trans-Blot®	 Turbo™	RTA	 Transfer	 Kit,	 LF	 PVDF	 (Bio-Rad,	USA,	 170-4274)	 and	 a	
Bio-Rad	Trans-Blotv®	Turbo™	Transfer	system.	Prior	to	transfer	the	membranes	were	first	immersed	
in	100%	Methanol	 for	2-3	min	or	until	 they	became	translucent.	The	PVDF	membranes	were	 then	
moved	 into	 1x	 transfer	 buffer	 and	 left	 to	 equilibrate.	 Filter	 paper	 stacks	 were	 also	 placed	 in	 1x	
transfer	 buffer	 and	 left	 to	 equilibrate.	 The	 apparatus	 was	 run	 according	 to	 Bio-Rad’s	 standard	
protcols	 for	 1.5	mm	gels	 (25V	 and	1.3A	 for	 10	min),	 to	 ensure	maximal	 protein	 transfer	 onto	 the	
membrane.	After	proteins	were	successfully	 transferred	to	the	LF	PVDF	membrane,	 it	was	washed	
three	 times	 in	1x	TBS-Tween	buffer	 for	5	min.	 The	membrane	was	 then	blocked	with	5%	 (v/v)	 fat	
free	milk	(Parmalat)	in	1x	TBS-Tween	buffer	for	1	h,	to	prevent	non-specific	binding.	The	membrane	
was	 then	washed	 again	 three	 times	 in	 1x	 TBS-Tween	 buffer	 for	 5	min	 to	 remove	 trances	 of	milk.	
Primary	 antibody	 was	 then	 added	 to	 1x	 TBS-Tween	 with	 2%	 (w/v)	 BSA	 (Roche,	 Germany,	
10735086001)	 buffer	 and	 incubated	 overnight	 at	 4	 °C	 with	 constant	 agitation.	 After	 primary	
antibody	incubation	was	complete	the	membrane	was	washed	six	times	in	1x	TBS-Tween	buffer	for	5	
min	 and	 then	 incubated	with	 secondary	 HRP-linked	 antibodies	 at	 room	 temperature	 for	 1	 h	with	
constant	agitation.	Finally	the	membrane	was	washed	again	six	times	in	1x	TBS-Tween	buffer	for	5	
min	to	remove	any	non-specific	binding.	Proteins	were	visualized	with	the	aid	of	chemiluminescence	
SuperSignal®	West	 Femto	Maximum	 Sensitivity	 Substrate	 Kit	 (Thermo	 Scientific,	 USA,	 34096)	 and	
imaged	 using	 the	 ChemiDoc™	 MP	 Imaging	 system	 (Bio-Rad	 Laboratories,	 USA).	 Densitometric	
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analysis	of	the	protein	samples	was	performed	on	the	Image	Lab™	Software	(Bio-Rad	Laboratories,	
USA)	and	normalized	to	total	protein.	
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APPENDIX	I	- RNA	QUANTIFICATION	
Table	I.1:	mRNA	nanodrop	readings	
PHM	6	
p6	
1st	read	 2nd	read	 Average	
Concentration	 A260/A280 Concentration	 A260/A280	
Concentration	
(ng/μL)	 A260/A280	
PHMPM	 340.0	 2.01	 339.2	 2.01	 339.60	 2.01	
KOSR	10d	 97.0	 1.93	 107.4	 1.94	 102.20	 1.935	
Low	48	h	 142.4	 1.98	 143.8	 1.95	 143.10	 1.965	
Low	24	h	 257.4	 1.99	 253.1	 1.97	 255.25	 1.98	
High	48	h	 217.3	 1.99	 216.0	 2.01	 216.65	 2.00	
High	24	h	 186.2	 2.00	 189.4	 1.96	 187.8	 1.98	
PHM	6	
p7	
1st	read	 2nd	read	 Average	
Concentration	 A260/A280	 Concentration	 A260/A280	
Concentration	
(ng/μL)	 A260/A280	
PHMPM	 243.6	 2.02	 244.9	 2.02	 244.25	 2.02	
KOSR	10d	 60.3	 1.88	 62.5	 1.85	 61.40	 1.865	
Low	48	h	 132.6	 1.98	 126.8	 2.00	 129.7	 1.99	
Low	24	h	 144.9	 1.92	 144.8	 1.97	 144.85	 1.945	
High	48	h	 125.7	 1.95	 125.6	 1.98	 125.65	 1.965	
High	24	h	 176.8	 1.98	 175.0	 1.99	 175.90	 1.985	
PHM	6	
p8	
1st	read	 2nd	read	 Average	
Concentration	 A260/A280	 Concentration	 A260/A280	
Concentration	
(ng/μL)	 A260/A280	
PHMPM	 372.2	 1.99	 370.3	 1.99	 371.15	 1.99	
KOSR	10d	 91.1	 1.93	 91.4	 1.92	 91.25	 1.925	
Low	48	h	 127.4	 1.92	 112.1	 1.98	 119.75	 1.95	
Low	24	h	 127.0	 1.96	 124.5	 1.98	 125.75	 1.97	
High	48	h	 100.0	 1.98	 100.5	 1.95	 100.25	 1.965	
High	24	h	 129.6	 1.97	 128.7	 1.97	 129.15	 1.97	
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Table	I.2:	miRNA	nanodrop	readings	
PHM	6	
p6	
1st	read	 2nd	read	 Average	
Concentration	 A260/A280	 Concentration	 A260/A280	
Concentration	
(ng/μL)	 A260/A280	
PHMPM	 270.0	 1.97	 270.0	 1.97	 270.00	 1.97	
KOSR	10d	 124.9	 1.90	 125.3	 1.90	 125.10	 1.90	
Low	48	h	 181.7	 1.97	 181.4	 1.98	 181.55	 1.975	
Low	24	h	 169.9	 1.94	 170.3	 1.93	 170.10	 1.935	
High	48	h	 180.8	 1.97	 181.8	 1.97	 181.30	 1.97	
High	24	h	 202.9	 2.00	 202.9	 2.00	 202.90	 2.00	
PHM	6	
p7	
1st	read	 2nd	read	 Average	
Concentration	 A260/A280	 Concentration	 A260/A280	
Concentration	
(ng/μL)	 A260/A280	
PHMPM	 243.3	 1.97	 243.2	 1.97	 243.25	 1.97	
KOSR	10d	 107.6	 1.93	 109.6	 1.90	 108.6	 1.925	
Low	48	h	 142.9	 1.96	 143.2	 1.97	 143.05	 1.965	
Low	24	h	 276.5	 1.98	 274.6	 1.97	 275.55	 1.975	
High	48	h	 217.1	 1.89	 217.2	 1.88	 217.15	 1.885	
High	24	h	 216.2	 1.96	 217.1	 1.98	 216.65	 1.97	
PHM	6	
p8	
1st	read	 2nd	read	 Average	
Concentration	 A260/A280	 Concentration	 A260/A280	
Concentration	
(ng/μL)	 A260/A280	
PHMPM	 335.8	 1.94	 334.8	 1.94	 335.3	 1.94	
KOSR	10d	 168.0	 1.83	 171.0	 1.82	 169.5	 1.825	
Low	48	h	 138.8	 1.89	 140.0	 1.88	 139.45	 1.885	
Low	24	h	 110.8	 1.89	 109.8	 1.92	 110.3	 1.905	
High	48	h	 155.2	 1.98	 155.0	 1.98	 115.1	 1.98	
High	24	h	 127.0	 1.94	 125.8	 1.97	 126.4	 1.955	
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APPENDIX	J	- QPCR	RAW	DATA	ANALYSIS	
mRNA	RAW	DATA	ANALYSES:	
Sample	Name Target	Name Cт Cт	Mean d-CT dd-CT
p6	PHMPM	18S 18S 8,72720146 8,612462997
p6	PHMPM	18S 18S 8,49772549
p6	KOSR	10d	18S 18S 8,67298889 8,661458969
p6	KOSR	10d	18S 18S 8,64992809
p6	LOW	18S 18S 8,51294422 8,528255463
p6	LOW	18S 18S 8,54356766
p6	LOW_NONE	18S 18S 9,0076046 9,054648399
p6	LOW_NONE	18S 18S 9,1016922
p6	HIGH	18S 18S 8,68337727 8,644365311
p6	HIGH	18S 18S 8,6053524
p6	HIGH_NONE	18S 18S 8,50586796 8,267632484
p6	HIGH_NONE	18S 18S 8,02939701
p7	PHMPM	18S 18S 8,29356861 8,257759094
p7	PHMPM	18S 18S 8,22195053
p7	KOSR	10d	18S 18S 8,73018742 8,680724144
p7	KOSR	10d	18S 18S 8,63126087
p7	LOW	18S 18S 8,75853157 8,715736389
p7	LOW	18S 18S 8,67294025
p7	LOW_NONE	18S 18S 8,60055065 8,518550873
p7	LOW_NONE	18S 18S 8,43655014
p7	HIGH	18S 18S 8,78733444 8,723031044
p7	HIGH	18S 18S 8,65872765
p7	HIGH_NONE	18S 18S 8,73664093 8,792633057
p7	HIGH_NONE	18S 18S 8,84862614
p8	PHMPM	18S 18S 8,76671886 8,768182755
p8	PHMPM	18S 18S 8,76964569
p8	KOSR	10d	18S 18S 8,86929131 8,891401291
p8	KOSR	10d	18S 18S 8,91351032
p8	LOW	18S 18S 8,28086758 8,315956116
p8	LOW	18S 18S 8,3510437
p8	LOW_NONE	18S 18S 8,64849663 8,638632774
p8	LOW_NONE	18S 18S 8,62876892
p8	HIGH	18S 18S 9,03274727 9,03503418
p8	HIGH	18S 18S 9,03732204
p8	HIGH_NONE	18S 18S 8,96844292 8,986784935
p8	HIGH_NONE	18S 18S 9,00512695
REF	SAMPLE	28S 18S 6,37882614 6,477839947
REF	SAMPLE	28S 18S 6,57685375
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Sample	Name Target	Name Cт Cт	Mean d-CT dd-CT
p6	PHMPM	PAX7 PAX7 28,6597195 28,80053329 20,1880703
p6	PHMPM	PAX7 PAX7 28,941349 0
p6	KOSR	10d	PAX7 PAX7 28,5954094 28,69867897 20,03722
p6	KOSR	10d	PAX7 PAX7 28,8019485 0
p6	LOW	PAX7 PAX7 29,5687294 29,62428284 21,09602737
p6	LOW	PAX7 PAX7 29,6798382 0
p6	LOW_NONE	PAX7 PAX7 30,0671711 30,05618668 21,00153828
p6	LOW_NONE	PAX7 PAX7 30,0452003 0
p6	HIGH	PAX7 PAX7 29,7587814 29,82271576 21,17835045
p6	HIGH	PAX7 PAX7 29,8866501 0
p6	HIGH_NONE	PAX7 PAX7 29,26511 29,33724976 21,06961727
p6	HIGH_NONE	PAX7 PAX7 29,4093876 0
p7	PHMPM	PAX7 PAX7 29,9554787 29,94314194 21,68538284
p7	PHMPM	PAX7 PAX7 29,9308033 0
p7	KOSR	10d	PAX7 PAX7 29,2166519 29,19285202 20,51212788
p7	KOSR	10d	PAX7 PAX7 29,1690521 0
p7	LOW	PAX7 PAX7 29,6203346 29,68282127 20,96708488
p7	LOW	PAX7 PAX7 29,7453079 0
p7	LOW_NONE	PAX7 PAX7 29,4224129 29,46364212 20,94509125
p7	LOW_NONE	PAX7 PAX7 29,5048714 0
p7	HIGH	PAX7 PAX7 29,6267452 29,72416878 21,00113773
p7	HIGH	PAX7 PAX7 29,8215923 0
p7	HIGH_NONE	PAX7 PAX7 29,9344273 29,9512558 21,15862274
p7	HIGH_NONE	PAX7 PAX7 29,9680862 0
p8	PHMPM	PAX7 PAX7 31,1360455 31,16293716 22,39475441
p8	PHMPM	PAX7 PAX7 31,1898308 0
p8	KOSR	10d	PAX7 PAX7 30,2933693 30,3055191 21,41411781
p8	KOSR	10d	PAX7 PAX7 30,3176708 0
p8	LOW	PAX7 PAX7 30,2746773 30,28073502 21,9647789
p8	LOW	PAX7 PAX7 30,2867908 0
p8	LOW_NONE	PAX7 PAX7 30,5468845 30,42866135 21,79002857
p8	LOW_NONE	PAX7 PAX7 30,3104401 0
p8	HIGH	PAX7 PAX7 30,7951336 30,74588776 21,71085358
p8	HIGH	PAX7 PAX7 30,6966438 0
p8	HIGH_NONE	PAX7 PAX7 30,7934914 30,74292755 21,75614262
p8	HIGH_NONE	PAX7 PAX7 30,6923656 0
REF	SAMPLE	PAX7 PAX7 27,0594482 27,02383423 20,54599428
REF	SAMPLE	PAX7 PAX7 26,9882221 0
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Sample	Name Target	Name Cт Cт	Mean d-CT dd-CT
p6	PHMPM	MYOD1 MYOD1 27,4682522 27,38825607 18,77579307
p6	PHMPM	MYOD1 MYOD1 27,30826 0
p6	KOSR	10d	MYOD1 MYOD1 30,1453323 30,13360214 21,47214317
p6	KOSR	10d	MYOD1 MYOD1 30,121872 0
p6	LOW	MYOD1 MYOD1 30,8871498 30,82301712 22,29476166
p6	LOW	MYOD1 MYOD1 30,7588825 0
p6	LOW_NONE	MYOD1MYOD1 32,8171578 32,82540512 23,77075672
p6	LOW_NONE	MYOD1MYOD1 32,8336525 0
p6	HIGH	MYOD1 MYOD1 31,436285 31,38267517 22,73830986
p6	HIGH	MYOD1 MYOD1 31,3290653 0
p6	HIGH_NONE	MYOD1MYOD1 33,2808914 33,2918663 25,02423382
p6	HIGH_NONE	MYOD1MYOD1 33,3028412 0
p7	PHMPM	MYOD1 MYOD1 28,4715805 28,49882507 20,24106598
p7	PHMPM	MYOD1 MYOD1 28,5260677 0
p7	KOSR	10d	MYOD1 MYOD1 30,243248 30,12640953 21,44568539
p7	KOSR	10d	MYOD1 MYOD1 30,0095711 0
p7	LOW	MYOD1 MYOD1 33,4603806 33,44024658 24,72451019
p7	LOW	MYOD1 MYOD1 33,4201126 0
p7	LOW_NONE	MYOD1MYOD1 33,2185211 33,21387482 24,69532395
p7	LOW_NONE	MYOD1MYOD1 33,2092285 0
p7	HIGH	MYOD1 MYOD1 33,6420593 33,7011795 24,97814846
p7	HIGH	MYOD1 MYOD1 33,7602959 0
p7	HIGH_NONE	MYOD1MYOD1 33,8028565 33,78619385 24,99356079
p7	HIGH_NONE	MYOD1MYOD1 33,7695351 0
p8	PHMPM	MYOD1 MYOD1 29,8712292 29,79683685 21,0286541
p8	PHMPM	MYOD1 MYOD1 29,7224464 0
p8	KOSR	10d	MYOD1 MYOD1 31,8451462 31,91547394 23,02407265
p8	KOSR	10d	MYOD1 MYOD1 31,9858017 0
p8	LOW	MYOD1 MYOD1 34,3705254 34,30290222 25,9869461
p8	LOW	MYOD1 MYOD1 34,2352829 0
p8	LOW_NONE	MYOD1MYOD1 34,3722153 34,37202454 25,73339177
p8	LOW_NONE	MYOD1MYOD1 34,3718338 0
p8	HIGH	MYOD1 MYOD1 34,8150024 34,92114258 25,8861084
p8	HIGH	MYOD1 MYOD1 35,0272789 0
p8	HIGH_NONE	MYOD1MYOD1 34,608017 35,09883499 26,11205006
p8	HIGH_NONE	MYOD1MYOD1 35,589653 0
REF	SAMPLE	MYOD1 MYOD1 25,4151135 25,51413727 19,03629732
REF	SAMPLE	MYOD1 MYOD1 25,613163 0
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Sample	Name Target	Name Cт Cт	Mean d-CT dd-CT
p6	PHMPM	Myf-5 Myf-5 26,0779629 26,15283203 17,54036903
p6	PHMPM	Myf-5 Myf-5 26,2277031 0
p6	KOSR	10d	Myf-5 Myf-5 29,3336449 29,36709785 20,70563888
p6	KOSR	10d	Myf-5 Myf-5 29,4005508 0
p6	LOW	Myf-5 Myf-5 29,7430286 29,5751133 21,04685784
p6	LOW	Myf-5 Myf-5 29,407198 0
p6	LOW_NONE	Myf-5 Myf-5 30,1672173 30,29964066 21,24499226
p6	LOW_NONE	Myf-5 Myf-5 30,4320641 0
p6	HIGH	Myf-5 Myf-5 30,0943527 30,0308342 21,38646889
p6	HIGH	Myf-5 Myf-5 29,9673176 0
p6	HIGH_NONE	Myf-5 Myf-5 29,7203999 29,66209602 21,39446354
p6	HIGH_NONE	Myf-5 Myf-5 29,6037922 0
p7	PHMPM	Myf-5 Myf-5 27,0123425 27,00811768 18,75035859
p7	PHMPM	Myf-5 Myf-5 27,003891 0
p7	KOSR	10d	Myf-5 Myf-5 29,668047 29,66497421 20,98425007
p7	KOSR	10d	Myf-5 Myf-5 29,6618996 0
p7	LOW	Myf-5 Myf-5 30,2847138 30,2488327 21,53309631
p7	LOW	Myf-5 Myf-5 30,2129536 0
p7	LOW_NONE	Myf-5 Myf-5 30,4419212 30,45293045 21,93437958
p7	LOW_NONE	Myf-5 Myf-5 30,4639416 0
p7	HIGH	Myf-5 Myf-5 30,3009453 30,36258698 21,63955594
p7	HIGH	Myf-5 Myf-5 30,4242268 0
p7	HIGH_NONE	Myf-5 Myf-5 30,4585114 30,40871048 21,61607742
p7	HIGH_NONE	Myf-5 Myf-5 30,3589096 0
p8	PHMPM	Myf-5 Myf-5 27,7964802 27,8704319 19,10224915
p8	PHMPM	Myf-5 Myf-5 27,9443836 0
p8	KOSR	10d	Myf-5 Myf-5 30,4535961 30,6472702 21,75586891
p8	KOSR	10d	Myf-5 Myf-5 30,8409462 0
p8	LOW	Myf-5 Myf-5 30,7584705 30,83395004 22,51799392
p8	LOW	Myf-5 Myf-5 30,9094315 0
p8	LOW_NONE	Myf-5 Myf-5 30,9686184 30,92282295 22,28419018
p8	LOW_NONE	Myf-5 Myf-5 30,8770275 0
p8	HIGH	Myf-5 Myf-5 31,2158203 31,20685959 22,17182541
p8	HIGH	Myf-5 Myf-5 31,1979008 0
p8	HIGH_NONE	Myf-5 Myf-5 31,0086365 31,14938164 22,16259671
p8	HIGH_NONE	Myf-5 Myf-5 31,2901268 0
REF	SAMPLE	Myf-5 Myf-5 25,6949406 25,74334526 19,26550531
REF	SAMPLE	Myf-5 Myf-5 25,79175 0
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Sample	Name Target	Name Cт	Mean d-CT dd-CT 2^-(dd-CT)
p6	PHMPM	PAX7 PAX7 28,8005333 20,1880703 -0,357924 1,281580
p6	KOSR	10d	PAX7 PAX7 28,698679 20,03722 -0,5087743 1,422841
p6	LOW	PAX7 PAX7 29,6242828 21,09602737 0,55003309 0,683004
p6	LOW_NONE	PAX7 PAX7 30,0561867 21,00153828 0,45554399 0,729235
p6	HIGH	PAX7 PAX7 29,8227158 21,17835045 0,63235617 0,645122
p6	HIGH_NONE	PAX7 PAX7 29,3372498 21,06961727 0,52362299 0,695623
p7	PHMPM	PAX7 PAX7 29,9431419 21,68538284 1,13938856 0,453952
p7	KOSR	10d	PAX7 PAX7 29,192852 20,51212788 -0,0338664 1,023752
p7	LOW	PAX7 PAX7 29,6828213 20,96708488 0,4210906 0,746860
p7	LOW_NONE	PAX7 PAX7 29,4636421 20,94509125 0,39909697 0,758333
p7	HIGH	PAX7 PAX7 29,7241688 21,00113773 0,45514345 0,729438
p7	HIGH_NONE	PAX7 PAX7 29,9512558 21,15862274 0,61262846 0,654004
p8	PHMPM	PAX7 PAX7 31,1629372 22,39475441 1,84876013 0,277631
p8	KOSR	10d	PAX7 PAX7 30,3055191 21,41411781 0,86812353 0,547859
p8	LOW	PAX7 PAX7 30,280735 21,9647789 1,41878462 0,374027
p8	LOW_NONE	PAX7 PAX7 30,4286613 21,79002857 1,24403429 0,422190
p8	HIGH	PAX7 PAX7 30,7458878 21,71085358 1,16485929 0,446008
p8	HIGH_NONE	PAX7 PAX7 30,7429276 21,75614262 1,21014833 0,432224
REF	SAMPLE	PAX7 PAX7 27,0238342 20,54599428 0 1,000000
p6	PHMPM	MYOD1 MYOD1 27,3882561 18,77579307 -0,2605043 1,197897
p6	KOSR	10d	MYOD1 MYOD1 30,1336021 21,47214317 2,43584585 0,184815
p6	LOW	MYOD1 MYOD1 30,8230171 22,29476166 3,25846433 0,104497
p6	LOW_NONE	MYOD1 MYOD1 32,8254051 23,77075672 4,7344594 0,037565
p6	HIGH	MYOD1 MYOD1 31,3826752 22,73830986 3,70201254 0,076839
p6	HIGH_NONE	MYOD1 MYOD1 33,2918663 25,02423382 5,98793649 0,015756
p7	PHMPM	MYOD1 MYOD1 28,4988251 20,24106598 1,20476865 0,433839
p7	KOSR	10d	MYOD1 MYOD1 30,1264095 21,44568539 2,40938806 0,188236
p7	LOW	MYOD1 MYOD1 33,4402466 24,72451019 5,68821287 0,019394
p7	LOW_NONE	MYOD1 MYOD1 33,2138748 24,69532395 5,65902662 0,019791
p7	HIGH	MYOD1 MYOD1 33,7011795 24,97814846 5,94185113 0,016268
p7	HIGH_NONE	MYOD1 MYOD1 33,7861939 24,99356079 5,95726347 0,016095
p8	PHMPM	MYOD1 MYOD1 29,7968369 21,0286541 1,99235677 0,251328
p8	KOSR	10d	MYOD1 MYOD1 31,9154739 23,02407265 3,98777533 0,063032
p8	LOW	MYOD1 MYOD1 34,3029022 25,9869461 6,95064878 0,008084
p8	LOW_NONE	MYOD1 MYOD1 34,3720245 25,73339177 6,69709444 0,009638
p8	HIGH	MYOD1 MYOD1 34,9211426 25,8861084 6,84981108 0,008670
p8	HIGH_NONE	MYOD1 MYOD1 35,098835 26,11205006 7,07575273 0,007413
REF	SAMPLE	MYOD1 MYOD1 25,5141373 19,03629732 0 1,000000
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Sample	Name Target	Name Cт	Mean d-CT dd-CT 2^-(dd-CT)
p6	PHMPM	Myf-5 Myf-5 26,152832 17,54036903 -1,7251363 3,306114
p6	KOSR	10d	Myf-5 Myf-5 29,3670979 20,70563888 1,44013357 0,368533
p6	LOW	Myf-5 Myf-5 29,5751133 21,04685784 1,78135252 0,290911
p6	LOW_NONE	Myf-5 Myf-5 30,2996407 21,24499226 1,97948695 0,253580
p6	HIGH	Myf-5 Myf-5 30,0308342 21,38646889 2,12096358 0,229893
p6	HIGH_NONE	Myf-5 Myf-5 29,662096 21,39446354 2,12895822 0,228623
p7	PHMPM	Myf-5 Myf-5 27,0081177 18,75035859 -0,5151467 1,429139
p7	KOSR	10d	Myf-5 Myf-5 29,6649742 20,98425007 1,71874475 0,303813
p7	LOW	Myf-5 Myf-5 30,2488327 21,53309631 2,267591 0,207676
p7	LOW_NONE	Myf-5 Myf-5 30,4529305 21,93437958 2,66887426 0,157249
p7	HIGH	Myf-5 Myf-5 30,362587 21,63955594 2,37405062 0,192903
p7	HIGH_NONE	Myf-5 Myf-5 30,4087105 21,61607742 2,35057211 0,196068
p8	PHMPM	Myf-5 Myf-5 27,8704319 19,10224915 -0,1632562 1,119812
p8	KOSR	10d	Myf-5 Myf-5 30,6472702 21,75586891 2,4903636 0,177961
p8	LOW	Myf-5 Myf-5 30,83395 22,51799392 3,25248861 0,104931
p8	LOW_NONE	Myf-5 Myf-5 30,922823 22,28419018 3,01868486 0,123392
p8	HIGH	Myf-5 Myf-5 31,2068596 22,17182541 2,9063201 0,133386
p8	HIGH_NONE	Myf-5 Myf-5 31,1493816 22,16259671 2,89709139 0,134242
REF	SAMPLE	Myf-5 Myf-5 25,7433453 19,26550531 0 1,000000
PAX7 p6 p7 p8 AVERAGE STD	ERROR
PHMPM 1,2815804 0,45395193 0,277630865 0,6710544 0,309477
KOSR	10d 1,42284083 1,0237521 0,547858971 0,99815063 0,252910
LOW	48	h 0,68300446 0,74685982 0,374027274 0,60129719 0,115120
LOW	24	h 0,72923515 0,7583328 0,422190409 0,63658612 0,107526
HIGH	48	h 0,64512196 0,72943764 0,446007756 0,60685579 0,084026
HIGH	24	h 0,69562274 0,65400408 0,432224173 0,59395033 0,081751
MYOD p6 p7 p8 AVERAGE STD	ERROR
PHMPM 1,19789732 0,43383891 0,251327985 0,62768807 0,289932
KOSR	10d 0,18481505 0,18823567 0,063031844 0,14536085 0,041176
LOW	48	h 0,10449716 0,01939444 0,008084371 0,04399199 0,030428
LOW	24	h 0,0375652 0,01979079 0,009637706 0,02233123 0,008161
HIGH	48	h 0,07683926 0,01626764 0,008669647 0,03392552 0,021569
HIGH	24	h 0,0157562 0,01609478 0,007412867 0,01308795 0,002839
MYF-5 p6 p7 p8 AVERAGE STD	ERROR
PHMPM 3,30611356 1,42913948 1,119811707 1,95168825 0,683074
KOSR	10d 0,36853318 0,30381294 0,177961418 0,28343585 0,055949
LOW	48	h 0,29091054 0,20767637 0,104930893 0,2011726 0,053786
LOW	24	h 0,25358003 0,15724933 0,123391519 0,17807363 0,038998
HIGH	48	h 0,22989332 0,19290325 0,133386069 0,18539421 0,028111
HIGH	24	h 0,22862289 0,19606826 0,134242055 0,18631107 0,027679
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miRNA	RAW	DATA	ANALYSES:	
	
1st	run 2nd	run
Sample	Name Target	Name Cт Cт	Mean Sample	Name Target	Name Cт Cт	Mean
p6	PHMPM RNU6-2 24,5921669 24,4056454 p6	PHMPM RNU6-2 24,857214 24,698204
p6	PHMPM RNU6-2 24,338232 24,4056454 p6	PHMPM RNU6-2 24,6905651 24,698204
p6	PHMPM RNU6-2 24,286541 24,4056454 p6	PHMPM RNU6-2 24,546833 24,698204
p6	KOSR	10d RNU6-2 26,9150105 26,8502522 p6	KOSR	10d RNU6-2 27,0835934 27,0402756
p6	KOSR	10d RNU6-2 26,8220139 26,8502522 p6	KOSR	10d RNU6-2 26,9849224 27,0402756
p6	KOSR	10d RNU6-2 26,813736 26,8502522 p6	KOSR	10d RNU6-2 27,0523071 27,0402756
p6	LOW RNU6-2 24,9034119 24,7814255 p6	LOW RNU6-2 24,9423637 24,9613476
p6	LOW RNU6-2 24,6964665 24,7814255 p6	LOW RNU6-2 24,9784641 24,9613476
p6	LOW RNU6-2 24,7444 24,7814255 p6	LOW RNU6-2 24,963213 24,9613476
p6	LOW_NONE RNU6-2 24,7470818 24,9749451 p6	LOW_NONE RNU6-2 25,0459404 25,1852722
p6	LOW_NONE RNU6-2 24,9873409 24,9749451 p6	LOW_NONE RNU6-2 25,1287937 25,1852722
p6	LOW_NONE RNU6-2 25,1904125 24,9749451 p6	LOW_NONE RNU6-2 25,3810844 25,1852722
p6	HIGH RNU6-2 24,2060413 24,2229481 p6	HIGH RNU6-2 24,4602699 24,441864
p6	HIGH RNU6-2 24,261755 24,2229481 p6	HIGH RNU6-2 24,423542 24,441864
p6	HIGH RNU6-2 24,2010517 24,2229481 p6	HIGH RNU6-2 24,4417801 24,441864
p6	HIGH_NONE RNU6-2 24,3255577 24,2578335 p6	HIGH_NONE RNU6-2 24,5984287 24,6059647
p6	HIGH_NONE RNU6-2 24,1766396 24,2578335 p6	HIGH_NONE RNU6-2 24,5583706 24,6059647
p6	HIGH_NONE RNU6-2 24,2712994 24,2578335 p6	HIGH_NONE RNU6-2 24,6610985 24,6059647
REF	SAMPLE RNU6-2 22,4629707 22,2869816 REF	SAMPLE RNU6-2 22,8259792 22,8765545
REF	SAMPLE RNU6-2 22,2572212 22,2869816 REF	SAMPLE RNU6-2 22,8807011 22,8765545
REF	SAMPLE RNU6-2 22,1407566 22,2869816 REF	SAMPLE RNU6-2 22,9229832 22,8765545
p7	PHMPM RNU6-2 23,8931637 24,0380878 p7	PHMPM RNU6-2 24,5478439 24,6157074
p7	PHMPM RNU6-2 23,9579125 24,0380878 p7	PHMPM RNU6-2 24,7624207 24,6157074
p7	PHMPM RNU6-2 24,2631893 24,0380878 p7	PHMPM RNU6-2 24,5368595 24,6157074
p7	KOSR	10d RNU6-2 28,0066567 28,1181583 p7	KOSR	10d RNU6-2 28,4711933 28,4277477
p7	KOSR	10d RNU6-2 28,1634884 28,1181583 p7	KOSR	10d RNU6-2 28,3557701 28,4277477
p7	KOSR	10d RNU6-2 28,1843319 28,1181583 p7	KOSR	10d RNU6-2 28,4562798 28,4277477
p7	LOW RNU6-2 24,104229 24,2130127 p7	LOW RNU6-2 24,6528454 24,720541
p7	LOW RNU6-2 24,3560581 24,2130127 p7	LOW RNU6-2 24,6198292 24,720541
p7	LOW RNU6-2 24,1787472 24,2130127 p7	LOW RNU6-2 24,8889427 24,720541
p7	LOW_NONE RNU6-2 23,8200283 23,8756733 p7	LOW_NONE RNU6-2 24,4984741 24,3403835
p7	LOW_NONE RNU6-2 23,8481941 23,8756733 p7	LOW_NONE RNU6-2 24,2608376 24,3403835
p7	LOW_NONE RNU6-2 23,9588013 23,8756733 p7	LOW_NONE RNU6-2 24,2618389 24,3403835
p7	HIGH RNU6-2 24,073822 24,0236607 p7	HIGH RNU6-2 24,5939102 24,5433178
p7	HIGH RNU6-2 24,1752052 24,0236607 p7	HIGH RNU6-2 24,5406761 24,5433178
p7	HIGH RNU6-2 23,8219528 24,0236607 p7	HIGH RNU6-2 24,4953651 24,5433178
p7	HIGH_NONE RNU6-2 23,7005291 23,8521137 p7	HIGH_NONE RNU6-2 24,4463024 24,3605175
p7	HIGH_NONE RNU6-2 23,9174347 23,8521137 p7	HIGH_NONE RNU6-2 24,3614044 24,3605175
p7	HIGH_NONE RNU6-2 23,9383812 23,8521137 p7	HIGH_NONE RNU6-2 24,2738457 24,3605175
REF	SAMPLE RNU6-2 22,4629707 22,2869816 REF	SAMPLE RNU6-2 22,927824 22,9145508
REF	SAMPLE RNU6-2 22,2572212 22,2869816 REF	SAMPLE RNU6-2 22,8432674 22,9145508
REF	SAMPLE RNU6-2 22,1407566 22,2869816 REF	SAMPLE RNU6-2 22,9725609 22,9145508
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1st	run 2nd	run
Sample	Name Target	Name Cт Cт	Mean Sample	Name Target	Name Cт Cт	Mean
p8	PHMPM RNU6-2 23,9224606 23,89534 p8	PHMPM RNU6-2 24,3377457 24,3361054
p8	PHMPM RNU6-2 23,8960819 23,89534 p8	PHMPM RNU6-2 24,3580647 24,3361054
p8	PHMPM RNU6-2 23,8674755 23,89534 p8	PHMPM RNU6-2 24,3125095 24,3361054
p8	KOSR	10d RNU6-2 24,4841366 24,2980785 p8	KOSR	10d RNU6-2 24,6734257 24,6950665
p8	KOSR	10d RNU6-2 24,171196 24,2980785 p8	KOSR	10d RNU6-2 24,723732 24,6950665
p8	KOSR	10d RNU6-2 24,2389031 24,2980785 p8	KOSR	10d RNU6-2 24,6880417 24,6950665
p8	LOW RNU6-2 24,6020927 24,7271729 p8	LOW RNU6-2 25,2119808 25,2115173
p8	LOW RNU6-2 24,6568375 24,7271729 p8	LOW RNU6-2 25,2087803 25,2115173
p8	LOW RNU6-2 24,9225941 24,7271729 p8	LOW RNU6-2 25,2137871 25,2115173
p8	LOW_NONE RNU6-2 28,9267502 28,9488297 p8	LOW_NONE RNU6-2 29,46628 29,4182968
p8	LOW_NONE RNU6-2 28,9525509 28,9488297 p8	LOW_NONE RNU6-2 29,2576599 29,4182968
p8	LOW_NONE RNU6-2 28,9671879 28,9488297 p8	LOW_NONE RNU6-2 29,5309486 29,4182968
p8	HIGH RNU6-2 24,2893086 24,2197781 p8	HIGH RNU6-2 24,8090477 24,8928776
p8	HIGH RNU6-2 24,1876183 24,2197781 p8	HIGH RNU6-2 25,0256786 24,8928776
p8	HIGH RNU6-2 24,1824074 24,2197781 p8	HIGH RNU6-2 24,8439064 24,8928776
p8	HIGH_NONE RNU6-2 24,1960125 24,3511028 p8	HIGH_NONE RNU6-2 24,8772488 25,0181427
p8	HIGH_NONE RNU6-2 24,548851 24,3511028 p8	HIGH_NONE RNU6-2 24,9008064 25,0181427
p8	HIGH_NONE RNU6-2 24,3084412 24,3511028 p8	HIGH_NONE RNU6-2 25,276371 25,0181427
REF	SAMPLE RNU6-2 22,4629707 22,2869816 REF	SAMPLE RNU6-2 22,7208328 22,8781834
REF	SAMPLE RNU6-2 22,2572212 22,2869816 REF	SAMPLE RNU6-2 22,9911614 22,8781834
REF	SAMPLE RNU6-2 22,1407566 22,2869816 REF	SAMPLE RNU6-2 22,9225617 22,8781834
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1st	run
Sample	Name Target	Name Cт Cт	Mean d-Cт dd-Cт 2^-(ddCт)
p6	PHMPM miR-31 24,1884842 24,2938976 -0,111747742 -0,8603344 1,81545906
p6	PHMPM miR-31 24,4141579 24,2938976 -0,111747742 -0,8603344
p6	PHMPM miR-31 24,279047 24,2938976 -0,111747742 -0,8603344
p6	KOSR	10d miR-31 26,8979416 26,7452717 -0,104980469 -0,85356712 1,8069632
p6	KOSR	10d miR-31 26,7111378 26,7452717 -0,104980469 -0,85356712
p6	KOSR	10d miR-31 26,6267376 26,7452717 -0,104980469 -0,85356712
p6	LOW miR-31 24,8188343 24,7619114 -0,019514084 -0,76810074 1,70302633
p6	LOW miR-31 24,6420479 24,7619114 -0,019514084 -0,76810074
p6	LOW miR-31 24,8248577 24,7619114 -0,019514084 -0,76810074
p6	LOW_NONE miR-31 24,8091888 24,9079285 -0,067016602 -0,81560326 1,76003395
p6	LOW_NONE miR-31 24,8755455 24,9079285 -0,067016602 -0,81560326
p6	LOW_NONE miR-31 25,0390511 24,9079285 -0,067016602 -0,81560326
p6	HIGH miR-31 24,4066696 24,3904877 0,167539597 -0,58104706 1,49593455
p6	HIGH miR-31 24,418541 24,3904877 0,167539597 -0,58104706
p6	HIGH miR-31 24,3462563 24,3904877 0,167539597 -0,58104706
p6	HIGH_NONE miR-31 24,226759 24,24543 -0,012403488 -0,76099014 1,69465329
p6	HIGH_NONE miR-31 24,1287365 24,24543 -0,012403488 -0,76099014
p6	HIGH_NONE miR-31 24,3807945 24,24543 -0,012403488 -0,76099014
REF	SAMPLE miR-31 23,1448402 23,0355682 0,748586655 0 1
REF	SAMPLE miR-31 23,0124664 23,0355682 0,748586655 0
REF	SAMPLE miR-31 22,9494 23,0355682 0,748586655 0
p7	PHMPM miR-31 23,9579716 23,9745846 -0,063503265 -0,81208992 1,75575302
p7	PHMPM miR-31 23,8890781 23,9745846 -0,063503265 -0,81208992
p7	PHMPM miR-31 24,076704 23,9745846 -0,063503265 -0,81208992
p7	KOSR	10d miR-31 25,4964752 25,4152222 -2,702936172 -3,45152283 10,9398635
p7	KOSR	10d miR-31 25,3287087 25,4152222 -2,702936172 -3,45152283
p7	KOSR	10d miR-31 25,4204865 25,4152222 -2,702936172 -3,45152283
p7	LOW miR-31 24,1005535 24,3867626 0,173749924 -0,57483673 1,48950889
p7	LOW miR-31 24,9171886 24,3867626 0,173749924 -0,57483673
p7	LOW miR-31 24,14254 24,3867626 0,173749924 -0,57483673
p7	LOW_NONE miR-31 23,8717899 23,9246883 0,049015045 -0,69957161 1,62402249
p7	LOW_NONE miR-31 23,8757362 23,9246883 0,049015045 -0,69957161
p7	LOW_NONE miR-31 24,0265369 23,9246883 0,049015045 -0,69957161
p7	HIGH miR-31 24,009594 23,9957581 -0,027902603 -0,77648926 1,71295738
p7	HIGH miR-31 24,0118237 23,9957581 -0,027902603 -0,77648926
p7	HIGH miR-31 23,9658546 23,9957581 -0,027902603 -0,77648926
p7	HIGH_NONE miR-31 24,0038815 23,9414444 0,089330673 -0,65925598 1,57926796
p7	HIGH_NONE miR-31 23,9465218 23,9414444 0,089330673 -0,65925598
p7	HIGH_NONE miR-31 23,8739281 23,9414444 0,089330673 -0,65925598
REF	SAMPLE miR-31 23,1448402 23,0355682 0,748586655 0 1
REF	SAMPLE miR-31 23,0124664 23,0355682 0,748586655 0
REF	SAMPLE miR-31 22,9494 23,0355682 0,748586655 0
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Sample	Name Target	Name Cт Cт	Mean d-Cт dd-Cт 2^-(ddCт)
p8	PHMPM miR-31 24,1070995 24,1648693 0,269529343 -0,47905731 1,39383261
p8	PHMPM miR-31 24,3256416 24,1648693 0,269529343 -0,47905731
p8	PHMPM miR-31 24,0618668 24,1648693 0,269529343 -0,47905731
p8	KOSR	10d miR-31 24,0347767 24,1451283 -0,152950287 -0,90153694 1,86805501
p8	KOSR	10d miR-31 24,221632 24,1451283 -0,152950287 -0,90153694
p8	KOSR	10d miR-31 24,1789818 24,1451283 -0,152950287 -0,90153694
p8	LOW miR-31 23,6792259 23,7552643 -0,971908569 -1,72049522 3,2954951
p8	LOW miR-31 23,8420219 23,7552643 -0,971908569 -1,72049522
p8	LOW miR-31 23,7445488 23,7552643 -0,971908569 -1,72049522
p8	LOW_NONE miR-31 26,0049763 26,1584377 -2,790391922 -3,53897858 11,6235478
p8	LOW_NONE miR-31 26,1659889 26,1584377 -2,790391922 -3,53897858
p8	LOW_NONE miR-31 26,3043461 26,1584377 -2,790391922 -3,53897858
p8	HIGH miR-31 24,2007351 24,1051941 -0,114583969 -0,86317062 1,81903162
p8	HIGH miR-31 24,0225487 24,1051941 -0,114583969 -0,86317062
p8	HIGH miR-31 24,0922985 24,1051941 -0,114583969 -0,86317062
p8	HIGH_NONE miR-31 24,0795956 24,0637837 -0,287319183 -1,03590584 2,05040065
p8	HIGH_NONE miR-31 24,1475315 24,0637837 -0,287319183 -1,03590584
p8	HIGH_NONE miR-31 23,9642239 24,0637837 -0,287319183 -1,03590584
REF	SAMPLE miR-31 23,1448402 23,0355682 0,748586655 0 1
REF	SAMPLE miR-31 23,0124664 23,0355682 0,748586655 0
REF	SAMPLE miR-31 22,9494 23,0355682 0,748586655 0
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2nd	run
Sample	Name Target	Name Cт Cт	Mean d-Cт dd-Cт 2^-(ddCт)
p6	PHMPM miR-31 24,6193543 24,6062527 -0,09195137 -0,62842178 1,54587298
p6	PHMPM miR-31 24,6604614 24,6062527
p6	PHMPM miR-31 24,5389404 24,6062527
p6	KOSR	10d miR-31 26,9604607 26,9429226 -0,097352982 -0,6338234 1,55167175
p6	KOSR	10d miR-31 26,9310684 26,9429226
p6	KOSR	10d miR-31 26,9372311 26,9429226
p6	LOW miR-31 25,0256081 25,068924 0,10757637 -0,42889404 1,3462012
p6	LOW miR-31 25,1117268 25,068924
p6	LOW miR-31 25,0694313 25,068924
p6	LOW_NONE miR-31 25,1688023 25,2415142 0,056241989 -0,48022842 1,39496452
p6	LOW_NONE miR-31 25,1470547 25,2415142
p6	LOW_NONE miR-31 25,4086876 25,2415142
p6	HIGH miR-31 24,6201935 24,6745472 0,232683182 -0,30378723 1,23438055
p6	HIGH miR-31 24,7494221 24,6745472
p6	HIGH miR-31 24,6540299 24,6745472
p6	HIGH_NONE miR-31 24,6381035 24,6853085 0,079343796 -0,45712662 1,37280491
p6	HIGH_NONE miR-31 24,7427559 24,6853085
p6	HIGH_NONE miR-31 24,6750679 24,6853085
REF	SAMPLE miR-31 23,4882698 23,4130249 0,536470413 0 1
REF	SAMPLE miR-31 23,435318 23,4130249
REF	SAMPLE miR-31 23,3154888 23,4130249
p7	PHMPM miR-31 24,634367 24,4990368 -0,116670609 -0,64296722 1,56153751
p7	PHMPM miR-31 24,4011135 24,4990368
p7	PHMPM miR-31 24,4616242 24,4990368
p7	KOSR	10d miR-31 25,9288044 25,8265457 -2,601202011 -3,12749863 8,7391843
p7	KOSR	10d miR-31 25,7658711 25,8265457
p7	KOSR	10d miR-31 25,7849636 25,8265457
p7	LOW miR-31 24,583519 24,5346909 -0,185850143 -0,71214676 1,63824004
p7	LOW miR-31 24,4737034 24,5346909
p7	LOW miR-31 24,5468483 24,5346909
p7	LOW_NONE miR-31 24,4379482 24,4459133 0,105529785 -0,42076683 1,33863889
p7	LOW_NONE miR-31 24,3915386 24,4459133
p7	LOW_NONE miR-31 24,5082493 24,4459133
p7	HIGH miR-31 24,4740677 24,4307385 -0,112579346 -0,63887596 1,5571155
p7	HIGH miR-31 24,3962555 24,4307385
p7	HIGH miR-31 24,4218884 24,4307385
p7	HIGH_NONE miR-31 24,3626576 24,4406261 0,080108643 -0,44618797 1,36243554
p7	HIGH_NONE miR-31 24,644392 24,4406261
p7	HIGH_NONE miR-31 24,3148308 24,4406261
REF	SAMPLE miR-31 23,4418049 23,4408474 0,526296616 0 1
REF	SAMPLE miR-31 23,4593468 23,4408474
REF	SAMPLE miR-31 23,4213867 23,4408474
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2nd	run
Sample	Name Target	Name Cт Cт	Mean d-Cт dd-Cт 2^-(ddCт)
p8	PHMPM miR-31 24,728447 24,7789364 0,44283104 -0,19062615 1,14125893
p8	PHMPM miR-31 24,909935 24,7789364
p8	PHMPM miR-31 24,6984272 24,7789364
p8	KOSR	10d miR-31 24,7451553 24,6203461 -0,07472038 -0,70817757 1,63373905
p8	KOSR	10d miR-31 24,556488 24,6203461
p8	KOSR	10d miR-31 24,559391 24,6203461
p8	LOW miR-31 24,3614712 24,243166 -0,96835136 -1,60180855 3,03523569
p8	LOW miR-31 24,194828 24,243166
p8	LOW miR-31 24,1732025 24,243166
p8	LOW_NONE miR-31 26,6289711 26,6332188 -2,78507804 -3,41853523 10,6925588
p8	LOW_NONE miR-31 26,5361767 26,6332188
p8	LOW_NONE miR-31 26,7345142 26,6332188
p8	HIGH miR-31 24,5286331 24,4864979 -0,4063797 -1,03983689 2,05599519
p8	HIGH miR-31 24,4990959 24,4864979
p8	HIGH miR-31 24,4317646 24,4864979
p8	HIGH_NONE miR-31 24,3379154 24,3878765 -0,63026619 -1,26372338 2,40114642
p8	HIGH_NONE miR-31 24,4456024 24,3878765
p8	HIGH_NONE miR-31 24,3801079 24,3878765
REF	SAMPLE miR-31 23,4711781 23,5116406 0,63345719 0 1
REF	SAMPLE miR-31 23,6033688 23,5116406
REF	SAMPLE miR-31 23,4603729 23,5116406
1st	run PHMPM KOSR	10	d LOW	48	hr LOW	24	hr HIGH	48	hr HIGH	24	hr
p6 1,81545906 1,8069632 1,70302633 1,760033948 1,495934552 1,69465329
p7 1,75575302 10,9398635 1,48950889 1,624022488 1,712957382 1,57926796
p8 1,39383261 1,86805501 3,2954951 11,62354779 1,819031623 2,05040065
2nd	run PHMPM KOSR	10	d LOW	48	hr LOW	24	hr HIGH	48	hr HIGH	24	hr
p6 1,54587298 1,55167175 1,3462012 1,394964516 1,234380547 1,37280491
p7 1,56153751 8,7391843 1,63824004 1,338638888 1,5571155 1,36243554
p8 1,14125893 1,63373905 3,03523569 10,69255876 2,055995191 2,40114642
miR-31 p6 p7 p8 AVERAGE STD	ERROR
PHMPM 1,68066602 1,65864527 1,26754577 1,535619019 0,13418728
KOSR	10	d 1,67931747 9,83952388 1,75089703 4,423246129 2,708217704
LOW	48	h 1,52461376 1,56387446 3,1653654 2,084617873 0,540492601
LOW	24	h 1,57749923 1,48133069 11,1580533 4,738961065 3,209666166
HIGH	48	h 1,36515755 1,63503644 1,93751341 1,645902466 0,165314206
HIGH	24	h 1,5337291 1,47085175 2,22577353 1,743451461 0,241843149
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APPENDIX	K	- PHM	10	DAY	CULTURE	IN	QUIESCENCE	MEDIA	EXTRA	DATA	
Figure	K.1:	Day	0	(PHM-PM	control)	PHM	samples.	
Multicolour	 flow	 cytometry	 data	 depicting	 the	 numerical	 results	 for	 the	 entire	 satellite	 cell	 population	
analysed.	Only	live	satellite	cells	were	used	for	marker	analyses.	
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Figure	K.2:	Day	3	PHM	samples.	
Multicolour	 flow	 cytometry	 data	 depicting	 the	 numerical	 results	 for	 the	 entire	 satellite	 cell	 population	
analysed.	Only	live	satellite	cells	were	used	for	marker	analyses.	
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Figure	K.3:	Day	5	PHM	samples.	
Multicolour	 flow	 cytometry	 data	 depicting	 the	 numerical	 results	 for	 the	 entire	 satellite	 cell	 population	
analysed.	Only	live	satellite	cells	were	used	for	marker	analyses.	
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Figure	K.4:	Day	7	PHM	samples.	
Multicolour	 flow	 cytometry	 data	 depicting	 the	 numerical	 results	 for	 the	 entire	 satellite	 cell	 population	
analysed.	Only	live	satellite	cells	were	used	for	marker	analyses.	
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Figure	K.5:	Day	10	PHM	samples.	
Multicolour	 flow	 cytometry	 data	 depicting	 the	 numerical	 results	 for	 the	 entire	 satellite	 cell	 population	
analysed.	Only	live	satellite	cells	were	used	for	marker	analyses.	
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APPENDIX	L	- CELL	CYCLE	ANALYSES	OF	PHMS	CULTURED	IN	KO-DMEM/20%
KOSR	FOR	10	DAYS
Figure	L.1:	Cell	cycle	analyses	of	PHMs	cultured	in	KO-DMEM/20%	KOSR	for	10	days.	
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